Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003434	pf-prot	g/l (g/l)	4292	6146	0.13%
3003434	pf-prot	— (—)	661	782	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1438

3134

3.22

321.05

1.5

1.4

30.71

34.07

g/l

15.25

1265

2850

Implicit Sepsis

1228

2702

3.50

319.65

1.5

1.4

29.41

34.83

g/l

32.42

1065

2464

Septicaemia

883

2031

4.19

314.01

1.6

1.4

29.05

33.38

g/l

15.83

774

1830

Asthma (mode)

565

366

8.35

309.81

1.5

1.2

32.56

25.79

g/l

14.83

524

295

Non-small cell lung cancer, adenocarcinoma

297

239

14.02

308.78

1.4

1.5

39.16

27.74

g/l

25.31

281

211

Heart failure and antihypertensive medication

640

485

9.02

307.65

1.6

1.3

27.50

38.42

g/l

49.40

556

452

Pleural effusion

2263

454

73.91

307.65

1.7

1.2

36.10

27.75

g/l

31.44

2138

366

COPD differential diagnosis

921

366

12.80

307.65

1.5

1.2

34.17

25.79

g/l

24.07

842

295

Heart failure, not strict

1579

1757

6.31

307.65

1.6

1.3

29.21

38.38

g/l

100.82

1385

1652

1651

1807

5.66

307.65

1.5

1.4

33.38

33.69

g/l

0.33

1496

1646

Malignant neoplasm of bronchus and lung, including Hilmo

733

878

7.45

307.65

1.4

1.5

38.39

29.00

g/l

54.56

689

768

Bacterial infection, other or unspecified

1245

2281

4.90

307.65

1.6

1.4

31.35

33.70

g/l

7.09

1119

2058

Malignant neoplasm of respiratory system and intrathoracic organs

841

858

8.82

307.65

1.5

38.63

29.05

g/l

58.64

792

750

Dyspnoea

1577

3032

3.93

307.65

1.6

1.4

32.24

33.30

g/l

2.10

1436

2710

Oxycodone

902

1817

4.65

307.65

1.5

1.4

35.85

31.61

g/l

16.25

844

1609

Asthma, unspecified (mode), excluding more controls

511

144

26.96

307.65

1.5

1.1

32.96

29.55

g/l

2.10

464

126

Later onset COPD, excluding more controls

422

246

13.80

307.65

1.5

1.2

31.79

24.38

g/l

13.82

373

192

Asthma, unspecified (mode)

541

359

11.52

307.65

1.5

1.2

32.86

25.80

g/l

15.47

488

290

Influenza and pneumonia

1816

2088

5.65

307.65

1.5

1.4

33.25

34.03

g/l

1.24

1635

1906

Non-small cell lung cancer, including Hilmo

578

697

8.41

307.65

1.4

1.5

38.94

28.60

g/l

51.82

544

601

Persons encountering health services for specific procedures and health care

1494

2497

3.64

307.65

1.5

1.4

33.03

33.55

g/l

0.66

1351

2237

Bacterial infection, other or unspecified

1307

2306

4.95

307.65

1.5

1.4

31.58

33.82

g/l

6.67

1176

2084

Heart failure and coronary heart disease

1075

1942

4.08

307.65

1.6

1.4

25.95

34.43

g/l

68.76

912

1776

Abnormal findings on diagnostic imaging of lung

1085

2729

3.94

307.65

1.5

1.4

34.70

31.78

g/l

10.27

999

2432

Suppurative and necrotic conditions of lower respiratory tract

479

276

21.90

307.65

1.6

1.5

37.00

31.56

g/l

8.09

446

249

Other medical care

1224

1981

5.80

307.65

1.5

1.4

34.71

32.65

g/l

5.28

1146

1768

Other bacterial diseases

1610

2664

4.15

307.65

1.5

1.4

31.39

34.42

g/l

13.09

1443

2409

All pneumoniae

1855

2143

5.93

307.65

1.5

1.4

33.20

33.89

g/l

1.03

1672

1949

Implicit bacterial Sepsis

985

2168

4.05

307.65

1.6

1.4

28.96

34.13

g/l

25.02

856

1968

Lung cancer and mesothelioma

872

212

38.69

307.65

1.5

1.2

38.62

24.77

g/l

40.77

824

167

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1651

1807

5.66

307.65

1.5

1.4

33.38

33.69

g/l

0.33

1496

1646

All chronic kidney diseases

1085

2282

4.00

307.65

1.6

1.4

27.45

34.34

g/l

45.83

933

2094

Asthma

615

364

8.95

307.65

1.5

1.2

32.74

25.80

g/l

15.79

565

294

Implicit bacterial Sepsis

945

2073

4.18

307.65

1.6

1.4

28.79

34.00

g/l

24.39

825

1883

Pneumonias (Asthma/COPD co-morbidities)

1853

2148

5.93

307.65

1.5

1.4

33.22

33.90

g/l

1.01

1669

1952

ILD differential diagnosis

921

366

12.80

307.65

1.5

1.2

34.17

25.79

g/l

24.07

842

295

Heart failure,strict

1439

1428

7.45

307.65

1.6

1.3

27.28

38.15

g/l

125.88

1239

1340

Other diseases of pleura

3025

1195

25.41

307.65

1.6

1.2

35.07

27.83

g/l

57.46

2836

981

Non-ischemic cardiomyopathy

782

1141

5.77

307.65

1.6

1.4

28.10

37.28

g/l

59.69

676

1065

Other pleural conditions

1266

293

60.31

307.65

1.8

1.2

35.27

26.64

g/l

22.09

1189

245

Pyothorax

438

225

26.07

307.65

1.6

1.5

37.26

30.78

g/l

10.26

408

201

Heart failure and bmi 25plus

770

976

5.54

307.65

1.6

1.4

28.02

37.86

g/l

61.97

668

906

COPD (mode)

570

296

15.64

307.65

1.4

1.2

33.26

25.22

g/l

18.00

502

233

Asthma, excluding more controls

580

145

21.09

307.65

1.5

1.1

32.88

29.65

g/l

1.96

532

127

Other pulmonary diagnosis

942

366

13.10

307.65

1.5

1.2

34.13

25.84

g/l

23.75

863

295

All-cause Heart Failure

1541

1933

5.88

307.65

1.6

1.4

27.13

37.05

g/l

121.96

1324

1794

Pneumonia, organism unspecified

1775

2068

6.18

307.65

1.5

1.4

32.98

34.02

g/l

1.90

1603

1889

Excluding asthma or asthma-COPD overlap

927

366

12.89

307.65

1.5

1.2

34.12

25.84

g/l

23.58

846

295

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1847

2186

5.91

307.65

1.5

1.4

33.18

33.81

g/l

0.93

1664

1985

Heart failure, strict

1587

1965

5.96

307.65

1.6

1.4

27.12

37.02

g/l

124.47

1363

1823

Bacterial Sepsis

1051

2193

4.23

307.65

1.6

1.4

29.14

34.20

g/l

24.97

915

1991

Any death

1580

1730

6.84

307.65

1.5

1.4

33.08

33.99

g/l

1.40

1419

1569

Asthma (only as main-diagnosis), excluding more controls

494

145

19.68

307.65

1.5

1.1

32.46

29.65

g/l

1.56

454

127

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1239

3161

3.60

307.65

1.5

1.4

34.37

32.15

g/l

6.94

1139

2821

Malignant neoplasm of bronchus and lung

647

766

7.49

307.65

1.4

1.5

38.49

28.75

g/l

52.15

609

665

Renal failure

1148

2550

4.13

307.65

1.6

1.4

26.97

33.73

g/l

49.59

976

2318

Other bacterial diseases

1558

2527

3.98

307.65

1.5

1.4

31.97

34.45

g/l

8.74

1398

2291

Non-small cell lung cancer

416

476

9.43

307.65

1.4

1.5

38.69

27.92

g/l

40.32

392

417

Renal tubulo-interstitial diseases

1425

2925

3.70

307.65

1.5

1.4

29.52

34.66

g/l

33.67

1234

2689

Diseases of the respiratory system

669

368

9.23

307.65

1.5

1.2

33.64

27.60

g/l

12.32

607

303

Asthma (only as main-diagnosis)

528

364

8.48

306.47

1.5

1.2

32.36

25.80

g/l

13.85

481

294

Explicit Sepsis

896

2134

4.03

302.87

1.6

1.4

29.09

34.15

g/l

21.94

785

1941

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

194

38.55

299.19

1.8

1.5

40.13

26.63

g/l

12.66

185

Other heart diseases, wide

1001

1574

3.94

287.96

1.5

1.3

31.18

38.61

g/l

46.58

898

1478

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

546

975

5.77

286.65

1.3

1.5

37.23

29.47

g/l

32.93

512

854

All kidney diseases

1316

2880

3.17

286.60

1.5

1.4

30.33

34.96

g/l

25.34

1144

2653

Abnormalities of breathing

1171

1949

3.54

285.54

1.6

1.4

33.23

33.87

g/l

0.72

1055

1752

Bacterial pneumoniae

725

1433

4.58

284.39

1.5

1.4

32.17

33.20

g/l

1.13

634

1307

Implicit Sepsis

1208

2741

3.28

282.69

1.5

1.4

29.60

34.99

g/l

31.96

1048

2507

Other heart diseases

530

510

6.89

280.55

1.5

1.3

31.63

39.63

g/l

25.03

467

474

Chronic kidney disease

783

1929

4.15

275.60

1.7

1.4

26.09

33.15

g/l

38.32

667

1746

Bacterial pneumonia, not elsewhere classified

697

1382

4.56

271.96

1.5

1.4

32.07

33.12

g/l

1.14

611

1259

Dialysis, with operation codes

397

554

7.66

271.56

1.7

1.4

26.17

33.96

g/l

19.25

339

505

Other septicaemia

786

1912

4.08

271.38

1.6

1.4

28.68

33.22

g/l

15.89

694

1726

Acute renal failure

595

1232

5.07

270.06

1.7

1.4

27.06

33.37

g/l

22.73

509

1104

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

445

716

6.52

265.07

1.3

1.5

38.34

29.10

g/l

32.51

416

623

Valvular heart disease excluding rheumatic fever

735

1207

4.50

263.76

1.6

1.3

28.38

38.33

g/l

65.89

648

1127

Non-rheumatic valve diseases

734

1205

4.50

263.22

1.6

1.3

28.29

38.32

g/l

66.81

648

1126

Early onset COPD, excluding more controls

248

194

13.07

257.93

1.4

1.2

35.63

26.83

g/l

12.31

218

156

Anaemias

245

23.23

248.11

1.6

1.4

31.16

41.22

g/l

7.77

217

Nephropathy related operations

385

577

7.14

246.84

1.7

1.4

26.08

33.21

g/l

15.83

330

523

Liquid cancers, helper endpoint

656

1329

4.42

245.57

1.5

32.29

29.82

g/l

4.44

601

1160

Malignant neoplasm

1007

1738

3.47

241.01

1.4

1.5

35.39

30.80

g/l

18.34

937

1524

COPD/asthma/ILD related infections

1165

1807

3.27

239.46

1.5

1.4

33.15

33.69

g/l

0.60

1053

1646

COPD/asthma related infections

1165

1807

3.27

239.46

1.5

1.4

33.15

33.69

g/l

0.60

1053

1646

Condition for Implicit Sepsis (Organ dysfunction codes)

1153

2708

3.05

238.21

1.5

1.4

29.78

35.14

g/l

30.33

998

2484

Malignant neoplasm of mesothelium and soft tissue

198

132

17.08

229.47

1.8

1.5

38.49

27.29

g/l

15.02

187

117

Non-small cell lung cancer, adenocarcinoma, helper endpoint

297

364

9.16

229.41

1.4

1.5

39.16

31.41

g/l

16.50

281

331

Malignant neoplasm, wide definition for exclusion

995

1755

3.37

226.89

1.4

1.5

35.10

30.93

g/l

15.10

922

1540

Atrial fibrillation and flutter

430

423

6.73

221.91

1.6

1.3

30.16

39.14

g/l

27.21

390

391

Condition for Implicit Sepsis (Organ dysfunction codes)

1114

2618

2.97

219.22

1.5

1.4

30.33

35.39

g/l

26.55

966

2410

Solid cancers, helper endpoint

961

1726

3.33

216.07

1.4

1.5

35.57

30.81

g/l

19.24

890

1514

Care involving dialysis

252

278

9.74

209.58

1.7

1.4

24.48

32.63

g/l

12.08

214

251

Fever of other and unknown origin

821

2248

3.31

206.47

1.5

1.4

32.30

33.95

g/l

2.94

754

2023

Any event in cancer register

1006

1918

3.12

205.00

1.4

1.5

35.13

31.30

g/l

13.50

931

1695

Atrial fibrillation and flutter with reimbursement

383

370

6.74

195.82

1.5

1.3

29.67

38.96

g/l

26.55

344

342

GASTRO-related operations

742

978

3.84

191.49

1.5

1.4

32.65

33.25

g/l

0.47

671

876

Any gastric operation

742

978

3.84

191.49

1.5

1.4

32.65

33.25

g/l

0.47

671

876

Cardiomyopathy

341

583

6.06

190.56

1.6

1.3

26.87

38.19

g/l

37.51

283

544

Pneumothorax

188

163

12.25

184.77

1.7

1.2

34.02

27.03

g/l

6.51

174

137

Erysipelas

925

2468

2.90

179.65

1.5

1.4

30.78

34.31

g/l

11.84

821

2235

Diseases of arteries, arterioles and capillaries (FINNGEN)

336

361

6.59

175.70

1.6

1.3

29.68

38.98

g/l

21.31

301

332

First line medication for Crohn's disease

1244

2652

2.56

173.50

1.5

1.4

33.77

32.66

g/l

1.94

1133

2363

Non-invasive ventilation

321

502

5.83

167.00

1.5

1.3

29.44

39.06

g/l

24.75

292

474

Aplastic and other anaemias

831

2797

2.83

160.73

1.5

29.65

32.56

g/l

8.02

733

2510

Continuous positive airway pressure

306

440

6.01

159.92

1.5

1.3

30.48

39.03

g/l

17.64

245

412

Bacterial pneumonia (organism specified)

769

2416

2.95

159.31

1.5

32.32

32.46

g/l

0.10

678

2161

Respiratory insufficiency

142

14.98

158.74

1.6

1.3

31.76

23.70

g/l

7.90

133

Non-allergic asthma (mode), excluding more controls

123

19.25

156.48

1.6

1.1

31.32

29.43

g/l

0.45

111

Cardiac arrhythmias

544

928

3.85

156.10

1.5

1.3

31.02

38.37

g/l

26.93

496

872

Ascites

239

359

7.12

153.13

1.6

1.4

33.18

32.46

g/l

0.29

212

331

Erysipelas

747

2383

2.82

142.57

1.5

1.4

30.39

33.94

g/l

10.28

667

2151

Extracorporeal dialysis

204

284

7.77

140.48

1.7

1.5

25.01

32.41

g/l

8.95

172

255

Other anaemias

760

2681

2.75

140.22

1.5

29.73

32.52

g/l

7.05

672

2401

Other and unspecified anaemias

753

2666

2.75

138.72

1.5

29.72

32.51

g/l

6.99

665

2387

Cardiomyopathy (excluding other)

239

401

6.18

136.36

1.5

1.3

26.65

38.20

g/l

26.74

196

374

Valvular operations

259

486

5.51

131.15

1.6

1.3

29.25

37.89

g/l

19.47

227

451

Other disorders of fluid, electrolyte and acid-base balance

548

1687

3.17

130.05

1.5

1.4

29.45

33.12

g/l

7.66

486

1511

Cardiomyopathies, Primary/intrinsic

228

386

6.12

128.91

1.5

1.3

26.49

38.02

g/l

25.49

187

361

Secondary uncertain malignant neoplasm

261

505

5.36

127.95

1.6

1.5

34.42

28.25

g/l

11.00

252

440

ILD medications: prednisolone, methylprednisolone, prednisone

1187

2991

2.24

125.94

1.6

1.4

32.70

33.25

g/l

0.66

1073

2680

Oral corticosteroids

1191

3212

2.22

125.78

1.5

1.4

33.02

33.06

g/l

0.04

1079

2883

Malaise and fatigue

698

2064

2.76

125.72

1.5

1.4

30.33

33.69

g/l

8.68

615

1851

Certain infectious and parasitic diseases

957

1936

2.50

124.35

1.5

1.4

31.77

34.92

g/l

8.90

860

1760

Implicit viral Sepsis

457

1396

3.35

120.41

1.6

1.4

29.43

33.85

g/l

9.79

401

1257

Haemorrhage from respiratory passages

524

1543

3.12

120.29

1.5

1.4

30.66

33.21

g/l

4.19

469

1379

Conduction disorders

401

879

3.77

119.76

1.6

1.3

29.35

38.16

g/l

30.95

357

829

Diseases of arteries, arterioles and capillaries

959

3112

2.31

116.57

1.5

28.68

33.59

g/l

23.01

833

2815

Presence of cardiac and vascular implants and grafts

763

2250

2.57

116.35

1.6

1.5

28.03

33.82

g/l

27.24

675

2025

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1017

2954

2.26

115.07

1.5

1.4

30.74

34.75

g/l

17.01

908

2679

Hypertensive heart and/or renal disease

478

1100

3.33

114.87

1.6

1.4

27.51

34.58

g/l

24.69

413

1001

Cardiovascular diseases (excluding rheumatic etc)

377

528

4.13

113.53

1.5

1.3

34.82

39.75

g/l

7.99

335

492

Undetermined asthma, excluding more controls

21.80

113.29

1.5

1.1

34.32

28.49

g/l

1.42

Acute tubulo-interstitial nephritis

741

2579

2.51

112.46

1.5

1.4

31.12

34.28

g/l

8.39

659

2374

Other arrhythmias

563

1465

2.93

111.62

1.5

1.3

31.00

38.36

g/l

31.18

507

1375

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

258

555

4.80

111.61

1.5

33.78

28.86

g/l

7.20

244

481

COPD

743

2459

2.52

111.22

1.4

1.5

33.04

32.35

g/l

0.71

652

2212

Glomerular disorders in diseases classified elsewhere

267

596

4.68

110.85

1.6

1.5

25.92

32.56

g/l

11.71

225

540

Glomerular diseases

347

943

3.80

110.04

1.6

1.5

25.94

32.70

g/l

14.78

294

855

ILD medications

1169

2996

2.13

109.48

1.6

1.4

32.89

33.26

g/l

0.40

1058

2684

AV-block

293

602

4.37

108.95

1.7

1.3

28.45

38.23

g/l

28.61

262

565

Cerebrovascular diseases (FINNGEN)

282

429

4.71

107.27

1.6

1.3

31.62

39.37

g/l

14.94

258

399

Other chronic obstructive pulmonary disease

716

2402

2.51

106.18

1.4

1.5

32.95

32.42

g/l

0.49

627

2161

Inflammatory bowel disease treatment related agents

1189

3221

2.08

105.61

1.5

1.4

33.07

33.10

g/l

0.02

1075

2891

Bleeding

1009

3342

2.17

105.45

1.5

1.4

30.03

33.72

g/l

14.55

895

3008

Implicit viral Sepsis

338

931

3.73

104.83

1.6

1.4

28.65

33.62

g/l

9.10

300

836

Viral Sepsis

338

931

3.73

104.83

1.6

1.4

28.65

33.62

g/l

9.10

300

836

Transplanted organ and tissue status

192

341

5.86

103.47

1.6

1.4

26.96

34.83

g/l

12.12

172

308

Complications of surgical and medical care, not elsewhere classified

1091

3607

2.09

102.91

1.5

1.4

31.56

33.38

g/l

4.30

980

3249

Malignant neoplasm of ovary, including Hilmo

116

119

10.17

101.36

1.2

1.4

39.02

27.15

g/l

11.34

108

100

Pericarditis

13.03

101.01

1.4

1.3

35.36

38.17

g/l

1.02

Pulmonary heart disease, diseases of pulmonary circulation

537

1987

2.76

100.97

1.4

1.5

33.55

31.94

g/l

2.17

489

1761

Opioids

924

2126

2.27

99.83

1.5

1.4

33.79

32.52

g/l

1.88

844

1891

Provisional assignment of new diseases of uncertain etiology

655

2675

2.48

99.67

1.5

32.49

32.92

g/l

0.36

590

2402

Codes for special purposes

656

2683

2.47

99.51

1.5

32.48

32.92

g/l

0.38

591

2409

Pleural plaque

182

320

5.92

99.18

1.4

1.2

35.70

26.32

g/l

15.56

170

254

Metabolic disorders

999

2860

2.15

98.56

1.5

1.4

31.35

34.14

g/l

8.12

897

2587

Diabetic nephropathy, excluding more controls

295

611

4.12

98.53

1.6

1.5

27.07

32.65

g/l

8.74

248

553

Other chronic obstructive pulmonary disease, including avohilmo

798

2917

2.30

98.17

1.4

1.5

33.28

32.26

g/l

1.36

701

2628

Any reimbursement code in KELA

326

380

4.32

97.69

1.5

1.3

34.21

37.49

g/l

2.91

292

351

Tramadol

797

2097

2.36

97.61

1.5

1.4

32.67

32.33

g/l

0.28

712

1863

Unspecified kidney failure

244

568

4.49

96.17

1.6

1.4

26.19

32.22

g/l

9.45

198

507

Hypertensive diseases (excluding secondary)

339

508

3.91

95.56

1.6

1.3

33.88

39.50

g/l

8.90

303

472

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

311

487

4.07

95.26

1.5

1.3

32.77

39.17

g/l

10.37

284

453

COPD, early/later onset

728

2663

2.35

94.18

1.4

1.5

32.98

32.26

g/l

0.77

637

2403

COPD, hospital admissions

723

2647

2.35

94.08

1.4

1.5

33.12

32.23

g/l

1.06

635

2389

Covid-19 confirmed case

541

2081

2.65

94.06

1.5

31.90

32.11

g/l

0.14

486

1862

General symptoms and signs

1016

2404

2.13

93.31

1.5

1.4

32.11

34.21

g/l

4.71

920

2168

Paroxysmal tachycardia

214

364

4.99

92.64

1.6

1.3

29.33

39.25

g/l

18.56

185

339

Symptoms and signs involving the circulatory and respiratory systems

874

1951

2.26

92.19

1.5

1.4

32.50

33.87

g/l

1.97

783

1754

L01XE Protein kinase inhibitors

155

253

6.56

91.86

1.4

1.5

36.49

32.43

g/l

3.39

148

228

Percutaneous Coronary Intervention

863

2413

2.22

91.54

1.5

1.4

29.75

35.60

g/l

28.92

770

2215

All influenza

299

834

3.65

90.71

1.6

1.4

30.26

32.89

g/l

2.51

260

754

COPD related to multimorbidity

667

2399

2.40

90.29

1.4

1.5

32.40

32.01

g/l

0.32

579

2168

Infections, IBD-co-morbidities

247

400

4.50

89.04

1.6

1.3

29.60

35.64

g/l

7.55

219

360

Neoplasms

567

1113

2.72

88.79

1.4

34.62

31.90

g/l

4.27

512

996

Pulmonary embolism

475

1764

2.75

88.75

1.4

1.5

34.41

31.91

g/l

4.12

433

1560

Peripheral artery disease

714

2519

2.30

87.00

1.5

27.77

33.04

g/l

19.23

602

2276

Pulmonary heart disease

475

1785

2.72

86.73

1.4

1.5

34.41

31.82

g/l

4.41

433

1579

Coronary revascularization (ANGIO or CABG)

850

2413

2.18

86.65

1.5

1.4

29.59

35.60

g/l

30.35

761

2215

Hypertensive Heart Disease

403

1058

3.05

85.73

1.6

1.4

27.78

34.43

g/l

19.46

349

964

Malignant neoplasm of breast, HER2-negative, including Hilmo

326

592

3.60

85.68

1.3

1.4

34.69

29.53

g/l

8.80

302

511

Malignant neoplasm of breast, including Hilmo

326

592

3.60

85.67

1.3

1.4

34.69

29.53

g/l

8.80

302

511

Emergency coronary revascularization (for ACS)

956

2837

2.07

85.37

1.5

1.4

29.54

34.80

g/l

26.66

846

2587

Non-allergic asthma (mode)

123

165

7.46

85.16

1.6

1.2

31.32

25.60

g/l

3.85

111

130

Malignant neoplasm of breast, HER2-negative

321

588

3.61

84.91

1.3

1.4

34.86

29.43

g/l

9.71

297

507

Other CVD (FINNGEN)

167

221

6.01

84.56

1.6

1.3

29.81

38.74

g/l

12.29

144

205

Venous thromboembolism

730

3238

2.21

84.56

1.4

1.5

33.56

32.27

g/l

1.89

662

2900

Malignant neoplasm of breast

321

589

3.59

84.24

1.3

1.4

34.87

29.46

g/l

9.59

297

508

Iron deficiency anaemia

585

2428

2.41

83.51

1.5

29.25

32.50

g/l

7.26

511

2173

COPD, hospital admission 2, with asthma infections

560

1961

2.50

83.47

1.4

1.5

33.05

31.92

g/l

1.22

488

1764

COPD, hospital admissions 3, with asthma pneumonia sepsis

511

1716

2.61

82.61

1.4

1.5

32.88

31.62

g/l

1.35

444

1535

DVT of lower extremities and pulmonary embolism

606

2600

2.36

82.45

1.4

1.5

33.76

32.11

g/l

2.37

549

2322

Viral pneumonia

187

397

4.83

82.18

1.6

1.4

30.03

32.41

g/l

1.53

167

365

malignant neoplasm of female genital organs

184

383

4.89

81.97

1.3

1.4

38.03

28.08

g/l

17.35

169

323

Dialysis

104

123

9.00

81.94

1.5

1.4

22.23

34.44

g/l

11.53

107

Non-Hodgkin lymphoma, all, including Hilmo

213

504

4.35

81.83

1.6

1.5

31.18

28.64

g/l

2.05

202

436

Secondary hypertension

116

154

7.65

81.11

1.5

1.3

25.53

38.86

g/l

14.89

141

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

14.12

80.98

1.3

1.4

40.24

27.61

g/l

7.36

Pacemaker

578

2360

2.40

80.44

1.6

1.5

27.43

32.18

g/l

16.80

503

2101

L04AD Calcineurin inhibitors

172

350

5.07

79.63

1.7

1.5

27.25

33.49

g/l

7.04

155

316

Asthma-related pneumonia

533

2200

2.46

79.58

1.5

31.99

32.17

g/l

0.11

476

1952

Asthma-related pneumonia or sepsis

533

2201

2.46

79.49

1.5

31.99

32.17

g/l

0.12

476

1953

Asthma, hospital admissions 3, pneumonia

533

2201

2.46

79.49

1.5

31.99

32.17

g/l

0.12

476

1953

Complications of procedures, not elsewhere classified

861

3531

2.04

79.04

1.5

1.4

31.66

33.39

g/l

3.32

780

3178

Major coronary heart disease event

891

2631

2.06

78.97

1.5

1.4

29.43

35.31

g/l

30.86

800

2410

Adjustment and management of implanted device

316

1004

3.23

78.54

1.7

1.4

28.74

31.34

g/l

3.38

268

878

Ulcer of lower limb, not elsewhere classified

289

882

3.39

77.01

1.6

1.5

27.85

31.62

g/l

4.70

239

793

Primary_lymphoid and hematopoietic malignant neoplasms

395

1448

2.79

75.93

1.6

1.5

31.76

32.03

g/l

0.15

372

1274

Hyperkalaemia

155

304

5.38

75.46

1.6

1.4

25.58

31.45

g/l

5.87

135

277

Atherosclerosis, excluding cerebral and coronary sclerosis

669

2425

2.22

75.44

1.5

27.76

32.91

g/l

17.62

566

2189

Hard cardiovascular diseases

812

2327

2.10

75.16

1.5

1.4

30.44

35.71

g/l

22.33

732

2142

Insulin medication

721

2876

2.13

74.87

1.6

1.4

29.32

33.34

g/l

12.54

627

2603

Dental caries

359

1209

2.90

74.22

1.6

1.5

32.09

33.55

g/l

1.14

309

1085

Polyarthropathies

781

2452

2.10

74.04

1.6

1.4

31.46

33.51

g/l

3.89

713

2192

Caries of dentine

332

1089

3.02

73.79

1.6

1.5

32.17

33.60

g/l

1.02

284

978

Nutritional anaemias

652

2922

2.18

73.27

1.5

29.39

32.71

g/l

8.34

572

2630

ILD medications: immunosuppressive drugs

593

2458

2.26

72.93

1.5

1.4

32.78

33.72

g/l

0.90

543

2216

Malignant neoplasm of ovary

9.76

72.92

1.2

1.5

39.81

26.93

g/l

10.17

Other respiratory disorders and diseases

367

1324

2.84

72.85

1.6

1.5

31.63

31.24

g/l

0.23

340

1170

Other diseases of the respiratory system

367

1324

2.84

72.85

1.6

1.5

31.63

31.24

g/l

0.23

340

1170

Ischemic heart diseases

825

2437

2.05

72.05

1.6

1.4

30.11

35.56

g/l

24.43

735

2238

Cardiomyopathy, other and unspecified

128

220

6.01

71.41

1.6

1.3

28.20

37.64

g/l

9.48

103

208

Type 2 diabetes, wide definition

862

2792

1.99

70.80

1.5

1.4

31.28

34.05

g/l

7.12

755

2539

Cardiovascular diseases

295

452

3.53

70.63

1.5

1.3

34.43

39.70

g/l

7.15

264

422

Complications of medical and surgical care

795

3699

1.99

70.31

1.5

1.4

31.56

33.12

g/l

2.64

709

3331

Explicit bacterial Sepsis

189

462

4.22

69.66

1.5

1.4

30.77

32.84

g/l

1.22

158

425

Malignant neoplasm of breast, ER-positive, including Hilmo

254

558

3.55

69.33

1.4

35.98

29.47

g/l

11.92

234

481

Hypertension, essential

658

1696

2.21

68.64

1.6

1.4

32.53

35.72

g/l

6.75

589

1550

Malignant neoplasm of breast, HER-positive

250

556

3.54

68.33

1.4

35.92

29.43

g/l

11.75

230

479

Malignant neoplasm of digestive organs

434

1349

2.57

68.27

1.4

1.5

31.81

29.60

g/l

2.58

390

1175

Certain infectious and parasitic diseases

673

1530

2.22

68.26

1.6

1.4

32.00

34.99

g/l

6.22

598

1400

Pain in throat and chest

684

1939

2.13

66.35

1.4

32.73

33.83

g/l

1.25

604

1743

Streptococcal septicaemia

168

394

4.42

65.55

1.5

1.4

30.97

32.52

g/l

0.71

139

355

Diabetic nephropathy

299

1012

3.01

65.30

1.6

1.5

27.06

31.42

g/l

6.49

251

901

Depression medications

126

7.86

64.42

1.6

1.4

35.47

42.54

g/l

4.01

113

Abscess of lung

12.27

64.37

1.3

1.5

35.67

30.38

g/l

1.80

Calcific aortic valvular stenosis

510

2213

2.28

63.55

1.6

1.5

27.93

32.04

g/l

11.00

445

1976

Calcific aortic valvular stenosis, operated

510

2213

2.28

63.55

1.6

1.5

27.93

32.04

g/l

11.00

445

1976

Calcific aortic valvular stenosis, diagnosis (helper)

509

2212

2.28

63.19

1.6

1.5

27.93

32.04

g/l

11.00

445

1975

Operations 2 for CAVS

509

2212

2.28

63.19

1.6

1.5

27.93

32.04

g/l

11.00

445

1975

Undetermined asthma

104

8.17

63.08

1.5

1.2

34.32

25.02

g/l

6.01

Coronary atherosclerosis

719

2248

2.04

63.05

1.5

1.4

29.54

35.33

g/l

24.06

636

2058

Myocardial infarction

609

2014

2.15

62.46

1.5

1.4

29.30

35.14

g/l

19.68

529

1839

Other and unspecified iron deficiency

438

1850

2.40

62.44

1.5

29.56

32.39

g/l

4.33

383

1646

Calcific aortic valvular stenosis, including rheumatic fever

509

2222

2.26

62.36

1.6

1.5

27.93

32.04

g/l

11.02

445

1984

Hypo-osmolality and hyponatraemia

280

946

3.01

61.99

1.6

1.4

30.90

32.17

g/l

0.79

252

841

Other disorders of skin and subcutaneous tissue

769

3570

1.93

61.72

1.5

1.4

30.19

33.27

g/l

8.57

675

3223

ILD, hospital admissions 3, with pneumonia sepsis

153

352

4.50

61.21

1.5

1.4

32.73

31.32

g/l

0.61

137

325

Nonischemic cardiomyopathy

180

467

3.98

61.20

1.5

1.4

28.07

33.93

g/l

6.88

147

429

Parasetamol

645

1533

2.14

60.72

1.5

1.4

33.16

33.20

g/l

0.03

584

1370

Gout

468

1811

2.32

59.66

1.6

1.4

28.60

32.70

g/l

9.66

418

1608

Other dialysis

119

7.74

59.58

1.6

1.4

21.89

33.14

g/l

8.38

107

Insulin, combination of fast acting with intermediate-acting or long-acting

722

3429

1.94

59.24

1.6

1.4

29.32

33.16

g/l

11.91

627

3092

ILD, hospital admission 2, with pulmonary infections

160

391

4.21

59.07

1.5

1.4

32.80

31.83

g/l

0.39

140

358

Oedema, not elsewhere classified

384

1553

2.47

58.39

1.6

1.4

29.94

33.50

g/l

6.07

334

1385

Care involving use of rehabilitation procedures

546

2373

2.13

58.20

1.4

30.76

33.35

g/l

4.33

483

2124

Hypertensive diseases

629

1699

2.10

58.12

1.6

1.4

32.57

35.73

g/l

6.49

564

1553

Hypertension

628

1699

2.10

57.77

1.6

1.4

32.58

35.73

g/l

6.43

563

1553

Disorders of lipoprotein metabolism and other lipidaemias

832

2765

1.88

57.22

1.5

1.4

31.80

33.94

g/l

4.48

743

2499

Major coronary heart disease event excluding revascularizations

693

2346

1.99

57.09

1.6

1.4

29.34

34.95

g/l

20.83

608

2137

Codeine

755

2107

1.96

57.07

1.5

1.4

32.90

32.51

g/l

0.32

695

1877

Chronic lower respiratory diseases

1083

3322

1.75

56.93

1.5

1.4

32.99

33.18

g/l

0.18

973

2995

Gout, FINNGEN

468

2121

2.24

56.52

1.6

1.4

28.60

32.32

g/l

8.41

418

1891

Amputation

206

623

3.42

55.88

1.6

1.4

27.21

31.61

g/l

4.40

167

557

Insulin, fast-acting

426

1866

2.31

55.86

1.7

1.4

27.60

33.28

g/l

14.57

370

1683

STROKE

507

1573

2.21

55.40

1.5

1.4

31.24

36.65

g/l

14.89

457

1461

Preparatory care for dialysis

110

216

5.39

53.66

1.6

1.5

24.61

32.13

g/l

5.78

194

Insulin, intermediate and long-acting

638

3209

1.95

53.64

1.6

1.4

29.09

33.15

g/l

11.59

555

2894

Malignant neoplasm of skin

472

1457

2.24

53.43

1.4

1.5

31.15

29.79

g/l

1.40

415

1271

Later onset COPD

490

1822

2.19

53.14

1.4

1.5

31.73

31.41

g/l

0.21

428

1632

Type 1 diabetes

273

994

2.78

52.90

1.6

1.4

27.04

34.21

g/l

13.64

233

906

Hernia of abdominal wall, postoperative

170

468

3.68

52.81

1.4

32.37

33.04

g/l

0.24

153

433

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

465

1418

2.25

52.76

1.4

1.5

31.42

29.61

g/l

2.09

410

1234

Cardiodefibrillation

516

2504

2.09

52.31

1.6

1.5

28.96

32.68

g/l

9.32

442

2260

Autoimmune diseases excluding thyroid diseases, strict definition

947

2964

1.76

51.60

1.5

1.4

31.89

33.58

g/l

3.12

846

2669

Hypothyroidism (congenital or acquired)

7.20

50.94

1.7

1.4

33.67

42.42

g/l

4.89

Autoimmune diseases excluding thyroid diseases

969

3061

1.74

50.48

1.5

1.4

31.87

33.52

g/l

3.10

868

2760

Asthma-related infections

600

3050

1.94

50.03

1.4

1.5

32.28

32.99

g/l

0.70

537

2733

Asthma, hospital admission 2, infections

600

3050

1.94

50.03

1.4

1.5

32.28

32.99

g/l

0.70

537

2733

Insulin, fast-acting or short human

428

1979

2.19

49.27

1.7

1.5

27.59

33.11

g/l

14.02

372

1775

Other malignant neoplasms of skin (=non-melanoma skin cancer)

440

1372

2.22

48.76

1.4

1.5

31.00

29.50

g/l

1.55

387

1195

Peripheral arterial reconstruction

310

1263

2.52

48.46

1.5

27.87

31.53

g/l

4.55

257

1115

Hypothyroidism and >3 levothyroxin purchases

7.10

48.40

1.6

1.4

33.71

42.04

g/l

4.38

Hypothyroidism, levothyroxine purchases

7.10

48.40

1.6

1.4

33.71

42.04

g/l

4.38

Type 1 diabetes, wide definition, subgroup 1

215

723

3.01

48.32

1.6

1.4

26.55

34.66

g/l

12.65

181

664

Other diseases of blood and blood-forming organs, wide

282

1102

2.60

47.86

1.5

33.89

32.55

g/l

0.99

255

992

Non-small cell lung cancer, squamous

106

223

4.96

47.57

1.4

36.79

26.91

g/l

13.73

199

Diabetes, varying definitions

874

2949

1.75

47.30

1.5

1.4

31.37

34.20

g/l

8.06

777

2684

Coronary artery bypass grafting

404

1357

2.26

46.97

1.5

1.4

29.06

34.31

g/l

12.27

343

1244

Kidney transplant status

163

5.66

46.62

1.6

1.5

23.75

34.26

g/l

8.49

146

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

233

840

2.84

46.57

1.7

1.5

28.10

33.21

g/l

5.97

208

755

Diabetes mellitus

873

2950

1.74

46.50

1.5

1.4

31.42

34.20

g/l

7.75

777

2685

Diseases of oesophagus, stomach and duodenum

966

3440

1.69

46.49

1.5

1.4

31.82

33.53

g/l

3.58

862

3116

L04AA Selective immunosuppressants

238

868

2.78

46.25

1.6

1.5

30.72

33.76

g/l

2.75

216

785

Basal cell carcinoma, including avohilmo

431

1371

2.19

46.13

1.4

1.5

31.41

29.49

g/l

2.27

377

1195

Implicit fungal Sepsis

115

265

4.48

46.02

1.7

1.4

29.57

33.30

g/l

2.04

106

245

Gout, idiopatic and unspecified

388

1781

2.22

45.93

1.6

1.5

28.39

32.54

g/l

8.43

343

1593

Basal cell carcinoma

425

1356

2.19

45.72

1.4

1.5

31.28

29.44

g/l

2.09

372

1179

Peripheral artery operations in Hilmo

228

823

2.84

45.45

1.5

1.4

27.59

32.37

g/l

5.49

189

728

Myocardial infarction, strict

541

1957

1.99

45.44

1.5

1.4

29.27

35.04

g/l

17.20

465

1785

Disorders resulting from impaired renal tubular function

150

5.90

45.43

1.6

1.5

25.41

31.77

g/l

3.53

136

COPD-related respiratory insufficiency

216

764

2.91

44.87

1.4

1.5

31.04

31.25

g/l

0.08

188

679

Other bacterial intestinal infections

250

952

2.67

44.79

1.6

1.5

27.31

32.27

g/l

7.59

217

846

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

629

3397

1.84

44.72

1.5

1.4

31.68

33.12

g/l

1.97

558

3063

Invasive ventilation

128

328

4.03

44.52

1.5

1.4

30.03

32.23

g/l

0.85

111

295

Iron deficiency anaemia secondary to blood loss (chronic)

232

854

2.77

44.48

1.5

28.10

31.38

g/l

3.44

206

760

Type 2 diabetes

859

2931

1.72

44.18

1.5

1.4

31.34

34.14

g/l

7.83

765

2666

Enterocolitis due to Clostridium difficile

182

589

3.17

44.17

1.6

1.5

26.21

31.17

g/l

5.85

156

534

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

228

374

3.07

43.65

1.4

1.3

32.84

35.51

g/l

1.69

200

332

Amputation of toe

150

438

3.56

43.25

1.6

1.5

27.07

31.32

g/l

3.17

123

394

Cirrhosis of liver, NAS

111

264

4.39

42.85

1.8

1.5

27.77

32.67

g/l

2.80

100

236

Type 1 diabetes, wide definition

223

819

2.75

42.65

1.6

1.5

26.69

34.30

g/l

12.14

189

748

Intestinal infectious diseases

845

3820

1.69

42.62

1.5

1.4

30.26

33.64

g/l

10.91

760

3437

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

169

359

3.40

42.05

1.5

1.3

33.06

35.31

g/l

1.24

145

323

Diseases of liver

376

1763

2.16

41.97

1.6

1.5

29.14

33.60

g/l

7.68

335

1591

Pure hypercholesterolaemia

726

2703

1.77

41.67

1.5

1.4

32.46

33.85

g/l

1.97

656

2443

Ischaemic heart disease, wide definition

751

2680

1.75

41.22

1.5

1.4

30.11

34.87

g/l

17.74

673

2437

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

824

2929

1.70

41.20

1.5

1.4

31.70

34.20

g/l

6.07

723

2664

Gout, unspecified

322

1435

2.29

41.08

1.6

1.5

27.99

32.49

g/l

7.97

281

1276

Gout, strict definition

298

1286

2.37

41.06

1.7

1.5

27.71

32.56

g/l

9.14

260

1145

Bacterial intestinal infections, IBD co-morbidities

246

984

2.54

39.90

1.6

1.5

27.14

31.91

g/l

7.00

214

876

Diabetes, insulin treatment (Kela reimbursement)

907

3346

1.65

39.87

1.5

1.4

31.55

33.75

g/l

5.18

797

3038

Enlarged lymph nodes

182

624

2.96

39.76

1.5

1.4

33.48

33.60

g/l

0.05

171

560

COPD, hospital admissions 1, only main diagnosis

490

2193

1.94

39.54

1.4

1.5

32.76

31.95

g/l

0.72

435

1968

Dilated cardiomyopathy

200

729

2.82

39.32

1.5

26.03

32.38

g/l

9.35

164

656

Fibrosis and cirrhosis of liver

132

377

3.61

39.29

1.7

1.5

28.41

32.80

g/l

2.84

118

339

Endocrine, nutritional and metabolic diseases

579

1558

1.89

39.15

1.5

1.4

32.32

35.39

g/l

6.10

522

1431

Dipeptidyl peptidase 4 (DPP-4) inhibitors

639

2902

1.78

39.11

1.6

1.4

30.87

32.83

g/l

3.32

554

2618

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

139

411

3.46

39.08

1.5

32.71

28.65

g/l

3.25

125

355

Malignant neoplasm, without specification of site, including Hilmo

189

4.82

38.48

1.4

37.44

26.33

g/l

13.32

166

Cough

340

1494

2.17

38.40

1.5

1.4

34.22

33.51

g/l

0.48

316

1351

Other bacterial intestinal infections

273

1166

2.37

38.30

1.6

1.5

27.59

32.46

g/l

8.00

238

1036

Fungal Sepsis

165

5.12

37.83

1.7

1.5

29.86

33.38

g/l

1.27

151

Heart failure and hypertrophic cardiomyopathy

7.01

37.69

1.8

1.5

25.48

32.10

g/l

2.76

Agranulocytosis

151

486

3.18

37.01

1.5

35.46

32.89

g/l

1.79

139

439

Diarrhoea and gastroenteritis of presumed infectious origin

618

3201

1.75

36.64

1.5

1.4

30.66

33.68

g/l

6.57

561

2869

Acute peritonitis

113

305

3.83

36.61

1.6

1.5

27.48

31.64

g/l

2.22

103

274

581

2988

1.77

35.84

1.5

32.30

33.24

g/l

0.92

514

2694

Diseases of the digestive system

525

2907

1.81

35.60

1.6

1.4

28.64

32.78

g/l

10.48

467

2604

Diabetes medication

872

3218

1.61

35.48

1.5

1.4

31.99

33.68

g/l

3.28

775

2921

Implicit fungal Sepsis

148

5.21

35.32

1.7

1.5

30.08

33.39

g/l

1.07

136

Disorders of lens

665

2418

1.73

35.29

1.5

1.4

30.19

34.44

g/l

12.71

595

2183

Antihypertensive medication - note that there are other indications

286

638

2.39

35.24

1.5

1.3

32.95

39.14

g/l

10.63

252

597

Malignant neoplasm of urinary organs

129

390

3.38

35.07

1.4

1.5

32.51

28.23

g/l

3.24

115

337

Hyperlipidaemia, other/unspecified

453

2223

1.90

34.86

1.5

1.4

30.65

33.29

g/l

3.97

401

1999

Myocardial infarction, without ST-elevation

547

2821

1.79

34.69

1.4

1.5

28.28

32.43

g/l

10.76

477

2530

Volume depletion

154

522

3.02

34.59

1.6

1.4

27.52

31.50

g/l

3.48

135

467

Substance abuse, excluding more controls

540

2587

1.79

34.46

1.4

1.5

33.24

33.36

g/l

0.08

491

2340

Fall on same level

927

3207

1.58

34.39

1.5

1.4

31.94

33.87

g/l

4.31

837

2887

Chronic lymphocytic leukaemia, helper endpoint

106

6.05

33.97

1.6

1.5

30.60

26.05

g/l

1.71

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

106

6.05

33.97

1.6

1.5

30.60

26.05

g/l

1.71

Chronic lymphocytic leukaemia

106

6.05

33.97

1.6

1.5

30.60

26.05

g/l

1.71

983

3263

1.56

33.97

1.5

1.4

32.44

33.09

g/l

0.78

891

2933

Morphin

6.61

33.82

1.9

1.5

35.83

26.70

g/l

5.14

GI-bleeding

419

2216

1.91

33.57

1.6

1.5

28.27

32.36

g/l

8.42

372

1967

589

3023

1.73

33.32

1.5

32.23

33.30

g/l

1.13

522

2722

Vocal cord dysfunction

124

332

3.39

33.29

1.5

1.4

33.48

38.93

g/l

4.25

113

317

Other acute lower respiratory infections

526

2842

1.78

33.21

1.5

32.73

32.63

g/l

0.06

478

2542

Disorders of choroid and retina

810

3611

1.60

33.21

1.5

30.41

33.22

g/l

7.47

721

3249

Cerebrovascular diseases

772

3365

1.62

33.11

1.5

30.02

33.31

g/l

9.52

670

3044

Infections of the skin and subcutaneous tissue

498

2761

1.80

33.00

1.6

1.5

31.67

33.65

g/l

2.67

454

2477

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

564

3275

1.73

32.86

1.4

1.5

31.66

32.80

g/l

1.23

502

2962

Non-Hodgkin lymphoma, all

186

4.52

32.74

1.7

1.5

29.90

26.62

g/l

1.45

164

Alcohol use disorder, Swedish definition

550

2906

1.75

32.63

1.5

32.05

33.24

g/l

1.25

486

2616

Other respiratory diseases principally affecting the interstitium

266

1208

2.24

32.53

1.5

31.89

31.36

g/l

0.26

234

1071

Other diseases of the digestive system

415

2212

1.90

32.50

1.6

1.5

28.30

32.47

g/l

8.67

368

1967

Malignant neoplasm of kidney, except renal pelvis

118

355

3.40

32.38

1.4

1.5

32.86

28.45

g/l

3.14

106

311

Mental and behavioural disorders due to psychoactive substance use

557

2996

1.73

32.24

1.4

1.5

33.22

33.17

g/l

0.02

505

2693

Syncope and collapse

437

2020

1.87

31.87

1.5

1.4

30.42

33.55

g/l

5.34

388

1811

Symptoms and signs involving the urinary system

738

3498

1.62

31.71

1.5

1.4

31.69

33.21

g/l

2.51

645

3160

Other CVD

288

1363

2.15

31.71

1.6

1.5

29.98

30.97

g/l

0.67

255

1196

Other disorders of glucose regulation and pancreatic internal secretion

113

337

3.43

31.43

1.6

1.5

28.50

31.67

g/l

1.63

304

Diabetic retinopathy, excluding more controls

279

695

2.28

31.33

1.5

1.4

28.81

32.94

g/l

5.17

244

636

Cardiac arrest

154

4.53

31.33

1.5

1.3

26.29

38.89

g/l

10.50

143

Persons encountering health services in other circumstances, wide

1015

3449

1.52

31.13

1.6

1.4

32.43

33.22

g/l

1.04

920

3092

Substance abuse

540

2956

1.73

30.96

1.4

1.5

33.24

33.17

g/l

0.04

491

2657

Used for control exclusion in common control thyroid runs

880

2843

1.57

30.95

1.6

1.4

31.81

33.60

g/l

3.23

787

2563

Hypertensive Renal Disease

192

4.34

30.62

1.6

1.3

24.21

33.71

g/l

7.91

176

Bronchitis

916

3772

1.54

30.61

1.5

1.4

32.50

33.11

g/l

0.71

832

3384

Benign neoplasm of colon, rectum, anus and anal canal

673

3610

1.63

30.52

1.5

1.4

31.02

32.98

g/l

3.63

584

3266

Disorders of gallbladder, biliary tract and pancreas

886

3631

1.55

30.46

1.5

32.04

33.20

g/l

1.76

795

3269

Other retinal disorders

685

3301

1.63

30.36

1.5

29.40

32.92

g/l

9.94

609

2969

Hypokalaemia

148

529

2.85

30.17

1.4

30.80

32.94

g/l

1.07

136

478

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

864

3594

1.55

29.89

1.5

1.4

32.32

33.17

g/l

1.08

786

3230

Other disorders of kidney and ureter

178

704

2.58

29.79

1.5

27.04

32.43

g/l

6.00

149

635

Osteopathies and chondropathies

513

2774

1.73

29.78

1.5

30.79

33.26

g/l

4.11

446

2494

Injuries to the head

920

3729

1.52

29.46

1.5

1.4

31.82

33.39

g/l

3.00

831

3351

Drug-induced neutropenia

103

303

3.49

29.37

1.4

1.5

36.10

33.13

g/l

1.73

272

Type 2 diabetes, definitions combined

777

2905

1.58

28.82

1.5

1.4

31.87

34.07

g/l

4.82

696

2641

Autoimmune diseases

918

3068

1.53

28.71

1.5

1.4

31.81

33.52

g/l

3.14

825

2765

All influenza (not pneumonia)

118

383

3.11

28.47

1.5

1.4

29.60

32.81

g/l

1.62

105

356

Sub-endpoint used in defining T1D endpoints

297

1455

2.03

28.31

1.6

1.5

26.88

32.37

g/l

9.75

250

1302

Abnormal findings on examination of blood, without diagnosis

522

2847

1.70

27.92

1.5

30.71

32.64

g/l

2.65

458

2565

Stroke, including SAH

682

3114

1.60

27.86

1.5

30.01

33.13

g/l

7.69

589

2809

Factors influencing health status and contact with health services

256

570

2.27

27.84

1.5

1.4

31.99

33.89

g/l

1.30

222

510

Non-follicular lymphoma

148

554

2.74

27.80

1.7

1.5

31.40

31.79

g/l

0.15

140

499

Type 2 diabetes, strict (exclude DM1)

778

2935

1.56

27.80

1.5

1.4

31.93

34.06

g/l

4.57

697

2668

Malignant neoplasm of breast, ER-negative, including Hilmo

143

498

2.76

27.53

1.3

1.4

32.06

28.90

g/l

2.11

129

422

Need for other prophylactic measures

221

3.86

27.47

1.4

30.81

32.32

g/l

0.44

195

Senile cataract

617

2316

1.64

27.21

1.5

30.03

34.36

g/l

12.46

549

2090

Early onset COPD

248

1178

2.13

27.07

1.4

1.5

35.63

32.97

g/l

2.73

218

1062

Gastroduodenal ulcer

343

1825

1.90

26.91

1.5

1.4

30.03

32.36

g/l

2.60

305

1630

Convulsions, not elsewhere classified

201

869

2.30

26.65

1.5

33.71

33.79

g/l

0.03

181

778

Glomerulonephritis

126

443

2.90

26.58

1.6

1.5

25.70

32.38

g/l

5.39

108

398

Amiodarone users

158

627

2.58

26.42

1.5

27.43

31.85

g/l

4.43

134

567

Use of hypnotics and sedatives

895

3443

1.50

26.29

1.4

1.5

33.33

33.07

g/l

0.23

816

3091

Hypoglycaemia, other or unspecified

271

3.47

26.18

1.6

1.4

28.43

31.99

g/l

1.61

242

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

189

4.04

26.02

1.6

1.5

29.47

27.53

g/l

0.51

167

Asthma (diagnoses ohter than nonallergic)

726

3927

1.54

25.90

1.5

1.4

32.51

33.08

g/l

0.61

661

3524

Diseases of peritoneum

134

495

2.76

25.78

1.6

1.5

27.81

32.16

g/l

3.03

123

449

Asthma/COPD (KELA code 203)

743

3319

1.54

25.76

1.5

1.4

32.34

33.19

g/l

1.06

678

2992

Misadventures to patients during surgical and medical care

165

675

2.48

25.72

1.8

1.4

30.00

32.70

g/l

1.89

151

608

Coagulation defects, purpura and other haemorrhagic conditions

206

928

2.25

25.71

1.5

30.59

32.46

g/l

1.23

183

837

Alcoholic liver disease

139

526

2.70

25.55

1.7

1.5

28.08

33.58

g/l

4.01

122

473

Intestinal infectious diseases

961

3754

1.47

25.50

1.5

1.4

30.52

33.71

g/l

10.60

867

3377

Intestinal stricture

350

1916

1.85

25.33

1.4

1.5

31.69

32.14

g/l

0.26

318

1699

Malignant neoplasm of breast, HER-negative

129

461

2.77

25.24

1.3

1.4

32.70

28.59

g/l

3.14

116

391

Oesophageal varices

176

4.12

25.20

1.9

1.6

27.10

32.40

g/l

2.33

156

Amyloidosis

111

5.13

25.16

1.7

1.4

24.91

31.26

g/l

2.77

102

Non-small cell lung cancer, squamous, helper endpoint

106

351

3.13

25.13

1.4

1.5

36.79

30.05

g/l

7.86

313

Pneumonia derived septicemia

139

4.55

24.96

1.3

1.4

34.75

32.46

g/l

0.59

122

Hypertrophic cardiomyopathy

200

3.89

24.91

1.7

1.5

27.49

32.25

g/l

2.14

179

Stroke, excluding SAH

655

3064

1.57

24.90

1.5

29.97

33.04

g/l

7.21

564

2765

Fracture of femur

354

1768

1.84

24.78

1.4

1.5

30.31

31.24

g/l

0.63

309

1555

Mental and behavioural disorders due to alcohol

475

2741

1.68

24.60

1.5

32.70

33.15

g/l

0.30

427

2462

Diabetic maculopathy, excluding more controls

130

485

2.73

24.52

1.6

1.4

26.19

33.46

g/l

7.19

109

445

Pneumonia due to Streptococcus pneumoniae

5.22

24.36

1.4

1.5

34.43

30.45

g/l

1.03

Medicines for HER+ breast cancer

276

1339

1.97

24.24

1.4

35.59

32.66

g/l

3.99

254

1211

Amputation of foot

152

4.37

24.14

1.6

1.5

26.20

31.60

g/l

2.20

138

L02BA Anti-estrogens

141

552

2.58

24.08

1.4

36.04

32.56

g/l

3.01

131

501

Hydronephrosis

136

524

2.64

24.08

1.5

1.4

32.69

32.85

g/l

0.05

124

475

Pain, not elsewhere classified

222

1059

2.11

23.92

1.5

1.4

34.95

34.21

g/l

0.34

195

946

Mental and behavioural disorders due to alcohol, excluding acute intoxication

420

2456

1.71

23.75

1.5

32.74

33.22

g/l

0.30

377

2202

Diseases of the skin and subcutaneous tissue

817

2742

1.50

23.55

1.5

1.4

32.00

33.65

g/l

2.80

731

2469

Benign neoplasm: Colon

569

3455

1.58

23.38

1.5

31.15

32.81

g/l

2.42

492

3123

Type 2 diabetes, definitions combined, including avohilmo

749

2892

1.51

23.29

1.5

1.4

31.95

34.10

g/l

4.50

670

2629

Pneumococcal septicemia

135

4.45

23.13

1.3

1.4

34.75

31.68

g/l

0.86

120

Symptoms and signs involving the digestive system and abdomen

833

2822

1.48

22.85

1.5

1.4

32.29

33.37

g/l

1.42

745

2539

Emphysema

113

408

2.84

22.83

1.3

1.5

32.49

31.28

g/l

0.43

102

358

Paralytic ileus and intestinal obstruction

298

1605

1.88

22.74

1.4

31.70

32.26

g/l

0.31

271

1425

Codeine or tramadol medication

923

3500

1.45

22.74

1.5

1.4

33.02

33.09

g/l

0.05

846

3140

Injuries to the hip and thigh

503

2828

1.62

22.71

1.5

31.26

32.32

g/l

1.06

450

2529

Amyloidosis, other/unspecified

5.30

22.66

1.7

1.4

24.16

31.40

g/l

3.11

Unspecified haematuria

476

2413

1.65

22.56

1.5

30.57

32.82

g/l

3.34

414

2178

Ischaemic Stroke, excluding all haemorrhages

624

3015

1.55

22.55

1.4

1.5

29.37

33.04

g/l

9.67

539

2729

Abnormalities of heart beat

270

1383

1.93

22.48

1.6

1.4

31.19

33.38

g/l

2.20

243

1243

Hepatic failure, not elsewhere classified

160

4.07

22.41

1.7

1.4

25.79

32.58

g/l

3.35

142

Viral pneumonia (unknown virus, not influenza)

235

3.43

22.18

1.7

1.5

30.24

32.31

g/l

0.64

209

Lymphoid leukaemia

287

3.19

22.04

1.6

1.5

31.44

31.54

g/l

0.02

259

Idiopathic gout

143

594

2.46

21.79

1.7

1.5

28.58

32.60

g/l

3.87

130

533

Acute bronchitis

397

2307

1.70

21.74

1.5

32.86

32.25

g/l

0.43

361

2050

Fentanyl

135

545

2.51

21.68

1.6

1.4

36.00

29.89

g/l

6.10

129

473

Presence of other functional implants

566

2510

1.57

21.60

1.5

29.88

34.15

g/l

12.20

514

2267

Other cataract

440

2010

1.67

21.60

1.5

30.58

34.03

g/l

6.35

399

1813

Other (not insulin) diabetes medications

788

3186

1.47

21.58

1.5

1.4

32.58

33.56

g/l

1.29

697

2890

Cellulitis

219

1083

2.04

21.55

1.6

1.5

31.61

32.99

g/l

0.84

196

984

Retention of urine

420

2066

1.68

21.55

1.6

1.5

31.67

32.55

g/l

0.67

358

1871

Persons encountering health services for other counselling and medical advice, not elsewhere classified

897

3396

1.44

21.51

1.6

1.4

32.33

33.31

g/l

1.34

809

3045

Osteomyelitis

318

3.03

21.41

1.7

1.5

28.12

31.81

g/l

1.83

289

Nausea and vomiting

254

1297

1.93

21.38

1.6

1.4

30.99

32.43

g/l

0.99

227

1142

Purpura and other haemorrhagic conditions

151

647

2.37

21.34

1.5

30.33

32.62

g/l

1.38

140

585

Pain in limb

665

2949

1.51

21.34

1.5

1.4

32.36

33.46

g/l

1.38

600

2638

Unspecified acute lower respiratory infection

157

684

2.32

21.32

1.4

1.5

31.60

32.54

g/l

0.40

142

614

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

114

429

2.72

21.30

1.7

1.5

30.52

31.84

g/l

0.46

106

390

Other soft tissue disorders, not elsewhere classified

753

2988

1.48

21.26

1.5

1.4

32.08

33.46

g/l

2.05

675

2673

Secondary right heart disease

233

3.42

21.23

1.5

28.27

30.94

g/l

1.09

210

Constipation

781

3712

1.46

21.19

1.5

1.4

32.21

33.04

g/l

1.00

703

3339

Hypotension

234

1196

1.99

21.09

1.6

1.5

29.30

30.79

g/l

1.02

205

1049

L02BG Aromatase inhibitors

235

1199

1.97

21.05

1.4

36.02

32.61

g/l

4.54

216

1091

Mycoses

254

1334

1.92

21.02

1.5

31.88

32.79

g/l

0.47

222

1200

Gastric ulcer

226

1148

1.99

20.71

1.5

28.50

31.82

g/l

3.58

198

1019

Cytomegalovirus infection, IBD co-morbidity

5.81

20.55

1.3

1.4

27.01

32.91

g/l

1.68

Cytomegaloviral disease

5.80

20.54

1.3

1.5

27.01

32.04

g/l

1.33

Polyneuropathies and other disorders of the peripheral nervous system

252

1334

1.91

20.45

1.5

28.99

32.31

g/l

3.65

227

1187

Viral pneumonia (known virus, not influenza)

115

4.53

20.32

1.4

1.5

29.85

31.66

g/l

0.43

102

Examination and observation for other reasons

493

1775

1.61

20.31

1.5

1.4

32.90

33.76

g/l

0.70

450

1600

Chronic pancreatitis

145

627

2.35

20.13

1.5

30.35

33.53

g/l

1.97

133

561

Other or unspecified ileus, impaction or obstruction

223

1145

1.97

19.80

1.4

1.5

32.35

31.91

g/l

0.19

201

1013

Other interstitial pulmonary diseases

204

1019

2.03

19.70

1.5

32.81

31.55

g/l

0.70

179

909

Colorectal cancer

210

1034

2.01

19.62

1.4

1.5

30.80

29.03

g/l

1.16

186

903

Nephrotic syndrome

114

4.44

19.59

1.5

1.4

24.42

32.26

g/l

2.53

102

Biguanides

784

3322

1.44

19.53

1.5

1.4

32.80

33.28

g/l

0.46

691

3008

Other pulmonary heart/vessel disease

256

3.18

19.48

1.5

1.4

28.29

31.09

g/l

1.19

232

Other diseases of intestines

787

3109

1.44

19.41

1.5

1.4

32.85

33.72

g/l

1.01

710

2804

Cardiomyopathy in other diseases

21.47

19.28

1.6

1.5

23.85

35.93

g/l

2.25

Interstitial lung disease

204

1027

2.02

19.28

1.5

32.81

31.54

g/l

0.71

179

916

Interstitial lung disease endpoints

204

1027

2.02

19.28

1.5

32.81

31.54

g/l

0.71

179

916

Left bundle-branch block

216

3.34

19.27

1.3

29.98

37.74

g/l

5.50

203

ILD, hospital admissions

200

1001

2.03

19.22

1.5

32.73

31.50

g/l

0.66

175

895

Decubitus ulcer and pressure area

368

2.76

19.04

1.5

28.63

31.69

g/l

1.73

336

Gout due to impairment of renal function

7.00

19.03

1.5

1.3

23.38

27.77

g/l

0.85

Sequelae of external causes of morbidity and mortality

254

1380

1.86

18.99

1.5

1.4

31.26

32.48

g/l

0.75

226

1244

Alcohol use disorder, ICD-based

375

2281

1.66

18.77

1.5

32.82

33.33

g/l

0.31

335

2044

Exposure to unspecified factor

774

3914

1.43

18.74

1.5

1.4

32.06

33.33

g/l

1.91

690

3527

Pleural plaque with presence of asbestos

138

608

2.33

18.58

1.4

1.5

35.38

30.51

g/l

5.12

130

542

Other disorders involving the immune mechanism, not elsewhere classified

4.58

18.33

1.5

1.4

27.89

31.56

g/l

0.95

Diagnoses used for exclusion with ILD

276

1556

1.79

18.31

1.5

31.15

32.21

g/l

0.70

251

1374

Persons encountering health services in other circumstances

310

1795

1.73

18.28

1.5

1.4

31.22

33.50

g/l

2.19

294

1614

Open wound of head

493

3101

1.54

18.19

1.5

31.62

32.95

g/l

1.61

455

2766

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

138

609

2.29

18.17

1.4

1.5

29.06

27.73

g/l

0.62

124

526

Certain disorders involving the immune mechanism

175

852

2.08

18.08

1.7

1.4

30.95

33.24

g/l

1.45

157

775

Injuries to the thorax

433

2753

1.58

18.04

1.5

1.4

32.54

32.55

g/l

0.01

399

2450

Osteoporosis

270

1417

1.80

17.97

1.5

29.60

31.93

g/l

2.12

238

1266

Malignant neoplasm of head and neck

322

2.81

17.94

1.4

1.5

32.26

28.60

g/l

1.66

278

L04AX Other immunosuppressants

417

2632

1.59

17.89

1.5

1.4

34.73

33.66

g/l

0.90

387

2383

Other disorders of white blood cells

232

3.18

17.89

1.7

1.5

35.10

32.48

g/l

0.85

205

Diabetic retinopathy

371

1393

1.68

17.89

1.5

28.28

31.74

g/l

5.40

321

1236

Falls/tendency to fall

799

2818

1.42

17.86

1.5

1.4

31.97

34.02

g/l

4.10

716

2544

Squamous cell neoplasms and carcinomas of the skin

102

397

2.61

17.82

1.5

29.97

26.81

g/l

1.75

348

Symptoms and signs concerning food and fluid intake

112

456

2.49

17.74

1.4

1.5

31.83

32.73

g/l

0.27

100

416

Left ventricular outflow tract obstruction (LVOTO), broad definition

358

2.69

17.69

1.5

31.86

33.55

g/l

0.58

322

Disorders of thyroid, IBD co-morbidities

133

400

2.35

17.46

1.6

1.3

33.28

35.71

g/l

1.24

119

361

Insulin, fast-acting (human)

118

496

2.40

17.45

1.5

1.4

26.73

33.00

g/l

5.31

100

452

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

333

2.75

17.43

1.7

1.5

29.18

32.13

g/l

1.34

301

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.64

17.39

1.6

1.4

28.69

31.39

g/l

0.60

Chronic ulcer of skin, not elsewhere classified

363

2.67

17.31

1.6

1.5

30.69

31.47

g/l

0.25

332

Other and unspecified polyneuropathies, also in other diseases

221

1187

1.89

17.26

1.6

1.5

29.26

32.09

g/l

2.58

197

1060

Persons encountering health services for specific procedures, not carried out

211

3.21

17.21

1.6

1.4

34.92

32.95

g/l

0.51

189

Malignant neoplasm of colon, including Hilmo

169

829

2.06

17.08

1.4

1.5

31.47

28.73

g/l

2.02

149

716

Second line medication for Crohn's disease

420

2696

1.56

16.79

1.5

1.4

34.69

33.64

g/l

0.89

390

2440

Bronchiectasis

101

404

2.55

16.77

1.6

1.4

33.22

32.01

g/l

0.46

364

Substance use, excluding alcohol

141

653

2.18

16.59

1.4

1.5

36.53

34.50

g/l

1.15

129

591

Aortic valve malfunction, age under 60 years

336

2.69

16.56

1.5

31.50

33.38

g/l

0.64

300

Problems related to lifestyle

308

2.76

16.50

1.5

1.4

35.31

33.82

g/l

0.45

279

Angina pectoris

491

2155

1.53

16.46

1.6

1.4

30.75

35.16

g/l

10.67

430

1971

Lung diseases due to external agents

182

933

1.98

16.40

1.5

31.21

30.88

g/l

0.13

165

824

Persons with potential health hazards related to communicable diseases

197

1026

1.91

16.30

1.5

1.4

32.74

34.67

g/l

1.14

169

936

ILD medications: azathioprine

108

452

2.41

16.16

1.5

1.4

31.90

33.54

g/l

0.58

100

409

Status post-ami

302

1365

1.70

16.10

1.5

1.4

28.39

34.28

g/l

11.28

259

1249

Intracranial trauma

418

1882

1.57

16.00

1.5

1.4

31.84

34.52

g/l

3.77

374

1686

Multiple myeloma, including Hilmo

176

3.38

15.94

1.3

1.5

29.32

27.19

g/l

0.44

155

Diabetic retinopathy, strict definition

190

875

1.94

15.94

1.6

1.5

26.11

32.06

g/l

7.81

161

773

Fracture of rib(s), sternum and thoracic spine

304

1833

1.67

15.89

1.5

32.54

32.34

g/l

0.10

278

1623

396

2.50

15.83

1.5

1.4

35.95

33.46

g/l

1.11

357

Other disorders of skin and subcutaneous tissue, not elsewhere classified

151

733

2.09

15.82

1.5

30.56

32.02

g/l

0.78

142

666

Malignant melanoma

121

538

2.27

15.80

1.6

1.5

31.44

28.62

g/l

1.66

109

467

Unspecified privation

110

470

2.37

15.79

1.6

1.5

32.02

31.98

g/l

0.01

427

Malignant melanoma, including Hilmo

143

680

2.12

15.79

1.7

1.5

31.36

28.86

g/l

1.65

127

587

Immunodeficiencies

148

3.58

15.75

1.8

1.4

32.91

32.73

g/l

0.03

126

Other embolism and thrombosis

142

675

2.13

15.74

1.6

1.5

30.05

32.19

g/l

1.19

131

609

Malnutrition

4.63

15.55

1.7

1.4

24.21

32.15

g/l

2.54

Abnormal results of function studies

296

2.74

15.50

1.7

1.5

33.02

32.46

g/l

0.13

269

Reimbursement for rheumatic diseases

437

2878

1.52

15.32

1.4

1.5

34.22

33.21

g/l

0.86

404

2583

Other symptoms and signs involving the circulatory and respiratory systems

206

3.10

15.26

1.5

1.3

32.24

33.19

g/l

0.21

192

Benign neoplasms

744

2947

1.40

15.24

1.5

1.4

32.44

33.41

g/l

1.15

665

2656

317

1937

1.63

15.15

1.4

32.62

33.08

g/l

0.26

291

1730

In situ neoplasms

354

2243

1.59

15.13

1.4

1.5

31.61

32.05

g/l

0.27

308

2005

Dermatitis

492

3332

1.48

15.09

1.5

1.4

32.97

33.02

g/l

0.03

446

2987

Congenital malformations of heart and great arteries

394

2.43

14.91

1.6

1.5

31.25

33.32

g/l

0.89

353

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

130

590

2.16

14.90

1.7

1.5

29.18

33.64

g/l

3.73

116

533

Other special examinations and investigations of persons without complaint or reported diagnosis

531

1819

1.48

14.81

1.6

1.4

31.92

33.67

g/l

2.21

481

1639

Injuries to the abdomen, lower back, lumbar spine and pelvis

353

2223

1.58

14.75

1.6

1.5

31.85

32.29

g/l

0.26

320

1969

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

124

554

2.19

14.74

1.7

1.5

29.22

33.61

g/l

3.39

110

501

Haemorrhage, not elsewhere classified

196

3.14

14.68

1.5

1.4

29.59

32.18

g/l

0.89

177

ILD, hospital admissions 1, main diag only

171

894

1.94

14.63

1.5

32.18

31.54

g/l

0.25

148

799

Gastrointestinal diseases

362

1129

1.61

14.58

1.5

1.4

32.62

34.57

g/l

1.88

322

1031

Thrombocytopenia, unspecified

324

2.61

14.54

1.5

30.68

32.34

g/l

0.60

292

Candidiasis

120

553

2.19

14.41

1.5

32.09

32.63

g/l

0.15

105

501

Other and unspecified disorders of white blood cells

178

3.23

14.34

1.7

1.4

32.99

31.95

g/l

0.22

159

Colorectal adenocarcinoma

170

889

1.92

14.33

1.3

1.5

31.06

28.77

g/l

1.46

153

770

Symptoms and signs involving cognition, perception, emotional state and behaviour

753

3760

1.37

14.33

1.5

32.09

33.29

g/l

1.71

665

3403

Covid-19 suspected case

138

672

2.07

14.32

1.6

1.5

34.37

33.50

g/l

0.34

123

605

Hernia

723

3530

1.38

14.20

1.5

1.4

32.23

33.26

g/l

1.35

649

3165

Open wound of lower leg

135

657

2.08

14.09

1.6

1.5

30.54

32.55

g/l

1.07

115

600

Sulfasalazine

209

1177

1.79

14.01

1.4

36.04

33.50

g/l

2.07

186

1065

Tobacco use

165

3.27

13.99

1.5

34.87

33.25

g/l

0.37

144

Azathioprine

108

483

2.25

13.94

1.5

31.90

33.46

g/l

0.55

100

438

Artificial opening status

240

2.85

13.91

1.5

1.4

31.61

33.41

g/l

0.53

219

Elevated blood glucose level

350

2.49

13.81

1.5

29.43

32.22

g/l

1.04

319

Asthma and opportunity respiratory infection

236

2.87

13.78

1.5

1.4

33.54

31.71

g/l

0.56

214

Unstable angina pectoris

371

1901

1.55

13.78

1.5

1.4

30.12

34.48

g/l

8.15

323

1734

Sequelae with surgical and medical care as external cause

196

1090

1.82

13.77

1.5

31.53

32.30

g/l

0.35

177

978

Discitis, unspecified

4.70

13.68

1.3

1.5

34.16

29.34

g/l

0.96

Diverticular disease of intestine

632

2894

1.40

13.59

1.5

1.4

31.19

33.33

g/l

3.70

563

2605

Benzodiazepine use

774

3956

1.35

13.56

1.5

34.03

32.83

g/l

1.86

704

3555

Other external causes of accidental injury

613

2172

1.42

13.56

1.6

1.4

31.87

34.04

g/l

3.70

551

1950

Rheumatoid arthritis

298

1666

1.61

13.49

1.4

34.78

33.31

g/l

1.17

278

1483

Other and unspecified dermatitis

401

2680

1.50

13.47

1.5

32.37

33.32

g/l

0.75

361

2407

Malignant neoplasm of oral cavity, including Hilmo

144

3.40

13.45

1.4

1.5

31.17

28.00

g/l

0.74

128

Malignant neoplasm of colon

129

632

2.06

13.25

1.4

1.5

30.99

28.41

g/l

1.45

116

540

Cholelithiasis, broad definition with cholecystitis

705

3486

1.37

13.20

1.4

1.5

32.30

33.05

g/l

0.78

631

3137

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

227

1337

1.71

13.06

1.4

1.5

35.32

32.33

g/l

2.71

209

1201

Seropositive rheumatoid arthritis

232

1369

1.70

13.06

1.4

35.40

33.05

g/l

1.89

214

1217

Diarrhoea and gastroenteritis of presumed infectious origin

759

3722

1.35

13.05

1.5

1.4

31.34

33.64

g/l

4.76

687

3350

Candidiasis

202

1151

1.77

13.05

1.6

1.5

32.05

33.04

g/l

0.48

183

1038

Fracture of lumbar spine and pelvis

229

1351

1.71

13.04

1.6

1.5

30.81

31.53

g/l

0.36

203

1190

Accidents

608

2172

1.41

12.88

1.6

1.4

31.83

34.04

g/l

3.79

545

1950

Autoimmune diseases related-to ILD

623

3880

1.38

12.81

1.5

1.4

32.03

33.28

g/l

1.56

565

3488

Rheumatoid arthritis, including avohilmo

315

2025

1.56

12.73

1.4

1.5

34.73

32.45

g/l

2.52

294

1810

Thyrotoxicosis, other and/or unspecified

149

779

1.93

12.72

1.6

1.5

30.80

32.96

g/l

1.32

133

704

Abnormal findings on diagnostic imaging of other body structures

115

549

2.12

12.69

1.8

1.4

33.48

31.71

g/l

0.70

106

500

Viral infections characterized by skin and mucous membrane lesions

313

2010

1.56

12.65

1.6

1.4

31.76

33.12

g/l

1.14

276

1813

Aortic aneurysm

271

1657

1.62

12.54

1.4

1.5

31.10

32.98

g/l

1.72

245

1504

Genitourinary diseases

421

1412

1.50

12.49

1.5

1.4

31.62

35.76

g/l

8.18

377

1287

Other diseases of intestine

150

793

1.91

12.45

1.5

1.4

29.53

32.30

g/l

1.51

132

717

Delirium, not induced by alcohol and other psychoactive substances

155

828

1.89

12.42

1.4

1.5

31.58

30.52

g/l

0.44

135

724

Dysphagia

232

1394

1.68

12.42

1.5

1.4

31.62

32.56

g/l

0.59

217

1236

Congenital malformations of the circulatory system

105

473

2.17

12.35

1.6

1.5

30.69

33.97

g/l

1.92

425

Disorders of mineral metabolism

351

2.40

12.31

1.5

1.4

31.55

33.15

g/l

0.50

320

Seropositive rheumatoid arthritis, wide

232

1399

1.67

12.26

1.4

1.5

35.40

32.43

g/l

2.77

214

1253

Other infectious diseases

100

459

2.21

12.25

1.7

1.5

31.00

31.38

g/l

0.10

418

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

102

472

2.19

12.24

1.5

32.56

32.22

g/l

0.09

421

Medical observation and evaluation for suspected diseases and conditions

508

1819

1.43

12.03

1.5

1.4

31.65

33.67

g/l

2.78

460

1639

Vascular disorders of the intestines

412

2.27

12.00

1.6

1.4

27.64

30.95

g/l

1.66

375

Cutaneous abscess, furuncle and carbuncle

196

1136

1.74

11.98

1.6

1.4

31.39

33.39

g/l

1.27

183

1030

Thyrotoxicosis

183

1042

1.77

11.91

1.5

31.03

33.10

g/l

1.38

164

939

Other complications of surgical and medical care, not elsewhere classified

376

2.31

11.82

1.5

33.68

33.08

g/l

0.17

346

Other arthritis (FG)

249

1546

1.62

11.72

1.5

1.4

32.74

33.79

g/l

0.70

236

1383

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

143

755

1.89

11.70

1.4

1.5

36.17

34.74

g/l

0.65

130

699

Other/unspecified seropositive rheumatoid arthritis

227

1379

1.66

11.68

1.4

1.5

35.32

32.43

g/l

2.56

209

1234

Obesity related asthma

254

1586

1.61

11.67

1.5

32.86

33.61

g/l

0.44

232

1437

Pulmonary oedema

3.77

11.63

1.5

1.4

24.87

29.52

g/l

1.46

Adenocarcinoma and ductal carcinoma of pancreas

128

3.36

11.56

1.1

1.5

35.72

27.12

g/l

1.97

113

Phlebitis and thrombophlebitis (not including DVT)

194

1137

1.72

11.44

1.4

1.5

34.07

32.76

g/l

0.67

176

1014

Other gastritis (incl. Duodenitis)

214

1288

1.67

11.44

1.6

1.4

30.48

32.78

g/l

1.70

185

1150

Congenital malformations, deformations and chromosomal abnormalities

333

2109

1.51

11.43

1.6

1.4

32.00

34.04

g/l

2.33

307

1912

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

351

2.34

11.39

1.5

1.4

31.90

33.14

g/l

0.35

316

Acute pancreatitis

185

1072

1.74

11.38

1.5

30.73

32.47

g/l

1.03

163

957

Malignant neoplasm of pancreas, including Hilmo

334

2.37

11.28

1.3

1.5

34.57

27.55

g/l

3.18

291

Sulfonylureas

403

2217

1.46

11.24

1.6

1.5

29.21

32.03

g/l

4.15

345

1995

Vitreous haemorrhage

105

509

2.09

11.22

1.5

28.82

31.96

g/l

1.65

457

Finngen Rheumatological endpoints

682

2898

1.34

11.21

1.5

1.4

32.54

33.56

g/l

1.23

626

2590

Other infectious diseases

386

2.26

11.18

1.7

1.5

31.22

31.62

g/l

0.10

353

Chronic nephritic syndrome

157

3.06

11.13

1.9

1.4

25.43

32.55

g/l

2.14

141

Malignant melanoma of skin, including Hilmo

110

545

2.04

11.05

1.7

1.5

31.41

28.68

g/l

1.67

473

Injury of other and unspecified intrathoracic organs

307

2.42

11.03

1.4

1.5

34.60

31.80

g/l

1.11

274

Other diseases of arteries and capillaries

415

2.20

10.94

1.6

1.4

27.74

32.61

g/l

2.89

369

Other nutritional deficiencies

417

2755

1.43

10.89

1.5

1.4

33.35

33.75

g/l

0.27

386

2493

Abdominal and pelvic pain

742

2822

1.32

10.88

1.5

1.4

32.20

33.37

g/l

1.49

668

2539

Periodontitis

734

3742

1.32

10.82

1.5

33.60

33.04

g/l

0.56

662

3371

Chronic apical periodontitis

829

3645

1.30

10.81

1.5

1.4

33.42

33.02

g/l

0.38

744

3284

Use of anticholinesterases

186

2429

0.60

10.79

1.3

1.5

30.74

31.20

g/l

0.22

165

2152

N06DA Anticholinesterases

186

2429

0.60

10.79

1.3

1.5

30.74

31.20

g/l

0.22

165

2152

Pneumonitis due to solids and liquids

105

518

2.06

10.75

1.6

1.5

29.03

30.47

g/l

0.48

457

Poisoning by drugs, medicaments and biological substances

135

725

1.87

10.69

1.4

1.5

36.04

33.77

g/l

1.16

122

660

Syphilis

3.81

10.65

1.6

1.5

28.69

34.09

g/l

1.48

Syphilis

3.81

10.65

1.6

1.5

28.69

34.09

g/l

1.48

Infection of intervertebral disc (pyogenic)

4.52

10.64

1.8

1.5

32.44

30.57

g/l

0.26

Chronic periodontitis, complicated

439

3103

1.41

10.58

1.4

1.5

33.76

33.14

g/l

0.48

391

2813

Amputation of ankle bones

126

3.28

10.53

1.5

24.03

30.80

g/l

2.14

114

Chronic periodontitis, including avohilmo

729

3736

1.31

10.53

1.5

33.59

33.06

g/l

0.52

657

3367

Malignant neoplasm of pancreas

265

2.49

10.51

1.3

1.5

34.52

27.13

g/l

2.87

236

Diabetic maculopathy

129

650

1.89

10.34

1.6

1.5

26.28

31.64

g/l

4.44

108

576

Dentofacial anomalies [including malocclusion]

158

2169

0.58

10.32

1.6

1.4

35.27

34.30

g/l

0.48

150

1990

Thyrotoxicosis with toxic multinodular goitre

274

2.45

10.29

1.7

1.4

33.00

32.47

g/l

0.13

248

Disorders of calcium metabolism

280

2.43

10.29

1.5

1.4

32.61

32.73

g/l

0.03

256

Congenital malformations of cardiac septa

153

2.94

10.26

1.9

1.4

29.46

32.46

g/l

0.91

134

Arterial embolism and thrombosis

324

2.32

10.24

1.4

26.50

31.36

g/l

2.49

290

Unspecified fall

405

2824

1.42

10.21

1.4

1.5

31.34

32.80

g/l

1.49

367

2525

Seropositive rheumatoid arthritis, strict definition

125

666

1.89

10.21

1.4

1.5

37.41

32.52

g/l

3.30

114

600

Other and unspecified local infections of skin and subcutaneous tissue

401

2.17

10.19

1.7

1.5

31.18

32.52

g/l

0.44

364

Malignant neoplasm of oral cavity

108

3.40

10.17

1.4

1.5

31.72

27.13

g/l

1.09

Disorders of other endocrine glands

304

2007

1.50

10.13

1.5

1.4

31.05

32.78

g/l

1.45

276

1793

Malignant neoplasm of tongue, including Hilmo

3.84

10.10

1.5

1.4

32.80

26.91

g/l

1.22

Other specified/unspecified systemic involvement of connective tissue

183

2.77

10.04

1.3

31.78

33.88

g/l

0.47

161

Congenital malformations, deformations and chromosomal abnormalities

366

2346

1.44

10.03

1.6

1.4

32.23

34.01

g/l

2.02

338

2125

Other antidepressants

811

3225

1.29

10.01

1.5

33.36

32.93

g/l

0.40

736

2907

Thoracic aortic aneurysm

147

831

1.79

9.97

1.4

1.5

31.86

33.64

g/l

1.04

136

747

Malignant neoplasm of bladder, including Hilmo

121

641

1.90

9.88

1.4

1.5

31.36

28.64

g/l

1.57

102

559

Supplementary factors related to causes of morbidity and mortality classified elsewhere

230

1467

1.58

9.76

1.5

31.83

32.84

g/l

0.54

209

1319

DVT of lower extremities

181

1090

1.67

9.75

1.4

1.5

32.22

32.09

g/l

0.04

158

958

Persons encountering health services for examination and investigation

500

1819

1.38

9.75

1.5

1.4

32.19

33.67

g/l

1.73

448

1639

Diseases of the myoneural junction and muscle

122

656

1.88

9.74

1.5

31.24

31.86

g/l

0.20

112

586

Intracranial injury

452

3107

1.38

9.71

1.5

31.57

33.10

g/l

1.72

404

2780

Drug-induced hypoglycaemia without coma

4.05

9.68

1.6

1.4

27.45

29.84

g/l

0.40

Concussion

334

1876

1.46

9.56

1.5

1.4

32.44

34.50

g/l

2.17

307

1680

Malignant neoplasm of rectum, including Hilmo

499

2.00

9.55

1.4

1.5

30.63

28.68

g/l

0.74

435

Zoster [herpes zoster]

172

1028

1.69

9.55

1.6

1.5

31.26

31.65

g/l

0.15

154

919

Duodenal ulcer

129

711

1.84

9.54

1.4

32.46

31.70

g/l

0.25

116

631

Cholecystitis

147

842

1.76

9.53

1.3

1.5

33.72

31.23

g/l

1.26

128

746

Injury, poisoning and certain other consequences of external causes

378

1314

1.45

9.51

1.6

1.4

32.72

34.37

g/l

1.64

346

1176

Benign neoplasm: Colon, unspecified

251

1645

1.54

9.50

1.5

30.04

32.34

g/l

2.04

204

1470

Other/unspecified rheumatoid arthritis

118

633

1.88

9.50

1.5

32.80

31.58

g/l

0.51

111

569

Systemic connective tissue disorders

278

1861

1.50

9.47

1.5

31.05

32.63

g/l

1.28

251

1671

External causes of morbidity and mortality

456

1642

1.40

9.42

1.6

1.4

32.19

34.24

g/l

2.71

417

1467

Mixed connective tissue disease

207

2.59

9.40

1.4

32.41

33.50

g/l

0.20

181

Other (seronegative) rheumatoid arthritis, wide

159

937

1.71

9.31

1.4

1.5

32.83

32.08

g/l

0.33

150

841

Fitting and adjustment of other devices

290

1769

1.49

9.30

1.4

30.35

32.07

g/l

1.44

267

1570

Acute posthaemorrhagic anaemia

163

2.82

9.29

1.2

1.4

31.90

31.03

g/l

0.16

150

Pain (limb, back, neck, head abdominally)

578

2167

1.34

9.28

1.6

1.4

31.41

33.68

g/l

3.79

510

1953

Tubulo-interstitial nephritis, not specified as acute or chronic

275

2.36

9.26

1.5

30.33

32.30

g/l

0.69

249

Other noninfective gastroenteritis and colitis

188

1158

1.63

9.24

1.4

1.5

31.71

32.39

g/l

0.30

166

1035

Cholelithiasis

651

3451

1.30

9.15

1.4

1.5

32.14

33.05

g/l

1.01

579

3102

Other local infections of skin and subcutaneous tissue

440

2.04

9.10

1.7

1.5

31.43

32.82

g/l

0.48

399

Other and unspecified drugs and medicaments

341

2.19

9.09

1.5

31.70

32.70

g/l

0.26

306

Other viral diseases

163

970

1.68

9.06

1.4

1.5

33.24

33.75

g/l

0.19

152

881

Sequelae of cerebrovascular disease

377

2320

1.41

9.03

1.4

1.5

30.56

32.46

g/l

2.01

334

2089

Tuberculosis, IBD comorbidity

442

2.04

9.03

1.4

1.5

35.30

30.48

g/l

2.47

400

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

421

2.05

8.99

1.3

1.4

36.67

34.79

g/l

0.63

379

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

226

1465

1.55

8.97

1.5

31.21

33.58

g/l

2.08

207

1340

Mycoses

591

3932

1.31

8.93

1.5

1.4

33.05

33.19

g/l

0.09

520

3552

Vascular diseases of the intestine

213

2.54

8.93

1.4

27.35

31.06

g/l

1.25

193

Disease of hard tissues of teeth, NOS

251

1968

0.66

8.92

1.6

1.5

33.65

32.90

g/l

0.44

234

1766

Asthma, including avohilmo

860

3842

1.26

8.91

1.5

1.4

32.56

33.19

g/l

0.76

783

3447

ILD-related respiratory insufficiency

196

2.62

8.91

1.4

1.5

31.99

31.26

g/l

0.15

176

Fracture of lower leg, including ankle

393

2809

1.39

8.88

1.5

32.17

33.68

g/l

1.62

352

2532

Malignant neoplasm of rectum

384

2.10

8.86

1.4

1.5

30.52

28.40

g/l

0.69

331

Other specified/unspecified arthritis

215

1384

1.56

8.83

1.5

1.4

32.73

33.81

g/l

0.64

203

1238

Acute pancreatitis (for exclusion)

185

1151

1.62

8.81

1.5

30.73

32.31

g/l

0.91

163

1035

Fracture of shoulder and upper arm

287

1962

1.47

8.79

1.5

31.00

32.67

g/l

1.43

257

1754

malignant neoplasm of male genital organs

247

983

1.54

8.76

1.5

31.70

30.47

g/l

0.71

205

867

Chronic gastritis

258

1732

1.50

8.74

1.5

1.4

30.55

32.35

g/l

1.48

222

1542

Other and unspecified myopathies

475

1.98

8.72

1.5

30.63

31.30

g/l

0.20

428

Other neurological diseases

613

3711

1.30

8.72

1.5

30.30

32.99

g/l

5.67

552

3328

Acidosis

3.50

8.57

1.5

29.46

32.42

g/l

0.51

Disorder of lipoprotein metabolism, unspecified

132

758

1.76

8.54

1.5

1.4

30.96

32.65

g/l

0.77

119

680

Use of rivastigmine

1171

0.44

8.47

1.4

1.5

28.65

30.43

g/l

0.54

1026

Colon adenocarcinoma

501

1.93

8.44

1.3

1.5

31.12

28.05

g/l

1.49

430

Type of accident

211

1368

1.55

8.41

1.5

31.55

32.87

g/l

0.74

192

1230

Superficial injury of head

184

1156

1.60

8.41

1.5

31.25

32.21

g/l

0.49

170

1019

Other symptoms and signs involving the digestive system and abdomen

119

666

1.80

8.38

1.5

1.4

33.52

32.95

g/l

0.17

112

606

Malignant melanoma of skin

406

2.04

8.38

1.6

1.5

30.92

28.67

g/l

0.98

351

Drug-induced osteoporosis with pathological fracture

4.20

8.33

1.5

1.2

25.75

31.99

g/l

1.11

Poisoning by medicine

114

631

1.82

8.31

1.3

1.5

35.54

33.78

g/l

0.76

103

571

Other viral diseases

191

1204

1.58

8.30

1.4

1.5

32.78

34.23

g/l

0.84

175

1095

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

3.90

8.29

1.5

1.3

33.49

25.76

g/l

1.55

Dissection of aorta

162

2.71

8.28

1.5

1.4

31.33

31.78

g/l

0.08

147

Arthropathies in other diseases classified elsewhere

145

2.81

8.27

1.6

1.4

29.47

33.03

g/l

0.89

128

Attention to artificial openings

162

2.70

8.26

1.2

1.3

32.07

31.71

g/l

0.06

145

Neurological diseases, wide definition

150

436

1.73

8.18

1.5

1.3

32.31

36.04

g/l

2.33

132

392

General examination and investigation of persons without complaint and reported diagnosis

468

1809

1.35

8.18

1.5

1.4

32.81

33.68

g/l

0.71

441

1630

Other diseases of urinary system

757

3371

1.26

8.18

1.5

1.4

31.51

33.30

g/l

3.07

663

3054

Other diseases of pancreas

424

2.01

8.18

1.4

1.5

31.21

32.63

g/l

0.43

381

Noninfectious colitis NAS

106

578

1.85

8.15

1.3

1.5

30.89

32.53

g/l

0.60

525

Congenital malformations of the urinary system

175

2.60

8.10

1.7

1.3

26.63

32.54

g/l

2.42

153

Migraine, single triptan purchase ok & required. ICD-code if available is included

192

2004

0.65

8.08

1.4

35.27

34.57

g/l

0.34

172

1839

Triptan medication for migraine, single purchase ok

192

2004

0.65

8.08

1.4

35.27

34.57

g/l

0.34

172

1839

Any mental disorder

814

3256

1.25

8.03

1.4

1.5

32.97

33.21

g/l

0.20

727

2944

Suicide or other Intentional self-harm

140

831

1.69

8.02

1.4

1.5

36.01

34.15

g/l

0.93

127

756

Noninfective enteritis and colitis

316

2238

1.42

8.02

1.4

1.5

31.07

33.43

g/l

2.47

285

2003

Multiple myeloma and malignant plasma cell neoplasms

275

2.26

8.01

1.4

1.5

30.10

31.18

g/l

0.21

247

Septal defects

144

2.75

7.98

1.8

1.4

31.35

32.33

g/l

0.21

126

Viral infections characterized by skin and mucous membrane lesions

589

3914

1.29

7.94

1.5

1.4

32.11

33.31

g/l

1.51

524

3527

Other and unspecified coagulation defects

126

2.89

7.92

1.6

1.4

33.02

32.73

g/l

0.04

110

Weight loss

499

1.90

7.90

1.4

1.5

32.56

32.19

g/l

0.09

450

Familial hypercholesterolemia

149

905

1.66

7.88

1.7

1.4

31.30

32.59

g/l

0.62

141

804

Pyogenic arthritis

342

2.10

7.86

1.5

29.36

32.68

g/l

1.28

310

Obesity due to excess calories

275

1912

1.44

7.80

1.5

33.45

33.94

g/l

0.26

254

1737

Corns and callosities

284

2.21

7.80

1.5

33.43

32.59

g/l

0.19

255

Tuberculosis, wide

468

1.93

7.73

1.4

1.5

35.30

30.41

g/l

2.54

420

Thiazolidinediones

117

670

1.77

7.71

1.7

1.4

32.55

32.16

g/l

0.12

101

608

Sequelae of other external causes

223

2.36

7.64

1.5

1.4

28.27

32.37

g/l

1.62

198

Carcinoma in situ of skin of other and unspecified parts of face

106

593

1.81

7.60

1.5

30.07

30.75

g/l

0.22

533

Intestinal malabsorption

146

2.71

7.59

1.9

1.4

25.68

34.08

g/l

3.01

128

Alcohol dependence

216

1443

1.51

7.56

1.6

1.5

34.66

33.39

g/l

0.76

196

1284

Obesity

373

2650

1.36

7.52

1.5

1.4

33.59

33.85

g/l

0.15

345

2400

Other coagulation defects

256

2.25

7.52

1.5

1.4

30.87

32.90

g/l

0.49

229

Malignant neoplasm of thyroid gland

136

2.74

7.44

1.5

32.72

28.97

g/l

1.09

120

Volvulus

131

2.81

7.44

1.4

28.44

29.19

g/l

0.11

121

Malignant neoplasm of prostate

241

972

1.49

7.43

1.5

31.50

30.48

g/l

0.55

200

858

Degeneration of macula and posterior pole

472

2864

1.32

7.38

1.4

1.5

29.85

32.34

g/l

4.24

430

2566

Obesity and other hyperalimentation

374

2666

1.35

7.33

1.5

1.4

33.56

33.87

g/l

0.19

346

2415

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

143

875

1.64

7.33

1.4

1.5

36.17

34.29

g/l

0.97

130

799

Embolic stroke with flimmer

110

2.97

7.31

1.3

1.4

24.64

33.37

g/l

3.19

100

Adenocarcinoma and papilloma adenocarcinoma of rectum

380

1.99

7.25

1.4

1.5

30.98

28.28

g/l

0.97

326

Asthma, hospital admissions , main diagnosis only

562

3881

1.28

7.25

1.5

1.4

32.42

33.15

g/l

0.76

512

3487

Exclusions for E4_PCOS_CONSORTIUM

362

1657

1.37

7.19

1.4

34.84

33.00

g/l

1.76

327

1500

Methotrexate

100

558

1.80

7.19

1.3

1.4

34.83

32.83

g/l

0.80

505

Tuberculosis

403

1.96

7.18

1.4

1.5

36.02

30.31

g/l

2.90

362

Open wound of ankle and foot

396

1.96

7.14

1.6

1.5

30.91

32.81

g/l

0.55

359

Other functional intestinal disorders

355

2429

1.36

7.11

1.5

1.4

31.96

33.09

g/l

0.91

316

2182

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

397

1.96

7.09

1.4

1.5

30.74

28.53

g/l

0.73

343

Respiratory tuberculosis, confirmed and not-confirmed

337

2.05

7.05

1.4

1.5

37.29

31.14

g/l

2.88

301

Respiratory tuberculosis

337

2.05

7.05

1.4

1.5

37.29

31.14

g/l

2.88

301

Chronic diseases of tonsils and adenoids

263

2349

0.71

7.03

1.4

34.19

34.25

g/l

0.03

242

2143

Congenital malformations of the urinary system

195

2.38

6.96

1.7

1.4

26.66

32.07

g/l

2.23

171

Malignant neoplasm of corpus uteri, including Hilmo

240

2.23

6.88

1.3

1.4

33.04

27.11

g/l

2.61

200

Osteonecrosis

260

2.18

6.87

1.4

1.5

33.57

32.31

g/l

0.33

239

Other symptoms and signs involving the urinary system

100

567

1.78

6.87

1.7

1.5

30.00

31.82

g/l

0.81

510

Malignant neoplasm of corpus uteri

209

2.32

6.83

1.3

1.5

32.30

26.83

g/l

2.16

174

Other disorders of veins

280

1994

1.40

6.80

1.5

33.24

33.34

g/l

0.04

254

1788

Zoster [herpes zoster]

392

2914

1.33

6.78

1.6

1.4

31.95

32.72

g/l

0.59

355

2618

Other disorders of urethra and urinary system

524

2953

1.28

6.77

1.5

1.4

31.61

33.10

g/l

1.79

458

2677

Personality disorders, excluding more controls

110

644

1.71

6.70

1.5

36.87

35.66

g/l

0.41

103

592

Complications of internal orthopaedic prosthetic devices, implants and grafts

200

1352

1.49

6.68

1.5

1.4

31.50

32.37

g/l

0.46

169

1214

Alcohol withdrawal state with delirium

330

2.02

6.68

1.4

1.5

32.46

32.73

g/l

0.05

294

Malignant neoplasm of tongue

3.78

6.68

1.5

1.4

34.10

26.49

g/l

1.32

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

15.54

6.53

1.4

1.3

36.28

25.87

g/l

—

Diseases of the eye and adnexa

477

1836

1.30

6.53

1.5

1.4

33.29

35.08

g/l

2.19

433

1666

L01XX Other antineoplastic agents

313

2.04

6.52

1.3

1.5

31.93

32.21

g/l

0.07

284

Other spirochaetal diseases

1483

0.56

6.51

1.4

1.5

34.11

33.52

g/l

0.17

1350

Dizziness and giddiness

565

3554

1.26

6.49

1.5

32.00

33.07

g/l

1.21

504

3212

Postmenopausal atrophic vaginitis

719

0.53

6.48

1.4

33.28

32.70

g/l

0.15

635

Statin medication

405

1720

1.33

6.43

1.5

1.4

31.20

35.28

g/l

7.91

356

1577

Benign neoplasm: Transverse colon

106

624

1.72

6.42

1.4

1.5

33.06

32.46

g/l

0.20

563

Other reaction to severe stress, and adjustment disorders

164

1072

1.53

6.41

1.4

35.02

34.49

g/l

0.20

147

983

Unspecific neurodegenerative disorder

275

2585

0.72

6.39

1.3

1.5

30.45

31.49

g/l

0.78

244

2307

Other diseases of biliary tract

448

1.85

6.39

1.5

1.4

30.27

31.45

g/l

0.34

407

Other spirochaetal diseases

1498

0.57

6.36

1.5

33.93

33.53

g/l

0.11

1363

Lyme disease

1470

0.57

6.32

1.4

1.5

34.11

33.53

g/l

0.17

1337

Spirochaetal infections, other/unspecified

1482

0.57

6.31

1.5

33.93

33.51

g/l

0.12

1348

Right hemicolectomy

331

1.99

6.29

1.3

1.5

29.05

31.58

g/l

0.74

302

Arterial embolism and thrombosis of lower extremity artery

180

2.37

6.26

1.5

1.4

27.29

31.30

g/l

1.30

164

Cystic kidney disease

109

2.80

6.24

1.7

1.4

25.52

32.12

g/l

2.10

Abnormal weight loss

459

1.83

6.24

1.4

1.5

32.90

32.31

g/l

0.13

412

Other viral diseases, not elsewhere classified

109

649

1.68

6.22

1.4

1.5

34.13

32.95

g/l

0.43

103

590

Malignant neoplasm of prostate, including Hilmo

238

989

1.44

6.17

1.5

32.22

30.44

g/l

1.20

197

875

Malignant neoplasm of stomach, including Hilmo

252

2.13

6.15

1.4

1.5

32.90

26.96

g/l

2.82

222

Actinic keratosis

385

2731

1.31

6.05

1.5

31.36

31.71

g/l

0.22

334

2438

Injury of intra-abdominal organs

3.50

6.03

1.5

35.60

33.37

g/l

0.32

Benign neoplasm: Ascending colon

132

836

1.59

6.02

1.7

1.5

30.67

32.15

g/l

0.80

118

751

Abscess of anal and rectal regions

296

2.01

5.94

1.5

33.40

33.60

g/l

0.04

270

Psychiatric diseases

729

2987

1.22

5.93

1.5

32.98

33.27

g/l

0.24

651

2702

Abnormal findings in nipple discharge synovial fluid wound secretions

4.09

5.93

1.3

1.4

31.73

33.81

g/l

0.26

Other and unspecified nonorganic psychotic disorders

532

1.74

5.92

1.5

35.01

34.68

g/l

0.09

481

Carcinoma in situ of skin

519

1.75

5.91

1.4

1.5

31.88

31.24

g/l

0.18

471

Transient ischemic attack

468

2979

1.28

5.90

1.5

29.61

33.05

g/l

6.98

417

2696

Epilepsy

238

1699

1.40

5.87

1.4

1.5

32.87

32.81

g/l

0.03

224

1520

Soft tissue disorders

716

3018

1.22

5.83

1.5

1.4

31.19

33.46

g/l

4.58

640

2700

Diabetic neuropathy

119

738

1.62

5.82

1.6

1.5

27.54

31.26

g/l

2.07

647

Injuries to the knee and lower leg

825

3807

1.20

5.81

1.5

1.4

31.79

33.37

g/l

2.99

734

3432

Carbimazole or st.post thyroidectomy, condition for graves disease

122

766

1.60

5.75

1.5

31.87

32.83

g/l

0.36

112

694

Skin changes due to chronic exposure to nonionizing radiation

389

2773

1.30

5.75

1.5

31.35

31.74

g/l

0.26

336

2476

Other specified disorders of kidney and ureter

126

2.58

5.73

1.1

1.4

27.13

31.90

g/l

0.94

113

Intestinal adhesions without obstruction

428

1.82

5.72

1.4

30.31

31.63

g/l

0.43

389

Smoking dependency

329

1.93

5.68

1.3

1.5

36.37

33.21

g/l

1.23

294

Retinal vascular disorders

124

786

1.59

5.67

1.5

29.61

31.19

g/l

0.74

109

699

Injuries to the elbow and forearm

446

3084

1.27

5.66

1.4

31.50

33.50

g/l

2.54

400

2761

Marginal zone B-cell lymphoma, including Hilmo

3.61

5.64

2.2

1.1

29.54

28.24

g/l

0.16

Diseases of the musculoskeletal system and connective tissue

348

1313

1.33

5.62

1.6

1.4

32.66

34.30

g/l

1.49

309

1166

Alzheimer disease, including avohilmo

241

2329

0.72

5.61

1.4

1.5

30.79

31.26

g/l

0.25

213

2062

Mental and behavioural disorders due to tobacco

331

1.92

5.58

1.3

1.5

36.37

33.36

g/l

1.14

297

Diaphragmatic hernia

289

2156

1.35

5.56

1.5

31.92

32.73

g/l

0.53

258

1932

Other and unspecified vascular occlusions

582

1.68

5.54

1.5

30.82

31.35

g/l

0.16

516

401

2869

1.29

5.51

1.5

31.51

31.85

g/l

0.22

346

2562

Abdominal aortic aneurysm (AAA)

124

785

1.58

5.51

1.5

29.88

31.89

g/l

0.95

111

696

Acute upper respiratory infections of multiple and unspecified sites

478

2812

1.26

5.51

1.5

1.4

32.74

33.28

g/l

0.39

435

2519

Malignant neoplasm of stomach

217

2.14

5.49

1.4

1.5

33.25

26.90

g/l

2.75

191

Retinal vascular occlusion

121

769

1.59

5.49

1.5

29.95

31.28

g/l

0.59

107

683

Benign neoplasm: Sigmoid colon

168

1146

1.48

5.47

1.6

1.5

33.76

31.98

g/l

1.12

152

1031

Other skin changes

156

1050

1.50

5.43

1.4

1.5

31.31

31.73

g/l

0.17

145

934

Oesophageal obstruction

186

2.24

5.42

1.6

1.4

32.96

32.10

g/l

0.18

169

Other diseases of stomach and duodenum

314

1.93

5.41

1.8

1.4

29.49

32.25

g/l

0.83

287

Cystic kidney disease

124

2.54

5.39

1.7

1.4

25.62

31.95

g/l

2.14

110

Other disorders of adrenal gland

142

2.42

5.39

1.6

1.4

26.49

32.26

g/l

1.66

126

Amputation of thigh

193

2.22

5.39

1.6

1.5

25.63

29.84

g/l

1.10

177

Other viral diseases, not elsewhere classified

133

861

1.54

5.38

1.4

1.5

33.48

33.50

g/l

0.00

123

780

Exposure to other specified factors

465

3399

1.26

5.38

1.5

1.4

33.30

33.41

g/l

0.07

425

3064

Injuries to unspecified part of trunk, limb or body region

444

1.77

5.37

1.6

1.5

31.40

32.24

g/l

0.27

401

Disorders of skin appendages

264

1956

1.35

5.28

1.5

32.66

33.71

g/l

0.63

239

1778

Carcinoma in situ of skin of scalp and neck

176

2.27

5.26

1.5

1.6

30.64

30.60

g/l

0.01

160

Other symptoms and signs involving cognitive functions and awareness

399

2851

1.28

5.25

1.4

1.5

31.54

32.70

g/l

1.01

343

2576

Spondyloarthritis

132

864

1.54

5.24

1.5

32.50

32.45

g/l

0.01

119

774

Gastro-oesophageal reflux disease

469

3235

1.25

5.22

1.5

1.4

33.69

33.46

g/l

0.15

426

2929

Focal epilepsy

156

1059

1.48

5.19

1.4

1.5

34.14

32.27

g/l

1.10

149

955

Alcohol-induced chronic pancreatitis

291

1.95

5.17

1.6

1.5

34.73

32.83

g/l

0.44

260

Insomnia

333

3141

0.77

5.15

1.5

1.4

33.24

33.64

g/l

0.23

302

2842

Alcohol abuse, main dg, excluding more controls

601

1.64

5.14

1.3

1.5

33.78

33.97

g/l

0.05

553

Fracture of foot, except ankle

137

910

1.51

5.08

1.5

1.4

33.89

33.66

g/l

0.07

121

828

Schizophrenia or delusion, excluding more controls

162

1105

1.46

5.00

1.4

1.5

34.81

33.89

g/l

0.46

146

1008

Gonarthrosis, primary, with knee surgery

330

3385

0.77

5.00

1.5

1.4

32.98

32.40

g/l

0.40

303

3023

Disorders of parathyroid gland

168

1154

1.45

4.97

1.5

30.32

31.84

g/l

0.74

148

1022

Umbilical hernia

200

1436

1.40

4.95

1.4

1.5

32.41

33.41

g/l

0.50

175

1294

Myeloproliferative diseases

434

1.74

4.93

1.3

1.5

31.86

32.02

g/l

0.04

392

Diseases of pulp and periapical tissues, including avohilmo

762

3312

1.19

4.89

1.5

1.4

33.13

32.81

g/l

0.26

679

2971

Dementia in Alzheimer disease

101

1333

0.64

4.89

1.3

1.5

29.68

30.54

g/l

0.31

1176

Idiopathic pulmonary fibrosis

535

1.66

4.85

1.6

1.5

33.63

30.92

g/l

1.33

478

Other diseases of liver

118

768

1.54

4.85

1.6

1.5

30.25

33.33

g/l

1.59

107

698

Symptoms and signs involving the skin and subcutaneous tissue

474

3755

1.24

4.83

1.5

32.44

33.06

g/l

0.50

439

3365

Benign neoplasm: Rectum

159

1102

1.45

4.82

1.5

31.73

32.16

g/l

0.15

134

992

Adrenocortical insufficiency

120

2.45

4.73

1.7

1.4

24.80

33.40

g/l

2.66

106

Familial hypercholesterolemia, with ischemic heart disease

608

1.61

4.73

1.8

1.4

31.43

32.71

g/l

0.49

549

Use of donepezil

112

1622

0.66

4.70

1.3

1.5

30.92

30.44

g/l

0.16

100

1417

Other systemic involvement of connective tissue (FG)

189

1341

1.40

4.66

1.4

31.48

32.85

g/l

0.78

169

1190

Leisure time condition

126

841

1.51

4.63

1.4

1.5

31.12

32.48

g/l

0.51

114

762

Progressive systemic sclerosis

8.57

4.62

2.2

1.1

32.61

25.92

g/l

—

Injury of nerves and spinal cord at thorax level

14.46

4.61

1.7

1.8

32.23

27.68

g/l

—

Background retinopathy and retinal vascular changes

2.66

4.60

1.2

1.4

31.27

29.97

g/l

0.16

Disorders of the thyroid gland

665

3627

1.20

4.57

1.6

1.4

32.71

32.89

g/l

0.13

607

3257

Abnormalities of gait and mobility

112

733

1.54

4.54

1.4

1.5

32.77

31.69

g/l

0.36

664

Benign neoplasm: Rectum, anus and anal canal

176

1259

1.41

4.51

1.5

32.18

32.05

g/l

0.05

150

1129

Spondylopathies

607

3013

1.21

4.50

1.5

1.4

32.58

33.08

g/l

0.42

551

2699

Injury of unspecified body region

342

1.80

4.49

1.7

1.5

31.82

31.90

g/l

0.02

308

Dermatophytosis

107

695

1.55

4.48

1.4

1.5

31.31

32.62

g/l

0.45

627

Caries of dentine, including avohilmo

645

2748

1.20

4.48

1.5

1.4

31.22

32.80

g/l

2.18

564

2466

Use of memantine

178

2034

0.72

4.46

1.4

1.5

29.52

30.94

g/l

0.91

156

1796

Use of other anti-dementia drugs

178

2034

0.72

4.46

1.4

1.5

29.52

30.94

g/l

0.91

156

1796

Other diseases of oesophagus

524

1.63

4.45

1.9

1.4

31.91

31.85

g/l

0.02

470

Dental pulpitis, including avohilmo

338

2782

0.79

4.44

1.4

1.5

35.74

34.04

g/l

1.56

310

2528

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

109

703

1.54

4.43

1.5

37.69

33.84

g/l

2.84

103

638

Primary gonarthrosis, bilateral

285

3146

0.77

4.42

1.5

33.95

32.45

g/l

1.28

266

2811

Unknown and unspecified causes of morbidity

272

1.89

4.40

1.5

33.00

32.72

g/l

0.05

251

Dental operations

549

2321

1.22

4.39

1.5

1.4

30.89

33.04

g/l

3.40

485

2057

Papillary adenocarcinoma of thyroid gland

100

2.52

4.38

1.6

1.4

33.12

28.09

g/l

1.22

Caries of enamel

336

3064

0.79

4.35

1.5

1.4

34.76

33.89

g/l

0.65

310

2783

Hyperparathyroidism

146

1006

1.44

4.33

1.5

30.15

31.86

g/l

0.83

127

887

Lichen simplex chronicus and prurigo

274

1.88

4.32

1.5

1.4

30.72

32.59

g/l

0.43

242

Cyst of kidney

369

1.75

4.32

1.5

1.4

29.79

32.38

g/l

0.89

334

Benign neoplasm of other and ill-defined parts of digestive system

139

962

1.45

4.30

1.5

31.08

32.31

g/l

0.52

119

863

Fracture of skull and facial bones

137

945

1.46

4.29

1.4

1.5

34.00

33.51

g/l

0.16

121

862

Infections with a predominantly sexual mode of transmission

110

724

1.52

4.29

1.4

33.23

34.80

g/l

0.66

101

656

Fracture of forearm

340

2464

1.27

4.27

1.4

30.94

33.22

g/l

2.54

301

2217

Other necrotizing vasculopathies

371

1.74

4.24

1.7

1.5

29.49

31.61

g/l

0.72

338

Viral and other specified intestinal infections

563

1.58

4.22

1.4

1.5

31.51

33.79

g/l

0.86

511

Congenital malformations of the respiratory system

3.18

4.22

1.6

1.4

33.30

33.86

g/l

0.06

Dementia, including avohilmo

315

2743

0.79

4.19

1.3

1.5

30.36

31.87

g/l

1.38

282

2449

Ulcer of oesophagus

388

1.72

4.17

1.5

1.4

28.83

32.13

g/l

1.30

347

Other systemic involvement of connective tissue

194

1430

1.36

4.16

1.4

1.5

31.33

32.38

g/l

0.55

174

1284

Any prescribed medicine buy

+∞

4.15

1.8

0.0

26.80

—

g/l

—

Superficial injury of hip and thigh

119

807

1.48

4.09

1.6

1.5

32.11

31.20

g/l

0.40

109

714

Specific personality disorders

638

1.54

4.08

1.5

1.4

37.65

34.56

g/l

1.85

581

Other metabolic disorders

413

1.68

4.06

1.6

1.4

31.97

33.89

g/l

0.57

377

Nerve, nerve root and plexus disorders

750

3930

1.17

4.03

1.5

1.4

31.92

33.19

g/l

1.81

678

3532

Diseases of oral cavity, salivary glands and jaws

521

2218

1.21

3.99

1.5

31.11

32.71

g/l

2.00

455

1982

Congenital malformations of the respiratory system

3.17

3.94

1.7

1.4

33.24

33.40

g/l

0.02

Other inflammatory liver diseases

247

1.88

3.93

1.8

1.4

30.06

32.97

g/l

0.64

219

Other and unspecified effects of external causes

137

963

1.43

3.91

1.5

1.4

33.54

33.47

g/l

0.02

123

870

Sleep apnoea

650

3571

1.18

3.91

1.5

1.4

34.05

33.10

g/l

1.14

595

3228

Obesity, other/unspecified

169

1234

1.37

3.87

1.7

1.4

34.64

33.70

g/l

0.46

155

1120

Paracetamol or NSAID medication

117

394

1.50

3.84

1.5

31.32

30.74

g/l

0.19

100

351

Alcohol abuse, main dg

648

1.52

3.84

1.3

1.5

33.78

33.72

g/l

0.02

589

Focal epilepsy, mode (most common among epilepsy diagnosis)

132

926

1.43

3.83

1.4

1.5

34.45

32.10

g/l

1.31

127

838

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

12.69

3.81

2.5

1.6

37.83

25.20

g/l

—

Sleep disorders

366

3257

0.81

3.81

1.5

1.4

33.26

33.49

g/l

0.13

328

2950

Myocardial infarction, with ST-elevation

176

1301

1.36

3.77

1.6

1.5

28.99

31.74

g/l

2.05

155

1148

Exclusions for E4_PCOS_BROAD

642

1.52

3.77

1.4

1.5

30.54

33.49

g/l

1.28

584

Disorders of eyelid, lacrimal system and orbit

606

3905

1.18

3.76

1.4

1.5

32.03

33.01

g/l

1.17

553

3505

Neurological diseases

555

2335

1.20

3.75

1.5

1.4

31.88

33.78

g/l

2.65

499

2090

Barrett oesophagus

230

1.89

3.75

1.5

29.44

33.30

g/l

1.21

209

Hypothyroidism, strict autoimmune

472

2572

1.21

3.75

1.6

1.4

32.63

33.36

g/l

0.58

429

2320

Sequelae of injuries, of poisoning and of other consequences of external causes

143

1023

1.40

3.73

1.5

32.76

33.52

g/l

0.29

129

930

Focal epilepsy, strict definition

141

1007

1.41

3.71

1.4

1.5

33.80

32.22

g/l

0.80

135

905

Other diseases of anus and rectum

232

1785

1.30

3.70

1.5

30.58

32.65

g/l

1.61

209

1591

Other and unspecified vasculitis limited to skin

103

2.37

3.69

1.4

1.5

33.99

31.67

g/l

0.26

Bacterial, viral and other infectious agents

289

1.77

3.68

1.7

1.5

31.32

33.45

g/l

0.66

258

Sarcoidosis

583

1.53

3.66

1.7

1.5

31.08

33.33

g/l

0.93

526

Dementia

300

2583

0.80

3.65

1.3

1.5

30.29

31.73

g/l

1.28

270

2307

Dental caries, including avohilmo

612

2653

1.18

3.65

1.5

1.4

30.84

32.83

g/l

3.07

531

2379

Hernia of abdominal wall

334

2698

1.24

3.63

1.4

1.5

32.51

33.00

g/l

0.30

302

2420

Personality disorders

110

754

1.46

3.62

1.5

1.4

36.87

35.04

g/l

0.73

103

685

Cholangitis (primary sclerosing, PSC)

299

1.75

3.60

1.5

30.87

31.60

g/l

0.16

267

302

2102

1.26

3.57

1.4

1.5

29.97

31.69

g/l

1.65

275

1861

Diseases of pulp and periapical tissues and dental caries

553

2385

1.19

3.57

1.5

30.82

32.66

g/l

2.52

487

2130

Inflammatory diseases of the central nervous system

315

1.73

3.55

1.3

1.4

30.93

32.00

g/l

0.21

281

Procreative management

132

782

1.41

3.50

1.4

35.85

34.90

g/l

0.36

118

713

Collagenous colitis

393

1.64

3.48

1.5

33.58

32.38

g/l

0.33

355

Schizophrenia, schizotypal and delusional disorders

164

1215

1.35

3.47

1.4

34.82

33.72

g/l

0.57

148

1101

Myocardial infarction, unclassifiable

240

1673

1.29

3.46

1.5

26.67

31.42

g/l

6.26

208

1475

Traumatic subdural haemorrhage

133

918

1.40

3.40

1.6

1.4

30.87

32.19

g/l

0.55

114

812

Oesophagitis

253

1.79

3.38

1.7

1.4

32.15

32.26

g/l

0.02

226

Injuries to the ankle and foot

364

2657

1.22

3.34

1.5

1.4

33.22

33.99

g/l

0.52

325

2417

Inguinal hernia

457

2556

1.20

3.34

1.5

32.69

33.00

g/l

0.20

414

2278

Schizophrenia or delusion

162

1208

1.34

3.31

1.4

34.81

33.71

g/l

0.58

146

1096

Visual impairment including blindness (binocular or monocular)

338

1.67

3.28

1.4

1.5

29.97

30.87

g/l

0.22

311

Other otitis externa (chronic)

248

1.79

3.28

1.4

1.5

32.49

g/l

0.00

222

Acute sinusitis

262

1928

1.26

3.28

1.5

1.4

33.14

33.87

g/l

0.39

236

1748

Osteoporosis with pathological fracture (FG)

377

1.63

3.27

1.4

26.54

31.61

g/l

2.06

331

Vasculitis limited to skin, not elsewhere classified

116

2.18

3.24

1.4

1.5

34.07

31.63

g/l

0.30

102

Respiratory disorders in diseases classified elsewhere

2.91

3.21

1.6

1.5

42.93

32.08

g/l

1.85

Malignant neoplasm of bladder

371

1.63

3.20

1.5

31.05

27.12

g/l

1.76

327

Viral and other specified intestinal infections

116

794

1.41

3.20

1.4

1.5

31.66

33.89

g/l

1.02

100

717

Other condition

571

1.50

3.16

1.5

32.02

33.20

g/l

0.40

520

Acute and transient psychotic disorders

373

1.62

3.14

1.5

36.78

33.73

g/l

1.38

334

Alzheimer disease

226

2092

0.79

3.12

1.4

1.5

30.07

31.03

g/l

0.60

198

1852

Disorders of adult personality and behaviour

112

795

1.41

3.11

1.5

1.4

37.64

35.03

g/l

1.38

105

722

Other aneurysm

298

1.69

3.10

1.4

1.5

31.06

32.60

g/l

0.30

267

Acute alcohol intoxication, ICD10

125

906

1.38

3.09

1.3

1.5

32.60

33.81

g/l

0.46

113

820

Migraine

121

1350

0.73

3.09

1.5

1.4

36.32

34.59

g/l

0.96

112

1240

Hydrocele

120

865

1.40

3.09

1.4

1.5

32.44

32.02

g/l

0.13

767

Other and unspecified diseases of blood and blood-forming organs

112

2.17

3.08

1.4

29.03

31.68

g/l

0.44

Colectomy operation

137

1010

1.36

3.07

1.3

1.5

30.35

31.82

g/l

0.69

124

905

Bacterial, viral and other infectious agents

276

1.71

3.06

1.7

1.5

30.66

33.38

g/l

0.89

246

Palmar fascial fibromatosis [Dupuytren]

150

1122

1.34

3.06

1.5

1.4

32.41

32.42

g/l

0.00

140

996

Cholecystectomy

500

3679

1.17

3.05

1.4

1.5

32.31

32.76

g/l

0.31

444

3314

Delivery, wide proxy

103

776

0.70

3.05

1.4

32.38

32.32

g/l

0.01

702

Malignant neoplasm of other and unspecified parts of biliary tract

2.94

3.04

1.1

1.2

33.58

25.47

g/l

1.41

CR(E)ST syndrome

2.93

3.04

1.4

1.2

29.50

33.51

g/l

0.41

Disorders of continuity of bone

323

1.65

3.01

1.6

1.5

31.37

33.68

g/l

0.54

294

Retinal detachments and breaks

283

2299

1.23

3.00

1.4

1.5

32.93

32.84

g/l

0.04

255

2072

Polycythaemia vera

120

2.10

2.99

1.1

1.6

31.67

26.39

g/l

1.18

107

Embolic stroke

317

1.66

2.97

1.3

1.5

29.02

30.52

g/l

0.30

291

Alzheimer’s disease, strict definition

172

1838

0.77

2.97

1.4

1.5

30.40

30.70

g/l

0.12

150

1623

Dermatitis and eczema

733

3983

1.14

2.96

1.5

1.4

32.77

33.14

g/l

0.31

675

3566

Acute lymphadenitis

148

1.97

2.95

1.3

34.64

32.79

g/l

0.27

128

Drug-induced adrenocortical insufficiency

2.73

2.90

1.6

1.5

22.89

32.31

g/l

1.37

Dorsalgia

662

3087

1.15

2.90

1.5

1.4

32.55

33.27

g/l

0.72

598

2769

Other and unspecified injuries of lower leg

221

1.77

2.89

1.5

1.4

32.61

32.71

g/l

0.02

204

Coeliac disease

453

1.53

2.89

1.4

1.5

29.24

33.75

g/l

1.85

414

Urticaria and erythema

183

1421

1.29

2.86

1.5

33.61

33.63

g/l

0.01

164

1290

Follow-up examination after treatment for conditions other than malignant neoplasms

272

1457

1.24

2.84

1.5

1.4

32.70

33.61

g/l

0.53

245

1319

Macular pucker

132

982

1.35

2.83

1.4

1.5

29.99

32.32

g/l

1.21

116

880

Fall on and from stairs and steps

169

1302

1.30

2.82

1.5

32.70

32.43

g/l

0.09

147

1176

Fracture of neck

322

1.63

2.82

1.6

1.5

33.22

31.64

g/l

0.37

289

Juvenile osteochondrosis

2.56

2.79

1.1

1.4

34.45

32.45

g/l

0.27

Gonarthrosis,primary

544

3869

0.86

2.78

1.5

1.4

33.17

32.66

g/l

0.46

511

3460

Behavioural syndromes associated with physiological disturbances and physical factors

404

3380

0.85

2.77

1.5

33.27

33.44

g/l

0.10

362

3058

Disorders of sclera, cornea, iris and ciliary body

332

2765

1.20

2.77

1.4

1.5

32.27

33.36

g/l

0.80

298

2493

severe traumatic brain injury, does not include concussion

195

1537

1.27

2.74

1.6

1.5

30.35

31.70

g/l

0.74

169

1360

Acute alcohol intoxication

178

1387

1.29

2.73

1.4

1.5

33.22

33.26

g/l

0.01

159

1235

Spinal stenosis

428

2765

1.18

2.72

1.5

1.4

31.86

32.73

g/l

0.70

382

2474

Other inflammation of eyelid

608

1.44

2.70

1.4

1.5

30.13

32.31

g/l

0.79

548

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

3.82

2.69

1.2

1.1

31.13

24.13

g/l

—

Fibroblastic disorders

191

1506

1.27

2.68

1.6

1.4

32.55

32.94

g/l

0.17

178

1345

Malignant neoplasm of cervix uteri

4.25

2.68

1.4

1.1

32.16

26.78

g/l

—

Triptan medication for migraine, min. 3 purchases

117

1205

0.74

2.68

1.5

1.4

36.84

34.90

g/l

1.15

107

1110

Other and unspecified tonsillitis

114

700

1.37

2.67

1.6

1.4

37.65

35.62

g/l

0.91

107

637

Myeloproliferative diseases (CML excluded)

398

1.54

2.67

1.2

1.5

31.35

32.10

g/l

0.20

362

Low back pain

489

3022

1.16

2.66

1.4

31.12

33.26

g/l

3.19

443

2707

Peptic ulcer

2.99

2.64

1.8

1.3

31.06

30.89

g/l

0.01

Degenerative diseases of the nervous system

257

2306

0.82

2.64

1.4

1.5

30.91

31.33

g/l

0.23

227

2044

Coxarthrosis [arthrosis of hip](FG)

433

2600

1.17

2.63

1.5

1.4

31.58

33.10

g/l

1.82

394

2319

Acute epiglottitis

2.97

2.63

2.3

1.5

30.01

33.50

g/l

0.49

Melanocytic naevi of trunk

464

1.49

2.62

1.4

1.5

33.93

32.89

g/l

0.25

418

Varicose veins

454

2942

1.17

2.60

1.5

1.4

32.66

32.86

g/l

0.12

415

2642

Gingivitis and periodontal diseases

732

3338

1.13

2.59

1.5

1.4

33.09

32.85

g/l

0.18

654

2998

Other maternal disorders predominantly related to pregnancy

115

973

0.74

2.59

1.4

35.70

35.01

g/l

0.22

106

903

Alcohol-induced acute pancreatitis

156

1.88

2.58

1.4

1.5

30.33

32.14

g/l

0.28

137

Symptoms and signs involving the nervous and musculoskeletal systems

389

3308

1.18

2.57

1.5

32.54

32.92

g/l

0.23

344

2985

Benign neoplasm: Caecum

624

1.42

2.56

1.6

1.5

30.05

32.04

g/l

0.80

562

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

326

2655

1.19

2.55

1.5

33.83

33.55

g/l

0.16

296

2414

Degenerative macular diseases

101

735

1.38

2.53

1.5

29.62

31.32

g/l

0.78

651

Complications of labour and delivery

150

1082

0.77

2.52

1.4

36.48

34.28

g/l

1.26

143

991

Alzheimer’s disease (Late onset)

163

1748

0.78

2.52

1.4

1.5

30.03

30.61

g/l

0.27

141

1544

Lesion of lateral popliteal nerve

209

1.74

2.51

1.8

1.5

33.31

32.19

g/l

0.13

186

Tinnitus

1197

0.72

2.49

1.6

1.5

33.58

33.43

g/l

0.04

1078

Benign neoplasm: Adrenal gland

365

1.54

2.48

1.8

1.5

32.63

32.84

g/l

0.04

330

Complications of other internal prosthetic devices, implants and grafts

173

1.81

2.47

1.3

1.4

31.45

31.47

g/l

0.00

156

Contact with and exposure to communicable diseases

676

1.39

2.44

1.5

33.80

35.47

g/l

0.60

620

Parkinson's disease, strict definition

1028

0.70

2.44

1.5

35.03

31.08

g/l

1.98

919

Combinations of oral blood glucose lowering drugs

209

1687

1.24

2.44

1.4

31.38

33.18

g/l

1.18

187

1532

Other and unspecified glaucoma

399

1.51

2.44

1.5

1.6

30.90

31.15

g/l

0.05

365

Viral haemorrhagic fevers, not elsewhere classified/unspecified

714

1.38

2.43

1.4

1.5

32.12

32.94

g/l

0.26

645

Other blood glucose lowering drugs, excl. Insulins

128

973

1.32

2.42

1.6

1.5

30.31

32.15

g/l

0.95

115

868

Injuries to the shoulder and upper arm

569

4028

1.14

2.39

1.5

1.4

32.37

33.12

g/l

0.75

518

3612

Female genital prolapse

762

0.73

2.38

1.3

1.4

31.70

32.57

g/l

0.26

669

Malignant neoplasm of oropharynx

2.64

2.37

1.3

1.4

37.04

27.75

g/l

1.82

Cysts of oral region, not elsewhere classified

221

1.68

2.34

1.3

1.5

31.38

32.51

g/l

0.17

195

Use of selegiline

263

0.41

2.34

1.5

35.28

31.87

g/l

0.45

235

Disorders of oesophagus in diseases classified elsewhere

2.11

2.34

1.6

1.4

28.11

31.87

g/l

0.47

Malignant neoplasm of oropharynx, including Hilmo

2.33

2.32

1.4

1.5

35.33

28.31

g/l

1.40

Type 1 diabetes, definitions combined

161

1.80

2.32

1.3

33.81

35.08

g/l

0.18

146

Nontoxic multinodular goitre

125

953

1.32

2.32

1.4

1.5

33.36

32.14

g/l

0.51

116

862

Cardiac murmurs and other cardiac sounds

219

1.68

2.31

1.5

1.3

34.77

33.24

g/l

0.30

205

Other anxiety disorders

179

1236

1.26

2.30

1.5

1.4

33.93

34.48

g/l

0.21

164

1134

Other ill-defined and unspecified causes of mortality

537

1.43

2.29

1.7

1.5

30.85

30.33

g/l

0.14

481

Other nonthrombocytopenic purpura

2.81

2.29

1.9

1.3

29.46

33.41

g/l

0.44

Benign neoplasm of other and unspecified intrathoracic organs

2.80

2.29

2.0

1.4

36.57

31.42

g/l

0.79

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

3.55

2.28

1.3

1.1

33.31

23.89

g/l

—

Malignant neoplasm of parotid gland

3.55

2.28

1.4

1.2

31.45

23.84

g/l

—

Type 1 diabetes, strict (exclude DM2)

162

1.79

2.28

1.3

33.81

34.98

g/l

0.17

148

Acute suppurative otitis media

547

1.40

2.27

1.4

1.5

35.25

34.64

g/l

0.15

498

Other peripheral vascular diseases

309

1.56

2.27

1.4

33.05

33.06

g/l

0.00

281

Parkinson's disease

1094

0.72

2.26

1.5

35.21

31.17

g/l

2.37

973

Rheumatic valve diseases

128

1.90

2.23

1.5

1.4

27.79

30.22

g/l

0.67

112

Vitamin B12 deficiency anaemia

599

1.39

2.22

1.5

30.17

31.07

g/l

0.25

537

Other disorders of bone

701

1.36

2.21

1.5

1.4

34.14

33.74

g/l

0.11

640

Use of antiglaucoma preparations and miotics

492

1.43

2.19

1.5

29.41

30.77

g/l

0.33

441

Ill-defined and unknown causes of mortality

593

1.39

2.18

1.7

1.5

30.95

30.25

g/l

0.21

527

Superficial injury of ankle and foot

328

1.53

2.18

1.5

33.10

33.32

g/l

0.04

297

Speech therapy

177

1423

1.25

2.18

1.7

1.4

32.19

32.49

g/l

0.11

160

1272

Non-selective monoamine reuptake inhibitors

253

2032

1.20

2.18

1.4

1.5

32.83

32.82

g/l

0.00

228

1825

Mental disorders, not otherwise specified

188

1.71

2.16

1.5

36.17

33.95

g/l

0.45

167

Arthropathies

561

2505

1.14

2.14

1.6

1.4

31.87

33.68

g/l

2.58

506

2240

Rheumatic fever incl heart disease

174

1.74

2.14

1.5

29.60

30.75

g/l

0.25

157

Seronegative rheumatoid arthritis

562

1.39

2.12

1.4

32.98

33.09

g/l

0.03

499

Overexertion and strenuous or repetitive movements

363

1.49

2.12

1.6

1.5

31.00

32.94

g/l

0.53

324

Scabies

355

1.50

2.11

1.2

1.5

32.83

34.03

g/l

0.28

320

Sleep apnoea, including avohilmo

653

3613

1.12

2.07

1.5

1.4

33.85

33.12

g/l

0.77

595

3264

205

1583

1.22

2.07

1.4

1.5

29.54

31.21

g/l

1.19

192

1385

Benign neoplasm: Rectosigmoid junction

215

1.64

2.04

1.3

1.5

33.57

31.93

g/l

0.24

195

Benign neoplasm: Stomach

499

1.41

2.04

1.5

29.47

32.06

g/l

0.77

456

Infections with a predominantly sexual mode of transmission

122

880

1.29

2.04

1.4

32.87

35.43

g/l

1.50

113

803

Malignant neoplasm of tonsil, including Hilmo

2.43

2.03

1.5

1.4

36.57

28.97

g/l

1.21

Tonsillectomy and adenotomy

122

1091

0.78

2.03

1.4

1.5

35.15

35.50

g/l

0.12

115

992

Diseases of inner ear

284

3227

0.85

2.03

1.4

1.5

33.23

32.66

g/l

0.33

256

2898

Colitis, primary sclerosing

3.11

2.02

1.4

1.3

33.75

32.98

g/l

—

Pregnancy, childbirth and the puerperium

103

708

0.76

2.00

1.5

1.4

31.29

31.76

g/l

0.12

630

Nonalcoholic fatty liver disease

319

1.51

2.00

1.7

1.5

30.68

33.82

g/l

0.83

283

Benign neoplasm of urinary organs

224

1.62

2.00

1.6

1.4

32.68

32.23

g/l

0.07

202

Benign neoplasm of other and unspecified endocrine glands

603

1.37

1.99

1.6

1.5

33.09

32.66

g/l

0.11

550

Parkinson's disease, including avohilmo

1137

0.74

1.99

1.5

34.66

31.29

g/l

1.86

1009

Other disorders of lacrimal gland

207

1714

1.21

1.96

1.4

1.5

31.62

33.20

g/l

1.04

194

1549

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

204

1949

0.83

1.95

1.4

1.5

33.57

33.41

g/l

0.06

193

1775

Malignant neoplasm of parotid gland, including Hilmo

3.01

1.94

1.4

1.2

31.45

23.68

g/l

—

Burns and corrosions

529

1.38

1.94

1.4

1.5

29.60

33.39

g/l

1.49

480

Otitis externa

125

980

1.28

1.94

1.4

1.5

32.98

32.94

g/l

0.01

113

884

Postmenopausal bleeding

106

737

0.77

1.93

1.5

1.4

32.91

32.45

g/l

0.13

646

Disorders of lacrimal system

264

2232

1.18

1.93

1.4

1.5

31.63

33.09

g/l

1.08

245

2010

Heartburn

429

1.43

1.93

1.6

1.4

33.61

32.54

g/l

0.24

392

Hyperkinetic disorders (excl. ADHD)

4.52

1.92

1.4

1.3

44.52

38.80

g/l

—

Benign neoplasm of ovary

624

1.35

1.92

1.3

1.4

32.51

33.17

g/l

0.17

564

Conductive and sensorineural hearing loss

594

3584

1.12

1.92

1.4

1.5

32.00

32.94

g/l

0.98

535

3214

Arthropod-borne viral fevers and viral haemorrhagic fevers

110

850

1.30

1.91

1.4

1.5

32.42

32.93

g/l

0.17

770

Episodal and paroxysmal disorders

715

3280

1.11

1.91

1.5

1.4

32.62

33.19

g/l

0.52

633

2940

Other diseases of blood and blood-forming organs

299

1.51

1.90

1.3

1.5

29.83

31.89

g/l

0.53

269

Monoplegia

2.34

1.89

1.5

1.6

32.94

30.26

g/l

0.27

Adverse effects, not elsewhere classified

652

1.34

1.88

1.6

1.5

33.92

33.29

g/l

0.18

591

Coxarthrosis

396

2283

1.15

1.88

1.5

1.4

31.53

33.19

g/l

1.94

361

2035

Other infective otitis externa

228

1.59

1.87

1.4

32.06

31.88

g/l

0.03

205

Hypertrophic disorders of skin

151

1.73

1.87

1.4

28.44

32.64

g/l

0.95

135

Injury of muscle and tendon at shoulder and upper arm level

178

2157

0.82

1.84

1.5

33.17

33.24

g/l

0.03

167

1940

Pain in thoracic spine

603

1.35

1.84

1.5

34.73

33.35

g/l

0.52

551

Fitting and adjustment of external prosthetic device

4.30

1.84

2.0

1.6

15.20

34.08

g/l

—

Anxiety (asthma-related co-morbidities)

248

1623

1.18

1.81

1.4

34.40

34.49

g/l

0.04

226

1493

Oral lichen planus, including avohilmo , including avohilmo

235

0.47

1.81

2.5

1.4

31.61

33.20

g/l

0.14

209

Blood alcohol or alcohol intoxication level

2.28

1.81

1.1

1.4

35.97

34.19

g/l

0.16

Erythema multiforme

2.02

1.80

1.7

1.5

31.29

32.85

g/l

0.18

Other/unspecified dorsalgia

235

1969

1.19

1.80

1.5

1.4

32.46

33.02

g/l

0.27

208

1764

Retinal detachment with retinal break

745

1.31

1.80

1.3

1.5

33.18

32.12

g/l

0.34

671

Other disorders of ear

630

3718

1.11

1.78

1.4

1.5

32.13

33.10

g/l

1.12

565

3336

Hypothyroidism, other/unspecified

570

3362

1.12

1.77

1.5

1.4

32.44

32.86

g/l

0.32

518

3024

False labour

244

0.59

1.76

1.2

1.4

41.11

36.78

g/l

0.85

227

Gluteal tendinitis

135

0.37

1.75

1.0

1.5

25.20

32.50

g/l

—

125

Postmenopausal osteoporosis with pathological fracture

289

1.50

1.75

1.3

1.4

27.28

30.95

g/l

0.92

265

Benign paroxysmal vertigo

132

1638

0.80

1.74

1.5

33.94

32.42

g/l

0.71

115

1472

Necrotizing fasciitis

3.92

1.72

3.4

1.6

24.58

32.44

g/l

—

Superficial injury of abdomen, lower back and pelvis

619

1.33

1.72

1.6

1.5

33.17

32.64

g/l

0.14

562

Disorders of muscles

448

1.39

1.72

1.5

1.4

32.50

33.65

g/l

0.28

409

Kyphosis

2.32

1.71

1.4

1.5

31.53

29.73

g/l

0.15

Iridocyclitis

134

1079

1.24

1.71

1.4

1.5

33.59

33.12

g/l

0.15

121

975

Injury of urinary and pelvic organs

2.02

1.70

1.2

1.5

29.37

31.34

g/l

0.26

Polyuria

167

1378

1.22

1.69

1.6

1.5

31.80

32.03

g/l

0.08

150

1243

Moderate visual impairment, binocular

164

1.66

1.69

1.6

1.4

29.46

29.23

g/l

0.04

150

Shoulder lesions

529

2870

1.12

1.69

1.5

1.4

33.08

33.37

g/l

0.21

484

2567

Burns and corrosions of external body surface, specified by site

391

1.41

1.68

1.3

1.5

27.37

33.14

g/l

2.43

351

Sensorineural hearing loss

577

3529

1.11

1.68

1.4

1.5

31.88

32.86

g/l

1.03

520

3162

Soft tissue disorders related to use, overuse and pressure

175

1452

1.21

1.68

1.6

1.4

31.94

33.99

g/l

1.34

160

1303

Bullous disorders

292

1.48

1.67

1.6

1.4

28.56

31.47

g/l

0.88

262

Sequelae of injuries of lower limb

333

1.45

1.67

1.4

1.5

32.20

33.19

g/l

0.18

298

Herpesviral [herpes simplex] infections

459

1.38

1.67

1.7

1.5

32.16

32.97

g/l

0.18

418

Other dorsopathies, not elsewhere classified

652

3088

1.11

1.67

1.5

1.4

32.75

33.27

g/l

0.45

584

2769

Pediculosis, acariasis and other infestations

493

1.36

1.67

1.3

1.5

33.51

34.03

g/l

0.12

449

Other injuries of upper limb, level unspecified

2.47

1.65

1.3

1.5

27.50

32.11

g/l

—

Schizophrenia

563

1.34

1.65

1.3

1.5

36.13

34.31

g/l

0.77

506

Psoriasis

166

1373

1.21

1.65

1.5

33.43

33.07

g/l

0.13

151

1241

Presence of other devices

185

1541

1.20

1.64

1.4

1.5

29.26

33.21

g/l

4.35

170

1369

Psoriasis vulgaris

111

880

1.26

1.63

1.7

1.5

33.84

33.18

g/l

0.20

101

794

Missing teeth due to accident, extraction or parodontitis

417

3490

1.13

1.63

1.5

32.65

32.91

g/l

0.16

376

3147

Focal brain injury

327

1.44

1.62

1.4

29.62

32.19

g/l

0.75

294

Use of galantamine

582

0.68

1.62

1.2

1.5

33.14

29.76

g/l

1.24

520

Fracture at wrist and hand level

183

1528

1.20

1.61

1.5

1.4

30.83

33.70

g/l

2.41

169

1379

Keratitis

200

1688

1.19

1.60

1.4

1.5

31.12

33.22

g/l

1.42

180

1521

Allergic purpura

1.92

1.60

1.4

1.3

31.52

32.60

g/l

0.10

Migraine without aura and triptan purchases

263

0.53

1.60

1.4

36.76

35.49

g/l

0.26

240

Visual disturbances and blindness

329

2885

1.14

1.59

1.4

1.5

31.69

32.82

g/l

0.93

294

2594

Superficial injury of lower leg

127

1026

1.24

1.59

1.4

1.5

30.38

33.24

g/l

1.97

112

926

Any dementia

301

2396

0.87

1.58

1.4

1.5

29.98

31.51

g/l

1.43

270

2123

Disorders of vestibular function (Vertigo)

242

2763

0.86

1.57

1.4

1.5

33.97

32.71

g/l

0.87

218

2474

Malignant neoplasm of tonsil

2.30

1.56

1.3

1.4

37.65

27.81

g/l

—

Diseases of external ear

212

1804

1.18

1.55

1.5

32.76

32.73

g/l

0.01

188

1616

Endometriosis

104

770

0.79

1.55

1.5

1.3

34.42

32.72

g/l

0.66

681

Artificial joint operation, meniscal resection

554

3973

0.90

1.55

1.5

33.21

32.84

g/l

0.30

520

3554

Intercostal neuropathy

2.46

1.55

1.1

1.5

31.84

33.06

g/l

—

Viral warts

314

1.44

1.54

1.4

1.5

30.63

32.46

g/l

0.47

283

Impotence

323

1.43

1.54

1.5

1.6

34.82

31.88

g/l

0.83

293

Abnormal serum enzyme levels

255

2150

1.16

1.52

1.5

30.33

32.60

g/l

2.04

216

1936

Generalized skin eruption due to drugs and medicaments

138

1.68

1.52

1.7

1.3

32.73

32.38

g/l

0.04

123

Other strabismus

737

1.27

1.49

1.6

1.5

34.20

33.28

g/l

0.28

670

Other and unspecified pemphigoid

2.47

1.49

2.0

1.4

25.73

30.07

g/l

—

Malignant neoplasm of testis

2.45

1.48

1.7

1.4

30.96

27.87

g/l

—

Schizoaffective disorder

194

1.55

1.48

1.4

1.5

35.91

33.75

g/l

0.48

171

Appendectomy

324

2730

1.14

1.47

1.5

1.4

35.09

33.75

g/l

1.15

296

2476

Nonorganic sleeping disorders, excluding more controls

618

1.30

1.47

1.5

32.68

33.65

g/l

0.28

571

Urticaria

130

1064

1.22

1.46

1.5

1.4

34.45

33.53

g/l

0.34

116

966

Abnormal findings on diagnostic imaging of breast

2.39

1.46

1.1

1.2

30.72

34.92

g/l

—

Sexual dysfunction

2.39

1.46

1.4

1.6

31.26

34.14

g/l

—

Noninflammatory disorders of female genital tract

128

788

0.81

1.46

1.4

33.85

32.73

g/l

0.38

120

695

Polymyalgia rheumatica

105

842

1.25

1.44

1.3

1.5

31.27

31.26

g/l

0.00

753

Female infertility, associated with anovulation

1.92

1.43

1.1

1.3

36.62

36.08

g/l

0.04

Spontaneous abortion

105

881

0.80

1.43

1.3

1.4

35.40

34.02

g/l

0.54

817

Other orthopaedic follow-up care

164

1.59

1.43

1.3

1.4

31.49

32.23

g/l

0.11

146

Functional dyspepsia

144

1195

1.21

1.42

1.4

32.63

33.26

g/l

0.23

129

1089

Papulosquamous disorders

231

1996

1.16

1.42

1.5

33.60

33.30

g/l

0.13

207

1810

Conjunctivitis (acute, non atopic)

133

1091

1.22

1.42

1.3

1.4

32.50

33.43

g/l

0.38

122

986

Benign neoplasm: salivary glands, exclude unknown (D119)

422

1.36

1.42

1.6

1.5

30.85

32.36

g/l

0.36

379

Malignant neoplasm of eye and adnexa, including Hilmo

2.10

1.39

1.7

1.2

36.04

24.92

g/l

1.64

Parkinson's disease, strict definition, excluding more controls

884

0.77

1.38

1.5

1.4

35.03

32.70

g/l

0.89

786

Pain in joint

349

1974

1.13

1.38

1.6

1.4

32.74

33.85

g/l

0.89

312

1778

Inguinal hernia, bilateral

731

1.26

1.38

1.6

1.5

33.95

32.20

g/l

0.69

643

Inguinal or femoral hernia, bilateral

740

1.26

1.38

1.6

1.5

33.83

32.21

g/l

0.63

652

Carcinoma in situ of other and unspecified digestive organs

190

1.54

1.38

1.4

1.5

31.15

32.32

g/l

0.20

173

Acute generalized exanthematous pustulosis

158

1.59

1.37

1.7

1.4

32.57

32.06

g/l

0.07

142

Other and unspecified injuries of abdomen, lower back and pelvis

2.21

1.37

1.9

1.3

27.90

34.11

g/l

—

Benign neoplasm of major salivary glands

494

1.32

1.37

1.6

1.5

31.28

32.40

g/l

0.28

446

Vasomotor and allergic rhinitis

112

1346

0.82

1.37

1.5

1.4

33.31

34.36

g/l

0.41

1231

Iron deficiency

2.20

1.37

1.0

1.3

30.60

33.54

g/l

—

Anterior Iridocyclitis

115

938

1.23

1.37

1.4

1.5

33.30

32.94

g/l

0.11

104

854

Periapical abscess

245

2135

1.15

1.36

1.5

34.02

33.86

g/l

0.06

223

1933

Nontoxic goitre/thyroid nodule

172

1459

1.18

1.35

1.4

1.5

33.22

32.34

g/l

0.40

155

1317

Single spontaneous delivery

135

863

0.83

1.34

1.5

1.4

32.45

32.58

g/l

0.03

119

787

Mandibular retrognathia AND surgery (BSSO)

0.00

1.34

0.0

1.4

—

34.54

—

Dermatophytosis

364

3255

1.12

1.32

1.4

1.5

33.77

33.14

g/l

0.40

316

2948

Adenomyosis (Endometriosis of uterus)

558

0.71

1.32

1.6

1.4

33.88

32.94

g/l

0.15

496

Hypothyreosis and Thyroxine purchase for inclusion criteria

585

3510

1.09

1.32

1.5

1.4

32.45

32.89

g/l

0.35

533

3155

Chronic laryngitis and laryngotracheitis

709

1.26

1.32

1.4

1.5

34.30

32.74

g/l

0.58

640

Abnormal findings in secretions and smears from cervix uteri vagina vulva

103

957

0.81

1.30

1.3

1.4

33.96

34.55

g/l

0.18

885

Dermatitis due to substances taken internally

201

1.50

1.30

1.6

1.4

32.13

32.31

g/l

0.02

177

Benign neoplasm: Parotid gland

379

1.35

1.27

1.6

1.5

32.30

32.38

g/l

0.01

340

Delivery

137

865

0.83

1.26

1.5

1.4

32.23

32.59

g/l

0.11

121

788

Memory loss

563

1.28

1.26

1.6

31.00

31.20

g/l

0.05

504

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

117

1411

0.83

1.25

1.5

34.12

33.32

g/l

0.30

105

1280

Progressive vascular leukoencephalopathy

253

1.43

1.25

1.3

1.5

28.64

30.03

g/l

0.28

236

Fenamates

607

0.78

1.24

1.6

1.5

33.14

30.57

g/l

0.89

533

Bipolar affective disorders

537

1.29

1.24

1.2

1.4

35.92

34.06

g/l

0.70

488

Benign neoplasm: Appendix

2.02

1.24

1.2

1.4

34.28

32.33

g/l

—

Extrapyramidal and movement disorders

214

2453

0.87

1.24

1.4

1.5

33.19

32.23

g/l

0.54

193

2192

Headache

290

2053

1.13

1.23

1.5

1.4

32.71

34.22

g/l

1.12

266

1851

Abnormality of red blood cells

2.67

1.22

1.8

1.6

28.46

32.98

g/l

—

Endometriosis of rectovaginal septum and vagina

289

0.62

1.22

1.3

1.4

35.94

32.25

g/l

0.53

263

Other meningitis

2.18

1.21

1.4

1.5

34.59

31.14

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

399

1.33

1.21

1.5

29.07

31.17

g/l

0.61

362

Artrosis, including avohilmo

504

3018

0.91

1.20

1.5

1.4

32.05

33.02

g/l

0.95

457

2709

Other autoimmune haemolytic anaemias

1.90

1.19

1.4

26.13

31.99

g/l

0.66

Myalgia

117

973

1.20

1.18

1.5

1.4

33.68

34.41

g/l

0.23

108

888

Open wound of shoulder and upper arm

1.89

1.18

1.3

1.4

32.81

31.60

g/l

0.12

Parkinson's disease, excluding more controls

927

0.80

1.18

1.5

1.4

35.21

32.97

g/l

0.96

826

Disorders of vitreous body and globe

343

2963

1.11

1.18

1.4

1.5

31.28

33.07

g/l

1.81

308

2686

Benign neoplasm: Skin of trunk

157

1.54

1.17

1.8

1.4

33.31

32.44

g/l

0.13

139

Helminthiases

1.71

1.17

1.6

1.4

30.99

32.37

g/l

0.14

Infectious mononucleosis

1.70

1.17

1.3

1.5

37.83

34.31

g/l

0.52

Carcinoma in situ of other and unspecified genital organs

2.02

1.17

2.1

1.2

32.70

33.58

g/l

—

Kela-code for severe mental illness

173

1491

1.16

1.3

1.5

35.33

33.51

g/l

1.29

157

1355

Disorders of male genital organs in diseases classified elsewhere

2.53

1.15

1.6

1.9

22.98

31.24

g/l

—

Unspecified mental disorder

188

1633

1.15

1.14

1.4

1.5

35.45

33.57

g/l

1.45

170

1483

Diseases of salivary glands

169

1457

1.16

1.14

1.4

1.5

33.07

33.27

g/l

0.07

154

1320

Special screening examination for neoplasms

292

1.38

1.13

1.4

32.47

33.41

g/l

0.17

261

Use of interferon beta-1a

2.34

1.12

1.6

1.4

37.16

34.41

g/l

—

All anxiety disorders

248

1733

1.13

1.12

1.4

34.40

34.27

g/l

0.06

226

1594

Allergic rhinitis

835

0.79

1.12

1.4

1.5

34.75

34.50

g/l

0.06

761

Deep endometriosis

282

0.64

1.11

1.3

1.4

35.94

32.21

g/l

0.54

258

Other specified/unspecified hearing loss

476

1.29

1.11

1.3

1.5

34.24

31.77

g/l

0.72

425

Other diseases of hard tissues of teeth

456

2152

1.10

1.11

1.5

31.37

32.80

g/l

1.57

402

1924

Other and unspecified disorders of vitreous body

208

2333

0.88

1.10

1.3

1.5

32.83

33.29

g/l

0.21

187

2117

Deficiency of other B group vitamins

1.68

1.10

1.2

1.4

36.23

31.30

g/l

1.02

Anxiety disorders, excluding more controls

438

2600

1.10

1.5

34.39

33.63

g/l

0.61

396

2352

Other specified/unspecified soft tissue disorders

218

1.43

1.09

1.3

33.75

31.99

g/l

0.26

201

Agoraphobia

2.19

1.08

1.6

1.2

46.71

35.19

g/l

—

Dislocation, sprain and strain of joints and ligaments of knee

218

2274

0.88

1.07

1.4

33.40

34.75

g/l

0.85

203

2078

Otosclerosis

362

0.69

1.07

1.5

31.10

32.27

g/l

0.19

328

Other sleep disorders

532

1.26

1.07

1.5

30.91

33.32

g/l

0.90

485

Acute gastritis

356

1.32

1.07

1.8

1.4

30.78

31.96

g/l

0.30

324

Open wound of hip and thigh

1.66

1.07

1.7

1.4

37.94

32.24

g/l

1.00

Unspecified dementia

843

0.81

1.06

1.3

1.5

31.13

29.81

g/l

0.39

737

Unspecified lump in breast

506

1.27

1.06

1.4

34.05

32.97

g/l

0.32

462

Undefined dementia

891

0.81

1.04

1.3

1.5

30.86

29.82

g/l

0.30

773

Symptoms and signs involving speech and voice

202

1779

1.14

1.03

1.6

1.5

33.62

32.79

g/l

0.43

185

1599

Allergic urticaria

246

1.39

1.03

1.4

35.61

33.21

g/l

0.44

222

Other abnormal products of conception

316

0.73

1.03

1.4

38.17

35.86

g/l

0.62

296

Alzheimer’s disease (Late onset), excluding more controls

109

849

0.84

1.02

1.4

29.73

32.41

g/l

1.83

756

Acute and subacute iridocyclitis

104

872

1.19

1.01

1.4

1.5

32.99

33.12

g/l

0.03

794

Recurrent aphthous stomatitis , including avohilmo

591

1.24

1.00

1.4

1.5

31.67

32.12

g/l

0.11

534

Excessive, frequent and irregular menstruation

122

787

0.85

1.00

1.5

1.4

34.25

32.71

g/l

0.64

115

694

Hypothyroidism, strict autoimmune, 3 medication purchases required

510

3182

1.08

0.99

1.5

1.4

32.96

32.85

g/l

0.07

461

2857

Acute upper respiratory infections

676

3888

1.07

0.98

1.5

1.4

32.81

33.00

g/l

0.14

617

3486

Urethral stricture

379

1.30

0.98

1.6

1.5

30.53

31.36

g/l

0.15

341

Sleep disorders, other/unspecified

1.81

0.98

1.6

1.4

31.90

33.70

g/l

0.17

Certolizumab pegol

2.18

0.98

1.0

1.3

39.06

30.99

g/l

—

Herpesviral [herpes simplex] infections

100

838

1.19

0.98

1.6

1.4

32.77

33.37

g/l

0.17

760

Lower back pain or/and sciatica

661

4029

1.07

0.98

1.5

32.05

33.23

g/l

1.54

595

3624

Corneal ulcer

775

1.20

0.97

1.4

1.5

30.27

33.51

g/l

1.72

703

Pulmonary eosinophilia, not elsewhere classified

1.82

0.97

1.2

1.5

32.78

33.05

g/l

—

Open wound of thorax

1.81

0.97

1.9

1.4

30.34

32.74

g/l

—

Benign leiomyoma with endometriosis

604

0.78

0.96

1.5

1.4

33.79

32.80

g/l

0.20

553

Thyroiditis, ILD-related definition

381

1.29

0.95

1.4

35.24

33.40

g/l

0.48

343

Benign neoplasm: Skin of other and unspecified parts of face

551

1.24

0.94

1.4

1.5

32.38

31.67

g/l

0.18

503

Other headache syndromes

161

1836

0.88

0.94

1.4

33.40

33.81

g/l

0.15

148

1674

Thyrotoxicosis with diffuse goitre

479

1.25

0.94

1.3

1.5

30.46

32.70

g/l

0.65

437

Hyperprolactinaemia

1.78

0.94

1.5

36.84

34.35

g/l

0.24

Disorders of ocular muscles, binocular movement, accommodation and refraction

217

1917

1.12

0.94

1.5

33.79

33.64

g/l

0.06

194

1737

Ventral hernia

154

1343

1.15

0.94

1.5

32.56

32.84

g/l

0.10

146

1195

Other disorders of the musculoskeletal system and connective tissue

724

1.20

0.93

1.3

1.5

31.59

32.38

g/l

0.23

656

Etanercept

158

1.46

0.93

1.5

1.4

39.50

32.89

g/l

1.59

139

Other and unspecified mood [affective] disorders

117

1.54

0.93

1.7

1.4

38.25

33.76

g/l

0.93

107

Post-traumatic stress disorder

117

1.54

0.93

1.7

1.5

34.01

34.81

g/l

0.09

107

Other obstetric conditions, not elsewhere classified

217

0.70

0.92

1.5

1.4

36.99

38.04

g/l

0.16

206

Carcinoma in situ of skin, other sites/unspecified

1.65

0.92

1.6

1.5

30.86

29.78

g/l

0.15

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

666

0.79

0.91

1.3

1.5

33.91

33.92

g/l

0.00

600

Any dementia, excluding more controls

279

2120

0.90

0.91

1.4

1.5

30.16

31.62

g/l

1.24

250

1899

Contusion of ankle

1.63

0.91

1.8

1.4

31.90

33.59

g/l

0.16

Localized swelling, mass and lump of skin and subcutaneous tissue

184

1629

1.13

0.90

1.4

1.5

31.08

32.80

g/l

1.10

168

1468

Alzheimer’s disease (Atypical or mixed)

823

0.82

0.90

1.3

1.5

30.71

29.65

g/l

0.32

710

Polycystic ovarian syndrome, broad definition

1.60

0.90

1.1

1.6

37.71

35.68

g/l

0.18

ILD medications: nintedanib

2.10

0.90

1.7

1.5

32.63

31.77

g/l

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

2.09

0.89

1.0

1.3

36.57

25.40

g/l

—

Orchitis and epididymitis

564

1.23

0.89

1.6

1.5

32.57

32.08

g/l

0.11

508

Other and unspecified urticaria

673

1.21

0.89

1.7

1.5

35.02

32.84

g/l

0.82

614

Nasal polyp

1111

0.84

0.89

1.4

1.5

33.24

33.02

g/l

0.06

999

Gastrojejunal ulcer

1.80

0.88

1.5

1.4

31.84

33.63

g/l

—

Flat foot [pes planus] (acquired)

392

0.74

0.87

1.3

1.4

28.71

33.54

g/l

0.98

353

Nonorganic sleeping disorders

666

1.20

0.87

1.5

32.68

33.55

g/l

0.25

609

Subjective visual disturbances

136

1184

1.15

0.87

1.4

1.5

33.46

33.09

g/l

0.14

121

1072

Salpingitis and oophoritis

539

1.23

0.87

1.4

32.65

33.83

g/l

0.31

493

Dermatitis herpetiformis

1.73

0.86

1.7

1.4

28.17

32.45

g/l

0.60

Crushed, pushed or stepped on by crowd or human stampede

161

1.43

0.86

1.4

33.97

32.84

g/l

0.15

141

Hallux valgus (acquired)

161

1313

0.88

0.86

1.4

32.89

33.43

g/l

0.21

149

1178

Mental retardation, wide definition

1.60

0.85

1.4

40.02

32.48

g/l

1.66

Idiopathic thrombocytopenic purpura

120

1.51

0.85

1.3

1.4

29.20

31.19

g/l

0.40

107

Sleep disorders (combined)

734

3626

1.06

0.85

1.5

1.4

33.34

32.93

g/l

0.38

664

3258

Persons encountering health services in circumstances related to reproduction

177

1344

0.89

0.85

1.5

1.4

35.98

35.23

g/l

0.35

157

1229

Burn and corrosion of wrist and hand

1.57

0.84

1.6

1.4

27.97

33.48

g/l

0.93

Alzheimer disease, excluding more controls

126

956

0.87

0.84

1.4

1.5

31.31

32.92

g/l

0.86

110

851

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

205

0.71

0.84

1.4

37.82

38.03

g/l

0.03

196

Atopic dermatitis

185

1699

0.89

0.83

1.6

1.4

33.78

34.58

g/l

0.36

174

1543

Leiomyoma of uterus

267

1371

1.10

0.83

1.4

33.70

33.17

g/l

0.25

241

1244

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

140

0.57

0.83

1.9

1.4

32.63

34.03

g/l

—

125

Propionic acid derivatives

186

1051

0.89

0.82

1.5

31.93

30.55

g/l

0.85

166

925

Wet age-related macular degeneration

157

1345

1.13

0.82

1.4

1.5

30.12

30.89

g/l

0.34

136

1179

Follow-up examination after treatment for malignant neoplasms

590

1.21

0.81

1.5

32.96

32.45

g/l

0.14

530

Benign mammary dysplasia

518

1.22

0.79

1.4

34.23

32.35

g/l

0.55

471

Alzheimer’s disease (Atypical or mixed), excluding more controls

598

0.82

0.79

1.3

1.5

31.25

31.77

g/l

0.14

537

Stomatitis and related lesions

794

1.17

0.78

1.4

1.5

30.36

32.94

g/l

1.16

716

Fissure and fistula of anal and rectal regions

131

1148

1.14

0.78

1.5

1.4

32.13

33.17

g/l

0.44

122

1031

Lumbar disc prolapse

335

2787

0.92

0.78

1.5

1.4

33.14

33.28

g/l

0.07

306

2506

Intracerebral haemorrhage

850

1.17

0.78

1.4

1.5

33.58

31.61

g/l

0.88

761

Communicating hydrocephalus

0.50

0.78

1.2

1.4

43.64

31.49

g/l

—

Fourth [trochlear] nerve palsy

100

0.50

0.77

1.8

1.4

26.42

33.34

g/l

—

Pedal cyclist injured in transport accident

901

0.84

0.77

1.5

34.50

33.54

g/l

0.25

812

Dorsopathies

646

3092

1.06

0.77

1.5

1.4

32.46

33.27

g/l

0.81

579

2773

Viral warts

750

1.17

0.76

1.5

30.94

33.43

g/l

1.13

682

Postpartum care and examination

1.43

0.75

1.3

37.39

37.71

g/l

0.04

Disorders of vitreous body

324

2887

1.08

0.75

1.4

1.5

31.39

33.10

g/l

1.62

291

2621

Ulcerative colitis (strict definition, require KELA)

615

0.81

0.75

1.3

1.5

33.59

33.83

g/l

0.04

556

Mental retardation, excluding more controls

1.65

0.75

1.4

40.75

31.65

g/l

1.76

Inflammatory bowel disease, strict (require KELA)

852

0.84

0.73

1.4

1.5

34.22

34.25

g/l

0.00

768

Benign neoplasm: Tongue

100

1.51

0.73

1.4

1.3

30.22

32.29

g/l

0.30

Visual disturbances

283

2603

1.09

0.72

1.4

1.5

32.04

33.02

g/l

0.68

253

2344

Circumscribed brain atrophy

110

0.54

0.72

1.0

1.4

28.67

29.85

g/l

—

100

Hypogonadotropic hypogonadism

1.67

0.72

1.3

1.6

40.48

33.09

g/l

—

Contact with nonpowered hand tool

159

0.63

0.72

1.5

1.6

36.05

32.29

g/l

—

139

Other disorders of penis

534

1.20

0.72

1.8

1.5

31.44

32.84

g/l

0.38

480

Superficial injury of forearm

326

1.26

0.71

1.3

1.5

33.04

32.28

g/l

0.14

296

Lichen ruber planus, wide definition including periferal and oral lichen planus

1021

0.86

0.71

1.6

1.5

34.04

33.02

g/l

0.31

922

Other disorders of optic [2nd] nerve and visual pathways

229

1.31

0.71

1.3

1.5

26.95

32.31

g/l

2.03

205

Benign lipomatous neoplasm of other sites/unspecified

444

1.22

0.71

1.4

1.5

29.98

31.68

g/l

0.40

404

Strabismus

121

1062

1.14

0.70

1.5

34.35

32.78

g/l

0.68

110

960

Atopic dermatitis, strict definition with reimbursement

748

1.16

0.70

1.5

1.4

34.56

35.00

g/l

0.12

678

Endocrine disorders, other/unspecified

1.56

0.70

1.1

1.4

33.11

33.43

g/l

—

Vestibular neuronitis

421

0.78

0.69

1.4

1.5

35.82

32.65

g/l

0.82

381

Nontraumatic intracranial haemmorrhage

153

1368

1.12

0.69

1.6

1.5

32.37

31.75

g/l

0.25

136

1219

Excessive attrition of teeth

218

2390

0.91

0.69

1.5

32.77

34.31

g/l

1.05

203

2178

Disorders of breast

184

1508

1.11

0.69

1.3

1.4

35.61

33.26

g/l

1.79

170

1371

Mild mental retardation

1.67

0.68

1.1

1.4

42.84

31.06

g/l

—

Cervicobrachial syndrome

962

0.86

0.67

1.4

32.38

33.66

g/l

0.50

880

Other specified and unspecified disorders of eye and adnexa

136

1.40

0.67

1.1

1.4

31.15

32.18

g/l

0.11

117

L02BB Anti-androgens

778

0.85

0.67

1.5

29.60

31.11

g/l

0.51

685

Mental retardation

1.59

0.67

1.4

1.3

40.75

31.74

g/l

1.75

Other mental disorders due to brain damage and dysfunction and to physical disease

734

1.16

0.66

1.5

32.15

30.94

g/l

0.43

649

Other hammer toe(s) (acquired)

935

0.87

0.66

1.5

1.4

35.03

32.71

g/l

1.08

836

Disorders of synovium and tendon

253

2406

0.92

0.65

1.6

1.4

33.24

33.56

g/l

0.15

230

2156

Neuromuscular dysfunction of bladder

458

1.20

0.65

1.5

32.70

32.83

g/l

0.02

418

Polycystic ovarian syndrome

1.59

0.65

1.1

1.3

37.37

35.55

g/l

—

Injuries to the wrist and hand

532

3898

0.94

0.64

1.5

1.4

32.82

33.31

g/l

0.39

496

3499

Disorders of optic nerve, not elsewhere classified

1.48

0.64

1.4

1.5

23.93

31.37

g/l

—

Labour and delivery complicated by umbilical cord complications

1.52

0.62

1.3

1.4

34.30

33.89

g/l

0.04

Hereditary ataxia

1.64

0.62

1.3

1.7

30.09

33.25

g/l

—

Glaucoma

425

3439

1.06

0.62

1.4

1.5

30.50

32.52

g/l

2.57

382

3087

Atypical facial pain

176

0.68

0.62

1.4

1.3

29.01

32.61

g/l

0.63

156

Injuries to the neck

104

917

1.14

0.61

1.6

1.5

32.95

33.22

g/l

0.07

831

Unspecified visual impairment (binocular)

1.61

0.61

1.4

28.85

32.68

g/l

—

Inflammatory bowel disease

152

1372

1.11

0.61

1.4

1.5

30.74

33.44

g/l

1.57

140

1242

IBD patients in KELA-register

835

0.86

0.60

1.4

1.5

34.22

34.36

g/l

0.03

753

Acute appendicitis, with complications

111

985

1.13

0.60

1.7

1.5

33.05

32.95

g/l

0.03

103

891

Other keratitis

417

1.20

0.59

1.4

1.5

32.64

33.44

g/l

0.12

372

Speech disturbances, not elsewhere classified

500

1.18

0.59

1.5

34.22

31.26

g/l

1.04

456

Meniscus derangement

319

2302

0.93

0.59

1.5

1.4

33.68

33.38

g/l

0.16

298

2057

556

1.17

0.59

1.7

1.5

23.90

31.52

g/l

4.40

489

Manic episode

1.53

0.59

1.3

1.4

38.59

34.30

g/l

0.81

Other joint disorders

502

2503

1.06

0.58

1.5

1.4

32.24

33.68

g/l

1.69

452

2239

Mouth breathing

186

2029

0.91

0.58

1.4

1.5

35.56

33.79

g/l

1.23

167

1834

Gastrointestinal stromal tumor and sarcoma

1.73

0.58

1.8

1.4

36.27

26.20

g/l

—

Intentional self-harm by sharp object

1.72

0.57

1.5

1.4

36.85

31.50

g/l

—

Lesion of plantar nerve

253

0.75

0.57

1.5

1.4

35.76

33.12

g/l

0.50

230

Neurotic, stress-related and somatoform disorders

439

2899

1.06

0.57

1.5

1.4

34.32

33.63

g/l

0.55

396

2635

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.46

0.56

1.5

37.89

33.30

g/l

—

Other specific joint derangements/joint disorders

387

2352

1.06

0.56

1.6

1.4

32.37

33.75

g/l

1.35

348

2105

Menorrhagia

126

779

0.90

0.56

1.6

1.4

32.88

32.57

g/l

0.09

115

686

Follicular cysts of skin and subcutaneous tissue

859

1.13

0.56

1.5

32.22

32.97

g/l

0.20

779

Mood disorders, excluding more controls

544

3084

1.05

0.56

1.5

34.64

33.25

g/l

1.72

491

2783

Ulcerative colitis

117

1048

1.12

0.56

1.4

1.5

30.91

33.33

g/l

1.06

106

945

Benign neoplasm: Short bones of upper limb

1.63

0.55

1.2

1.3

30.33

32.56

g/l

—

Voice disturbances

144

1305

1.10

0.55

1.6

1.5

33.36

32.76

g/l

0.23

133

1174

Female infertility, tubal origin

0.55

1.0

1.3

34.46

35.18

g/l

—

Suppurative and unspecified otitis media

122

970

1.11

0.55

1.4

1.5

33.68

33.89

g/l

0.06

111

877

Pneumoconiosis due to asbestos and other mineral fibres

168

1.32

0.55

1.5

35.44

30.59

g/l

1.28

153

Recurrent or chronic depression

135

1051

0.90

0.55

1.5

1.4

34.69

34.61

g/l

0.02

124

965

Chronic sinusitis

222

2052

1.08

0.54

1.7

1.4

33.64

33.74

g/l

0.04

201

1865

Benign neoplasm: Skin of scalp and neck

1.42

0.54

1.2

1.5

34.89

31.54

g/l

0.48

Injury of eye and orbit

536

0.84

0.54

1.5

32.46

33.73

g/l

0.23

488

Other bursopathies

692

1.14

0.54

1.5

1.4

29.36

33.63

g/l

2.20

626

Premature rupture of membranes

204

0.77

0.54

1.2

1.4

37.86

36.45

g/l

0.20

189

Disorders of tooth development and eruption

491

1.15

0.54

1.5

1.4

34.14

34.12

g/l

0.00

449

Other extrapyramidal and movement disorders in other diseases

118

1311

0.90

0.54

1.4

1.5

33.03

32.31

g/l

0.25

107

1179

Sequelae of injuries of upper limb

349

1.21

0.53

1.7

1.5

34.13

33.73

g/l

0.08

311

Malignant neoplasm of ureter, including Hilmo

1.55

0.53

1.5

1.3

32.33

27.03

g/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

199

1010

1.09

0.53

1.5

31.39

30.17

g/l

0.68

179

889

Chondropathies

562

1.16

0.53

1.6

1.5

34.27

33.18

g/l

0.31

517

Hyperplasia of prostate

312

1658

1.07

0.53

1.5

32.29

32.85

g/l

0.34

280

1488

Other benign neoplasms of connective and other soft tissue

414

1.19

0.53

1.4

1.5

31.76

32.34

g/l

0.13

374

Other benign neoplasms of skin

234

2175

1.08

0.52

1.4

1.5

32.31

32.40

g/l

0.04

215

1937

Persistent mood disorders

807

1.13

0.52

1.6

1.5

33.04

32.55

g/l

0.14

732

Benign neoplasm of other and unspecified female genital organs

136

0.66

0.51

1.2

1.3

34.69

33.07

g/l

—

121

Inflammation of lacrimal passages (chronic)

1.48

0.51

1.7

1.4

33.28

32.90

g/l

0.03

Nonsuppurative otitis media

577

1.14

0.50

1.3

1.5

34.71

33.32

g/l

0.39

525

Primary coxarthrosis, bilateral

186

2012

0.92

0.50

1.5

31.51

31.98

g/l

0.21

174

1782

Sicca syndrome [Sjögren]

325

1.20

0.49

1.4

1.5

28.14

32.80

g/l

1.08

294

Ovarian cyst

122

778

0.90

0.49

1.5

1.4

33.54

32.66

g/l

0.28

113

688

Monoamine oxidase A inhibitors

529

1.15

0.49

1.3

1.5

35.98

33.10

g/l

1.05

477

Otitis media, unspecified

237

0.78

0.49

1.4

34.00

34.05

g/l

0.01

213

Impacted maxillary molar

1.56

0.49

1.6

1.2

39.47

34.69

g/l

—

Anxiety disorders

445

2948

1.05

0.48

1.4

34.34

33.62

g/l

0.58

401

2681

Polycystic ovarian syndrome, consortium definition

265

1469

1.07

0.47

1.5

1.4

33.76

33.38

g/l

0.18

250

1320

L04AC Interleukin inhibitors

137

1.32

0.47

1.5

1.4

36.58

32.34

g/l

0.77

117

Melanocytic naevi

139

1273

1.09

0.46

1.5

33.40

33.21

g/l

0.06

122

1151

Redundant prepuce, phimosis and paraphimosis

121

1090

1.10

0.46

1.6

1.5

32.21

33.60

g/l

0.55

106

979

Inflammatory disorders of breast

120

1.34

0.46

1.4

32.39

33.11

g/l

0.07

110

Metatarsalgia

365

1.18

0.46

1.6

1.4

33.29

33.97

g/l

0.14

327

Excessive earwax

329

3392

0.95

0.46

1.5

32.69

32.66

g/l

0.01

298

3048

Erectile dysfunction

599

1.14

0.46

1.4

1.5

31.35

31.97

g/l

0.14

533

Hypermobility syndrome

0.59

0.45

1.4

1.5

38.38

36.12

g/l

—

Conductive hearing loss, unspecified

352

0.82

0.45

1.6

1.5

33.57

32.46

g/l

0.21

319

Fall on same level involving ice and snow

319

3018

1.06

0.44

1.5

31.92

33.21

g/l

1.01

290

2721

Other degenerative diseases of the nervous system

198

1376

1.08

0.44

1.3

1.4

31.94

33.45

g/l

0.96

178

1231

Polyp of the female genital tract

121

763

0.91

0.44

1.5

1.4

33.89

32.62

g/l

0.47

111

672

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

404

1.17

0.44

1.4

1.5

32.94

32.77

g/l

0.03

363

Hypopituitarism

220

1.23

0.43

1.3

1.5

33.78

34.16

g/l

0.05

197

Other/unspecified disorders of vestibular function

185

0.75

0.43

1.6

1.5

27.84

31.59

g/l

0.64

166

Other disorders of eyelid

317

2859

1.06

0.42

1.4

1.5

31.03

32.46

g/l

1.34

284

2557

Ganglion

808

0.89

0.42

1.6

1.4

33.59

34.45

g/l

0.21

734

Effects of foreign body entering through natural orifice

103

1132

0.91

0.42

1.4

1.5

33.47

g/l

0.00

1030

Other disorders of choroid

1.36

0.41

1.3

1.5

31.04

30.81

g/l

—

Necrosis of pulp, including avohilmo

233

2469

0.94

0.41

1.5

34.57

34.24

g/l

0.15

217

2243

Other juvenile arthritis

1.36

0.41

1.8

1.1

27.79

34.87

g/l

—

Dyshidrosis [pompholyx]

1.47

0.40

2.4

1.4

27.40

31.25

g/l

—

Open wound of wrist and hand

202

2105

0.94

0.40

1.5

34.81

33.70

g/l

0.59

193

1892

Benign lipomatous neoplasm

145

1563

0.93

0.39

1.4

1.5

33.36

32.87

g/l

0.18

131

1410

Primary hyperparathyroidism

503

1.13

0.39

1.3

1.5

32.09

31.70

g/l

0.08

454

Cervical disc disorders

196

2089

0.94

0.39

1.5

1.4

31.99

33.22

g/l

0.64

182

1882

Guillain-Barre syndrome

1.37

0.38

1.2

1.5

22.99

32.95

g/l

—

Ovarian dysfunction

1.38

0.38

1.4

38.19

34.30

g/l

0.34

Acute myeloid leukaemia

1.39

0.38

1.8

1.2

36.64

23.62

g/l

—

Acute myeloid leukaemia, helper endpoint

1.39

0.38

1.8

1.2

36.64

23.62

g/l

—

Acute myeloid leukaemia, including Hilmo

1.39

0.38

1.8

1.2

36.64

23.62

g/l

—

Rotator cuff syndrome

403

2765

1.05

0.38

1.5

1.4

33.23

33.31

g/l

0.04

366

2474

Reactive arthropathies

382

1.15

0.38

1.4

35.13

33.43

g/l

0.47

350

Sudden idiopathic hearing loss

543

1.13

0.37

1.5

33.06

32.38

g/l

0.14

489

Multiple gestation

112

0.71

0.37

1.6

1.4

38.76

36.71

g/l

—

103

Lichen planus, including avohilmo

893

0.91

0.37

1.5

33.72

32.84

g/l

0.24

804

Acute nasopharyngitis (common cold)

334

1.16

0.37

1.6

1.4

33.66

35.11

g/l

0.27

296

Personal history of malignant neoplasm

216

1.21

0.36

1.5

33.54

34.59

g/l

0.16

199

Diplopia

658

1.11

0.36

1.4

1.5

31.96

32.30

g/l

0.08

595

Pedal cyclist injured in noncollision transport accidents

407

0.86

0.36

1.5

37.60

33.00

g/l

1.30

361

Cluster headache, strict

1.36

0.36

1.8

1.5

37.83

33.46

g/l

0.42

Panhypopituitarism

1.27

0.36

1.2

1.5

32.58

29.80

g/l

—

Trochanteric bursitis

640

0.89

0.36

1.4

31.79

33.79

g/l

0.53

579

Special screening examination for infectious and parasitic diseases

470

1.11

0.36

1.3

37.80

36.79

g/l

0.29

427

Childhood allergy (age < 16)

0.62

0.35

1.2

1.3

28.50

41.35

g/l

—

Viral meningitis

0.66

0.35

1.4

36.44

34.46

g/l

—

Calcific tendinitis of shoulder

212

0.80

0.35

1.3

1.4

31.93

34.59

g/l

0.43

193

Subarachnoid haemorrhage

555

1.12

0.35

1.8

1.5

31.55

32.64

g/l

0.26

495

Other enthesopathy of foot (+metatarsalgia)

385

1.14

0.35

1.6

1.4

33.31

33.90

g/l

0.13

346

Transport accidents

220

1788

1.06

0.35

1.6

1.4

32.63

34.17

g/l

0.94

198

1613

Other hearing loss

224

2074

1.06

0.35

1.4

1.5

32.16

31.69

g/l

0.21

195

1832

Peritonsillar abscess

743

0.90

0.35

1.5

1.4

32.90

34.52

g/l

0.48

672

Bicipital tendinitis

178

0.78

0.34

1.2

1.5

30.78

33.86

g/l

0.33

162

Other and unspecified trigeminal disorders

1.34

0.34

1.7

1.2

37.18

31.68

g/l

—

Car occupant injured in noncollision transport accident

100

1.30

0.33

1.5

31.51

32.64

g/l

0.14

Other nutritional anaemias

1.31

0.33

1.3

1.5

35.92

31.85

g/l

—

6-mercaptopurine

1.31

0.33

1.3

1.5

31.68

35.32

g/l

—

Benign neoplasm of eye and adnexa

501

1.12

0.33

1.5

36.42

32.06

g/l

1.93

454

Other noninflammatory disorders of uterus, except cervix

724

0.92

0.33

1.4

32.06

32.44

g/l

0.12

635

Other sexually transmitted chlamydial diseases

0.67

0.33

1.5

1.4

34.38

38.59

g/l

—

Mixed and other personality disorders

173

1.22

0.32

1.2

1.5

37.42

34.81

g/l

0.34

153

Spermatocele

540

0.89

0.32

1.3

1.5

32.54

31.95

g/l

0.10

484

Other and unspecified visual disturbances

435

1.13

0.32

1.3

1.5

32.50

32.74

g/l

0.05

398

Organic, including symptomatic, mental disorders

423

2897

1.04

0.32

1.4

1.5

31.56

32.09

g/l

0.37

380

2595

Other and unspecified paralytic syndromes

1.28

0.32

1.5

1.4

34.87

32.60

g/l

—

Scoliosis

274

0.84

0.32

1.3

1.4

34.66

32.15

g/l

0.42

251

Striking against or struck by other objects

148

1386

1.07

0.32

1.4

1.5

34.61

33.67

g/l

0.40

133

1255

Other/unspecified enthesopathies of lower limb, excluding foot

229

1.18

0.32

1.9

1.5

29.17

32.17

g/l

0.64

210

Pregnancy with abortive outcome

233

1281

0.95

0.32

1.5

1.4

35.58

32.89

g/l

2.35

212

1164

Spondylolisthesis/Spondylolysis

915

0.92

0.31

1.4

1.5

33.89

33.61

g/l

0.07

833

Glaucoma suspect

214

2254

0.95

0.31

1.4

1.5

30.04

32.48

g/l

1.90

195

2014

Lesion of sciatic nerve

273

0.84

0.31

1.4

1.5

34.94

30.76

g/l

0.72

248

Other abnormal uterine and vaginal bleeding

110

730

1.08

0.31

1.4

31.01

32.64

g/l

0.61

102

643

Disorders of refraction and accommodation

902

1.08

0.31

1.5

33.41

34.14

g/l

0.25

819

Chronic Coagulation defects

1.35

0.31

1.6

1.4

26.09

32.16

g/l

—

Benign neoplasm of middle ear and respiratory system

380

1.13

0.31

1.3

1.5

31.26

32.23

g/l

0.18

341

Other symptoms and signs involving the nervous and musculoskeletal systems

220

2090

1.05

0.31

1.5

33.32

33.23

g/l

0.03

199

1888

Obstructive hydrocephalus

1.32

0.31

1.7

1.5

41.51

33.12

g/l

—

Crossbite

0.70

0.30

1.0

1.4

37.54

34.63

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

1.33

0.30

1.3

1.4

30.06

33.11

g/l

—

Other and unspecified injuries of thorax

1.28

0.30

1.1

1.5

31.77

31.16

g/l

—

313

0.86

0.29

1.7

1.4

30.69

30.00

g/l

0.09

275

Other disorders of cornea

429

1.12

0.29

1.4

1.5

29.12

32.35

g/l

0.92

388

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

231

1.17

0.29

1.5

1.4

31.86

34.64

g/l

0.41

207

Coxarthrosis, primary, with hip surgery

330

3211

0.96

0.29

1.5

31.99

32.26

g/l

0.16

305

2866

Glucosamine medication

326

2706

0.96

0.29

1.5

32.41

32.09

g/l

0.18

289

2422

Twin gestation

107

0.75

0.29

1.6

1.4

38.76

36.12

g/l

—

Other arthrosis

313

2255

0.96

0.28

1.5

1.4

33.18

33.38

g/l

0.10

282

2010

Diseases of the ear and mastoid process

670

3456

0.97

0.28

1.4

1.5

32.78

33.31

g/l

0.48

600

3102

Ocular pain

248

0.85

0.28

1.5

34.71

33.32

g/l

0.13

221

Oxicams

171

1025

0.95

0.27

1.4

1.5

33.53

30.29

g/l

2.76

156

901

Pollen allergy

328

0.87

0.27

1.4

1.5

36.53

36.00

g/l

0.09

294

Benign neoplasm: Skin of upper limb, including shoulder

1.21

0.26

1.0

1.4

25.82

31.63

g/l

—

Pedestrian injured in collision with car, pick-up truck or van

0.69

0.26

1.4

34.92

32.28

g/l

—

Dermatographic urticaria

171

0.82

0.26

1.4

31.81

33.15

g/l

0.16

154

Certain zoonotic bacterial diseases

1.24

0.25

1.2

1.4

31.96

32.67

g/l

—

Primary open-angle glaucoma

227

2289

0.96

0.25

1.4

1.5

30.78

31.78

g/l

0.56

203

2025

Benign neoplasm: Skin of lower limb, including hip

105

1.24

0.25

1.8

1.4

30.79

32.50

g/l

0.28

Abnormal involuntary movements

637

1.08

0.24

1.4

1.5

30.91

32.49

g/l

0.55

582

Diseases of male genital organs

368

1795

1.03

0.24

1.5

32.70

33.44

g/l

0.55

329

1610

Laparoscopic left hemicolectomy

1.17

0.24

1.4

1.6

32.76

30.81

g/l

—

Postpartum haemorrhage due to retained placenta

137

0.80

0.24

1.3

1.5

41.12

36.80

g/l

0.73

128

Other abnormal findings in urine

0.73

0.24

2.0

1.5

18.67

30.37

g/l

—

Viral conjunctivitis

0.72

0.24

1.7

1.4

29.52

33.04

g/l

—

Use of cabergoline

1.32

0.23

1.4

1.5

36.32

31.42

g/l

—

Glaucoma-related operations

332

1.12

0.23

1.4

1.5

28.57

30.74

g/l

0.51

301

Disturbances of skin sensation

110

1037

1.06

0.23

1.6

1.4

35.62

33.68

g/l

0.73

103

940

Guttate psoriasis

1.28

0.23

1.6

1.5

35.28

31.90

g/l

—

Cluster headache, wide

1.24

0.23

1.8

1.5

39.45

33.20

g/l

0.70

Deforming dorsopathies

126

1329

0.95

0.22

1.5

1.4

34.02

33.26

g/l

0.28

117

1210

Exposure to other specified electric current

1.25

0.22

1.2

1.3

23.88

36.23

g/l

—

Excessive vomiting in pregnancy

135

0.81

0.22

1.3

1.4

33.23

34.52

g/l

0.13

126

Other sudden death, cause unknown

0.00

0.21

0.0

1.7

—

28.19

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.8

—

33.11

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.19

0.21

2.0

1.5

42.76

30.89

g/l

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.5

—

28.18

—

Primary open-angle glaucoma, strict

181

1883

0.96

0.21

1.4

1.5

30.87

31.73

g/l

0.39

165

1665

Gonarthrosis

407

2384

0.97

0.21

1.5

1.4

33.33

33.35

g/l

0.01

378

2128

Subacute thyroiditis

103

0.78

0.21

1.6

1.4

36.81

33.82

g/l

—

LSIL lesion of the cervix uteri

177

0.85

0.21

1.3

1.4

39.52

35.38

g/l

0.63

163

Benign neoplasm of brain and other parts of central nervous system

272

0.88

0.20

1.4

1.5

33.59

32.24

g/l

0.23

240

Mood [affective] disorders

547

3627

0.98

0.20

1.5

1.4

34.72

33.06

g/l

2.34

493

3257

Depression or dysthymia

423

2272

1.03

0.20

1.6

1.5

33.83

33.22

g/l

0.42

390

2045

Other cestode infections

0.00

0.20

0.0

1.1

—

31.91

—

Other enthesopathies

142

1356

1.05

0.20

1.7

1.4

34.05

34.48

g/l

0.15

127

1237

Diseases of middle ear and mastoid

246

1943

1.04

0.20

1.4

1.5

33.27

33.48

g/l

0.08

221

1750

Disorders of conjunctiva

397

3272

0.97

0.20

1.4

33.17

33.42

g/l

0.15

359

2948

Struck by thrown, projected or falling objec

176

0.85

0.20

2.1

1.5

34.38

32.77

g/l

0.26

155

Malignant neoplasm of rectosigmoid junction

1.18

0.19

1.5

1.4

30.13

24.54

g/l

—

Radiculopathy

973

0.94

0.19

1.4

34.70

32.23

g/l

1.17

868

Lateral epicondylitis

489

0.92

0.19

1.9

1.4

35.84

35.56

g/l

0.05

444

Helminthiases

1.13

0.18

1.0

1.4

27.42

33.11

g/l

—

Blepharochalasis

183

1763

1.04

0.18

1.4

1.5

31.40

32.76

g/l

0.85

166

1573

Corneal degeneration

1.21

0.18

1.1

1.4

30.11

33.25

g/l

—

Cystitis

521

3030

1.02

0.18

1.5

1.4

31.90

33.12

g/l

1.29

463

2754

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.21

0.18

1.9

1.6

34.93

30.59

g/l

—

Selective serotonin reuptake inhibitors

631

3229

1.02

0.18

1.4

1.5

33.56

32.94

g/l

0.56

566

2910

Maternal care for known or suspected malpresentation of fetus

142

0.87

0.18

1.1

1.4

35.03

37.48

g/l

0.40

133

Postprocedural disorders of nervous system

147

1.16

0.18

1.4

38.89

35.09

g/l

0.67

132

Anankastic personality disorder

1.19

0.18

1.9

1.4

42.70

33.56

g/l

—

Somatoform disorder

580

1.07

0.18

1.5

33.48

32.92

g/l

0.14

529

Seborrhoeic keratosis

138

1323

1.04

0.18

1.4

1.5

30.14

32.60

g/l

1.41

125

1183

Golimumab

1.17

0.17

2.4

1.3

36.86

35.37

g/l

—

Glucagon-like peptide-1 (GLP-1) analogues

131

1255

1.04

0.17

1.6

1.4

31.59

34.45

g/l

1.86

123

1152

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

131

1255

1.04

0.17

1.6

1.4

31.59

34.45

g/l

1.86

123

1152

Lichen planus

599

0.93

0.17

1.4

1.5

34.99

32.24

g/l

0.80

543

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.11

0.17

1.6

1.4

41.44

31.83

g/l

—

Visual field defects

436

1.08

0.17

1.4

1.5

30.95

31.89

g/l

0.18

394

Synovial cyst of popliteal space [Baker]

359

1.09

0.16

1.5

1.4

28.83

32.81

g/l

1.17

328

Carpal tunnel syndrome

342

2940

1.03

0.16

1.5

1.4

32.40

33.35

g/l

0.70

307

2649

Short Achilles tendon (acquired)

1.18

0.16

2.1

1.3

29.25

33.79

g/l

—

Other superficial mycoses

282

1.10

0.16

1.5

1.6

32.14

33.66

g/l

0.28

253

Colonic or urogenital fistula

141

1356

1.04

0.16

1.5

31.79

32.85

g/l

0.47

130

1218

Type 1 diabetes, wide definition, subgroup 2

1.14

0.16

1.6

1.3

29.82

28.33

g/l

—

Occlusion and stenosis of arteries, not leading to stroke

1.20

0.16

1.6

1.5

25.00

29.62

g/l

0.57

Pure hyperglyceridaemia

1.20

0.16

1.7

1.4

31.16

32.27

g/l

0.07

Cutaneous lupus erythematosus

1.10

0.15

1.4

32.05

33.23

g/l

—

5-aminosalicylic acid

740

1.05

0.15

1.4

33.45

34.00

g/l

0.13

670

Other and unspecified hydrocephalus

1.16

0.15

1.6

1.4

33.29

31.42

g/l

—

Gonarthrosis [arthrosis of knee](FG)

466

2763

0.98

0.15

1.5

1.4

33.09

33.28

g/l

0.12

436

2466

Myasthenia gravis

1.13

0.15

1.6

1.5

32.42

32.86

g/l

—

Other disorders of conjunctiva

790

1.05

0.15

1.5

28.94

31.97

g/l

1.36

712

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.10

0.15

2.3

1.4

38.14

36.17

g/l

—

Mood disorders

552

3633

0.98

0.14

1.5

1.4

34.72

33.04

g/l

2.39

498

3261

Myopia

304

1.09

0.14

1.4

1.5

35.60

33.72

g/l

0.39

274

Other and/or unspecified nontoxic goitre

343

1.08

0.14

1.6

1.5

35.27

31.98

g/l

0.94

312

Other disorders of eye and adnexa

532

0.94

0.14

1.4

1.5

31.26

32.70

g/l

0.28

483

Allergic conjunctivitis

209

2093

0.97

0.14

1.4

34.81

33.80

g/l

0.62

186

1914

Conjunctivitis

330

2815

0.98

0.14

1.4

34.05

33.59

g/l

0.29

297

2544

Ankylosing spondylitis, strict definition

0.82

0.13

1.1

1.4

35.83

32.94

g/l

—

Perineal laceration during delivery

142

0.88

0.13

1.2

1.4

36.75

35.69

g/l

0.15

132

Other disorders of amniotic fluid and membranes

145

0.87

0.13

1.2

1.4

39.89

36.22

g/l

0.52

133

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

201

2005

0.97

0.12

1.4

34.67

33.82

g/l

0.48

178

1830

Pregnancy hypertension

857

0.96

0.12

1.6

1.4

34.58

35.16

g/l

0.15

796

Deviated nasal septum

183

1876

0.97

0.12

1.5

33.03

33.45

g/l

0.18

164

1695

Other intervertebral disc disorders

497

3038

0.98

0.12

1.5

1.4

32.93

33.16

g/l

0.14

451

2723

Glaucoma, exfoliation

728

1.04

0.12

1.4

1.5

29.42

30.48

g/l

0.30

643

Temporal arteritis

201

1.10

0.11

1.5

27.97

30.93

g/l

0.58

182

Giant cell arteritis with polymyalgia rheumatica

201

1.10

0.11

1.5

27.97

30.73

g/l

0.53

183

Disorders of optic nerve and visual pathways

337

1.07

0.11

1.3

1.5

28.87

32.45

g/l

1.11

304

Anti-inflammatory and antirheumatic products, non-steroids

204

1051

0.98

0.11

1.5

31.68

30.55

g/l

0.68

180

925

Aneurysms, operations, SAH

877

1.04

0.11

1.6

1.5

31.87

32.86

g/l

0.30

786

Coxarthrosis, primary

437

3642

1.02

0.11

1.5

31.57

32.53

g/l

0.93

402

3253

Other disorders of the genitourinary system

598

0.95

0.11

1.7

1.5

32.64

32.23

g/l

0.09

540

Hypertrophy of breast in women and men

602

1.05

0.11

1.4

1.5

34.82

33.85

g/l

0.26

548

Entropion and trichiasis of eyelid

573

1.05

0.10

1.3

1.5

28.91

31.16

g/l

0.82

516

Urolithiasis

209

2134

0.98

0.10

1.6

1.5

31.72

32.46

g/l

0.35

185

1918

Unspecified urinary incontinence

402

0.94

0.10

1.7

1.5

35.21

31.70

g/l

1.00

368

Benign neoplasm of thyroid gland

114

0.88

0.09

1.6

1.4

35.52

32.65

g/l

—

101

Carcinoma in situ of breast, other/unspecified

1.06

0.09

1.0

1.2

30.40

32.41

g/l

—

Acute appendicitis, no complications

237

2403

0.98

0.09

1.5

34.32

33.99

g/l

0.15

213

2178

Other disorders of binocular movement

1.04

0.09

1.4

28.64

33.27

g/l

—

Other specified/unspecified inflammatory spondylopathies

116

1.12

0.09

1.2

1.5

26.60

31.76

g/l

0.65

105

Sciatica+with lumbago

269

2516

0.98

0.09

1.5

1.4

33.89

33.39

g/l

0.28

240

2264

Exfoliative dermatitis

1.09

0.09

1.5

31.28

31.84

g/l

—

Enteropathic arthropathies

1.09

0.09

1.3

1.1

34.25

34.22

g/l

—

Major anomalies of jaw size

1.09

0.09

1.2

1.4

33.57

34.09

g/l

—

Diseases of appendix

375

3425

0.99

0.08

1.6

1.4

33.82

33.40

g/l

0.27

341

3089

Effects of other external causes

1.07

0.08

1.5

1.4

28.58

33.73

g/l

—

Cluster headache, strict, including avohilmo

107

1.12

0.08

1.8

1.4

38.09

33.85

g/l

0.46

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.83

0.08

1.2

31.62

32.43

g/l

—

Benign neoplasm: Lip

1.14

0.08

1.0

1.4

33.25

31.95

g/l

—

Use of pramipexole

123

1259

0.98

0.08

1.5

30.83

32.11

g/l

0.53

114

1128

Suppurative otitis media, unspecified

1.08

0.07

1.5

34.04

31.16

g/l

—

Aggressive periodontitis

1.05

0.07

1.1

1.4

30.45

30.89

g/l

—

Complications predominantly related to the puerperium

530

1.04

0.07

1.4

36.75

35.37

g/l

0.35

491

Oligomenorrhoea

1.04

0.07

1.3

32.58

33.22

g/l

—

Testicular dysfunction

108

1.11

0.07

1.4

1.5

32.17

34.00

g/l

0.29

Acetic acid derivatives and related substances

205

1046

1.02

0.07

1.5

31.25

30.52

g/l

0.36

179

921

Presbycusis

117

1133

1.02

0.07

1.4

1.5

31.19

30.73

g/l

0.14

101

987

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

153

0.91

0.07

2.2

1.4

37.14

35.39

g/l

0.22

140

Intrahepatic Cholestasis of Pregnancy (ICP)

1.02

0.07

2.3

1.4

38.14

35.05

g/l

—

conjunctival degenerations and deposits

1.13

0.07

1.2

1.5

31.04

32.65

g/l

—

Appendicitis, broad definition

372

3400

0.99

0.06

1.6

1.4

33.90

33.43

g/l

0.30

338

3064

Other fall from one level to another

105

1026

1.02

0.06

1.7

1.5

31.34

33.28

g/l

0.84

932

Vascular dementia (undefined)

331

1.05

0.06

1.3

1.5

27.60

28.13

g/l

0.10

292

Disorders of acoustic nerve

100

0.90

0.06

1.6

1.5

29.53

32.48

g/l

—

Hyperkinetic disorders

1.11

0.06

1.3

1.4

43.42

38.52

g/l

0.92

Injury of nerves at wrist and hand level

109

1.10

0.06

1.3

1.4

33.19

33.05

g/l

0.01

Trigger finger

628

0.97

0.06

1.8

1.4

32.65

34.35

g/l

0.46

571

Spondylosis

348

2808

1.01

0.05

1.5

1.4

33.53

33.01

g/l

0.32

320

2510

Antepartum haemorrhage, not elsewhere classified

100

1.10

0.05

1.5

1.4

40.58

35.35

g/l

0.52

Chronic rhinitis, nasopharyngitis and pharyngitis

141

1389

1.02

0.05

1.6

1.5

35.24

34.00

g/l

0.67

129

1266

Coxibs

196

1045

0.99

0.05

1.6

1.5

31.80

30.51

g/l

0.74

173

920

Benign neoplasm: Skin of eyelid, including canthus

813

1.02

0.04

1.4

1.5

33.08

32.23

g/l

0.26

730

Medical abortion

234

1255

1.01

0.04

1.5

1.4

34.73

32.97

g/l

1.17

216

1143

Traumatic amputation of wrist and hand

209

1.05

0.04

1.5

1.6

30.40

32.00

g/l

0.23

186

Inflammatory diseases of prostate (prostatitis)

874

1.02

0.04

1.7

1.5

31.55

32.44

g/l

0.30

784

Amenorrhoea

101

1.09

0.04

1.3

36.95

33.15

g/l

0.59

Foreign body entering into or through eye or natural orifice

299

1.04

0.03

1.7

1.5

32.41

32.55

g/l

0.02

265

Pre-eclampsia or poor fetal growth

581

0.98

0.03

1.8

1.4

32.32

35.61

g/l

0.94

538

Other disorders of bladder

776

1.02

0.03

1.7

1.5

32.02

32.33

g/l

0.08

696

Depression

488

3324

0.99

0.03

1.5

1.4

34.93

33.31

g/l

2.04

442

2989

Car occupant injured in other and unspecified transport accidents

682

0.98

0.03

1.8

1.5

28.96

33.56

g/l

1.94

620

Calculus of kidney and ureter

192

1936

0.99

0.03

1.6

1.5

31.88

32.60

g/l

0.32

169

1739

Acute appendicitis

348

3234

1.01

0.02

1.5

1.4

33.90

33.49

g/l

0.25

316

2921

Toxic effect of contact with venomous animals

128

0.94

0.02

1.3

1.4

36.45

32.18

g/l

0.55

113

Stenosis and insufficiency of lacrimal passages

450

1.02

0.02

1.5

30.33

31.89

g/l

0.35

411

Vascular dementia

763

0.99

0.02

1.3

1.5

27.93

29.83

g/l

0.82

659

Haemorrhoids and perianal venous thrombosis

192

1928

0.99

0.02

1.5

1.4

32.49

32.71

g/l

0.09

174

1731

Mixed conductive and sensorineural hearing loss

711

1.01

0.01

1.4

1.5

31.10

31.91

g/l

0.20

636

Injury of muscle and tendon at lower leg level

729

0.99

0.01

1.5

31.48

34.00

g/l

0.92

670

Erosion of teeth , including avohilmo

811

1.01

0.01

1.5

33.25

33.82

g/l

0.15

736

Polyarthrosis

119

1096

1.01

0.01

1.5

1.4

33.83

32.84

g/l

0.34

108

975

Other diseases of lip and oral mucosa

192

1910

1.01

0.01

1.5

34.14

33.28

g/l

0.43

175

1732

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

115

992

1.01

0.01

1.6

1.4

34.33

34.94

g/l

0.18

104

921

Internal derangement of knee

200

1982

1.00

0.01

1.5

1.4

32.95

33.62

g/l

0.36

173

1776

Benign neoplasm of male genital organs

126

0.95

0.00

1.2

1.5

25.94

31.35

g/l

0.72

112

Foreign body or object entering through skin

206

0.97

0.00

1.3

1.5

35.02

33.44

g/l

0.27

181

Lichen sclerosus et atrophicus

386

0.98

0.00

1.5

1.4

31.94

32.89

g/l

0.19

346

Arthrosis

444

2432

1.00

0.00

1.5

1.4

32.18

33.39

g/l

1.20

404

2172

Cervicalgia

105

1044

1.01

0.00

1.4

1.5

31.81

33.07

g/l

0.52

945

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

111

1109

1.00

0.00

1.5

1.4

35.17

34.54

g/l

0.21

103

1015

Inflammatory diseases of female pelvic organs

203

1489

1.00

0.00

1.4

33.66

33.68

g/l

0.01

188

1358

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

364

0.99

0.00

1.5

1.4

29.80

34.16

g/l

1.37

332

Retinal breaks without detachment

814

1.00

0.00

1.5

36.48

33.19

g/l

1.93

739

Amblyopia ex anopsia

105

0.95

0.00

1.2

1.4

27.28

32.76

g/l

—

Cluster headache, wide,, including avohilmo

125

1.04

0.00

1.7

1.4

39.57

34.31

g/l

0.62

108

Cerebral aneurysm, nonruptured

372

0.99

0.00

1.2

1.5

33.81

33.08

g/l

0.12

335

Endometriosis diagnosis and infertility diagnosis occurring together

175

1.03

0.00

1.2

1.4

39.83

35.62

g/l

0.65

160

Impingement syndrome of shoulder

126

1255

1.00

0.00

1.4

31.89

34.61

g/l

1.54

113

1138

Benign neoplasm: Cranial nerves

116

1.03

0.00

1.4

1.5

32.27

32.66

g/l

0.05

106

Nonspecific lymphadenitis

156

1.03

0.00

1.9

1.5

30.46

34.42

g/l

0.40

134

Fall on and from ladder

394

0.99

0.00

1.5

33.43

32.00

g/l

0.33

355

Other and unspecified corneal deformities and disorders

108

1.02

0.00

1.5

1.4

25.28

33.70

g/l

1.61

Embedded and impacted teeth

364

1.00

0.00

1.2

1.5

38.06

35.22

g/l

0.68

329

Other diseases of upper respiratory tract

717

3734

1.00

0.00

1.5

1.4

32.21

32.97

g/l

0.88

650

3354

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

144

0.97

0.00

2.2

1.4

37.14

34.68

g/l

0.34

132

Ulcerative ileocolitis

112

0.98

0.00

1.2

1.4

36.11

32.45

g/l

0.64

Myotonic dystrophy (Steinert)

0.00

0.0

1.6

—

37.54

—

Familial chondrocalcinosis

0.00

0.0

1.4

—

37.44

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.4

—

38.16

—

Other sexually transmitted chlamydial diseases

0.93

0.00

1.6

1.5

35.16

38.06

g/l

—

Calcium deposit in bursa

0.00

0.0

1.3

—

33.44

—

Disorders of puberty, other/unspecified

0.00

0.0

1.4

—

24.28

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.0

1.5

—

31.15

—

Enterobiasis

0.00

0.0

1.5

—

35.83

—

Congenital syphilis

0.00

0.0

1.2

—

27.66

—

Precocious central puberty

0.00

0.0

1.4

—

27.96

—

Congenital syphilis

0.00

0.0

1.2

—

27.66

—

Syndactyly

0.00

0.0

1.2

—

33.16

—

Diseases of thymus

0.00

-0.00

0.0

1.4

—

26.62

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.4

—

32.20

—

Hyperhidrosis

1.01

-0.00

1.1

1.4

37.49

34.48

g/l

—

Relapsing fevers

0.00

-0.00

0.0

1.4

—

32.76

—

Knuckle pads

0.00

-0.00

0.0

2.2

—

34.36

—

Sunburn

0.00

-0.00

0.0

1.2

—

20.72

—

Other hypertrichosis

0.00

-0.00

0.0

1.2

—

29.00

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.4

—

35.12

—

Flexion deformity

0.00

-0.00

0.0

1.1

—

27.44

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.6

—

32.16

—

Postpartum haemorrhage due to anatomy

0.93

-0.00

1.6

1.5

32.27

37.13

g/l

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

2.0

—

31.65

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

-0.00

0.0

1.3

—

28.38

—

Actinic reticuloid

0.00

-0.00

0.0

1.5

—

26.83

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.6

—

34.92

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.3

—

30.17

—

Pedal cyclist injured in collision with motor vehicle

0.89

-0.00

1.3

1.4

37.16

33.28

g/l

—

Relapsing fevers

0.00

-0.00

0.0

1.4

—

32.76

—

Lichen planopilaris

0.00

-0.00

0.0

1.5

—

32.08

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

2.0

—

34.29

—

Yaws

0.00

-0.00

0.0

1.4

—

37.90

—

Disturbance of activity and attention

0.90

-0.00

1.3

1.4

41.04

38.49

g/l

—

Other helminthiases

0.00

-0.00

0.0

1.5

—

31.89

—

Foreign body in ear

0.96

-0.00

1.2

1.4

32.64

31.68

g/l

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.7

—

36.47

—

Maxillary prognathism

0.00

-0.00

0.0

1.4

—

34.10

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

0.96

-0.00

1.9

1.4

40.51

34.49

g/l

—

Polyp of middle ear

0.00

-0.00

0.0

1.2

—

37.44

—

Toxic encephalopathy

0.00

-0.00

0.0

1.2

—

28.24

—

Oral leukoplakia, including avohilmo

110

1.00

-0.00

1.7

1.4

34.74

31.90

g/l

0.61

Mechanical strabismus

0.00

-0.00

0.0

1.2

—

31.55

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.7

—

34.45

—

Pelvic region

0.00

-0.00

0.0

1.2

—

33.02

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.4

—

30.00

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.4

—

34.82

—

Use of bromocriptine

0.00

-0.00

0.0

1.4

—

35.33

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

28.02

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

34.44

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.1

—

30.31

—

Hypervitaminosis D

0.00

-0.00

0.0

1.2

—

20.44

—

Gender identity disorders

0.00

-0.00

0.0

1.4

—

35.56

—

Other infestations

0.88

-0.00

1.3

1.4

36.33

31.54

g/l

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

-0.00

0.0

1.5

—

26.98

—

Disorders of hypoglossal nerve

0.00

-0.00

0.0

1.2

—

26.12

—

Mumps

1.01

-0.00

1.6

1.5

36.37

31.99

g/l

—

Benign neoplasm: Vulva

1.02

-0.00

1.3

1.2

32.38

33.53

g/l

—

Carcinoma in situ of oral cavity and pharynx

0.00

-0.00

0.0

1.1

—

31.89

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.8

—

30.04

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.2

—

24.86

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.8

—

29.94

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.3

—

33.68

—

Testicular hypofunction

1.01

-0.00

1.6

31.19

33.16

g/l

—

Urethritis and urethral syndrome

0.91

-0.00

1.6

1.3

37.81

33.00

g/l

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.6

—

37.74

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS